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Abstract 
The human skin surface is covered with a lipid film that represents the actual 
interface between the viable epidermal layers and outer environment and is crucial 
for our understanding of the colonisation of bacteria. The relationship between 
staphylococci and the abundant skin lipid squalene, which comprises about 12% of 
total skin surface lipids, remains poorly understood. This study therefore aimed to 
comparatively investigate the effects of the lipid squalene upon S. aureus and S. 
epidermidis.  
Here, it was determined that culture of S. aureus with squalene dramatically 
reduced expression of staphyloxanthin, its eponymous golden pigment . Culture of 
cells with squalene lowered the survival of S. aureus, but not S. epidermidis, to both 
H2O2 and nisin, while squalene mediated enhanced survival of S. epidermidis to LL-
37, but did not alter S. aureus survival. The transcriptional response of both species 
to squalene challenge was investigated using RNA-Seq and the proteome of S. 
aureus at late exponential phase of growth with squalene was studied using 
quantitative methods. While major similarities in the response of both species to 
squalene were observed with large changes to cellular pathway gene expression,  
reduced carotenoid (crt) operon expression was shown to be mediated at the level 
of transcription.  Unexpectedly, challenge with squalene caused derepression of all 
the Fur-iron regulated uptake transporter genes in both S. aureus and S. epidermidis.  
This induction was accompanied by significantly decreased cellular iron. The means 
by which squalene causes iron starvation was not determined.  
Similar to squalene, ethanol was found to reduce pigment expression in S. aureus 
and major similarities in the crt operon and overall transcriptional profiles of 
expression  were revealed after challenge. The experimental evolution of S. aureus 
with a sub-bactericidal concentration of ethanol and selection for increased growth 
yield identified three SNPs, with one SNP potentially implicating altered cell wall 
meso-diaminopimelic acid biosynthesis in enhanced survival. This study revealed 
that squalene has potential to play a role in colonisation of staphylococci by 
decreasing pigment expression, modulating resistance to skin antimicrobials and 
through starvation for iron. The mechanistic basis for these phenomena requires 
further study. 
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Chapter 1 Introduction 
 
1.1 Staphylococcus 
The genus Staphylococcus is comprised of over forty species of Gram-positive 
cocci and are one of the most abundant colonisers of mammalian skin and 
mucosa (Cogen et al., 2008; Costello et al., 2009; Taylor et al., 2003; Nagase et al., 
2002). Due to the ubiquitous colonisation of several species on human skin and 
the wide spectrum of diseases they can cause, staphylococci have become the 
most investigated member of the skin microflora. The dominant staphylococcal 
species on skin is Staphylococcus epidermidis, which belongs to coagulase-
negative staphylococci (CoNS) grouping, and is considered part of the normal 
skin microflora that is carried by 100 % of healthy individuals (Foster, 2009; 
Roth and James, 1988). Multiple CoNS can be found across different body sites 
including S. epidermidis,  S. capitis, S. cohnii, S. haemolyticus,  S. hominis, S. 
saprophyticus, S. simulans, S. warneri and S. xylosus (Kloos and Schleifer, 1975;  
Kloos and Musselwhite, 1975; Coates et al., 2014). While CoNS are not 
considered pathogenic, people with compromised immune systems, such as 
new-borns or patients after catheter or other surgical implant surgery are at 
risk of developing infection owing to the ability of several CoNS species to  form 
biofilms that grow on these devices which can result in serious infections 
(Becker et al., 2014).  
S. aureus, in contrast, is a coagulase-positive transient skin coloniser and skin 
pathogen, which only persistently colonises 25%–30% of the human population 
in the anterior nares (Peacock et al, 2001). This species is the most notorious 
member of the staphylococci due to the broad arsenal of virulence factors it 
possesses, which enable it to invade the human body and cause a diverse range 
of infections, from mild skin and soft tissue infections such as abscesses (Archer, 
1998), to severe and life-threatening diseases such as pneumonia, bacteraemia 
and infective endocarditis (Lowy, 1998).  
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1.2 Methicillin-resistant S. aureus (MRSA) 
Methicillin is a narrow-spectrum β-lactam antibiotic of the penicillin class, 
which was discovered in 1960 to replace penicillin to treat penicillin-resistant 
organisms that had evolved and spread (Lowy, 2003; Peacock and Paterson, 
2015). However, it did not take long before reports of methicillin-resistance 
started to emerge. S. aureus was one of the first species to acquire resistance to 
methicillin, so the strains were named as methicillin-resistant S. aureus (MRSA) 
(Barber, 1961; Jevons, 1961). Horizontal gene transfer of an element, 
Staphylococcal Chromosome Cassette mec element (SCCmec) from a related 
staphylococcal species was proposed as the donor for this emergence (Peacock 
and Paterson, 2015; Wu et al., 1996). A penicillin binding protein (PBP2a/PBP2’) 
that is encoded by mecA binds methicillin with extremely low affinity (Hartman 
and Tomasz, 1984), which results in PBP2a/PBP2’ remaining functional even in 
presence of the methicillin. Therefore, possession of mecA significantly 
increased bacterial resistance to methicillin. The enzyme  is a transglycosylase 
and transpeptidase involved in peptidoglycan biosynthesis which is the primary 
target for many antibiotics (Utsui and Yokota, 1985). To date, eleven SCCmec 
elements have been identified, of which four are commonly found in S. aureus 
from patients (Shore and Coleman, 2013). 
HA-MRSA, the abbreviation for hospital-acquired MRSA, mainly infects 
immunocompromised people in hospitals such as patients with HIV, diabetes or 
after radiotherapy/ chemotherapy or those whose natural barriers are 
compromised by surgery (Enright et al., 2002). However, in the 1990s, there 
emerged MRSA strains in the community (community-associated MRSA; CA-
MRSA) capable of infecting healthy individuals who had not been in contact with 
health care facilities. CA-MRSA was considered more virulent than HA-MRSA 
but researcher revealed  that CA-MRSA did not evolve from the HA-MRSA 
(Calfee, 2011). In addition to HA-MRSA and CA-MRSA, livestock-associated 
MRSA (LA-MRSA) was observed in Korea, Brazil, Switzerland, Malaysia, India, 
Great Britain, Denmark, and China (Gopal and Divya, 2017). 
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1.3 Global regulators of S. aureus 
The ability of S. aureus to adapt to different host environments is largely owing 
to a global regulatory network, including such loci as sigB, sae, agr, sarA, rot, 
srrAB, arl, and svrA. (Arvidson and Tegmark, 2001; Bronner et al., 2004; 
Yarwood and Schlievert, 2003; Liu et al., 2016). Each of these regulators is 
involved in stress responses and control expression of virulence factors (Goerke 
et al., 2005). 
 
1.3.1 SigB 
The alternative sigma factor gene sigB encoding SigB controls the transcription 
of genes involved in stress adaptation. SigB binds to the core (subunits ββ'α2ω) 
of RNA polymerase to form the holoenzyme that initiates the transcription by 
recognition and opening of promoters as well as the initial steps in RNA 
synthesis (Paget 2015). The role of SigB in stress responses of Gram-positive 
bacteria including Bacillus subtilis, S. aureus and Listeria monocytogenes has 
been studied for decades, with the best-investigated system being that in B. 
subtilis (Hecker et al., 2007) (Fig 1.1a). The activity of SigB is regulated by a 
post-translational mechanism. The sigB operon in B. subtilis comprises rsbR, 
rsbS, rsbT, rsbU, rsbV, rsbW, sigB, and rsbX (Pané-Farré et al., 2006). RsbW binds 
with SigB to form an inactive complex under normal growth conditions, but the 
affinity of RsbW for its antagonists, SigB and RsbV, can change due to a variety 
of stresses. This change in affinity promotes the binding of RsbV to RsbW, thus 
leaving SigB free, which is then able to proceed to form holoenzyme complexes 
with core RNA polymerase (Voelker et al., 1995). However, only non-
phosphorylated RsbV is capable of competing with SigB for RsbW binding. The 
phosphorylation state of RsbV is regulated by the kinase activity of RsbW and 
the action of two phosphatases, RsbP and RsbU, under two different sources of 
stress. RsbU is active in response to physical and chemical stress, whereas RsbP 
phosphorylates RsbV under energy stress (Hecker et al., 1996; Vijay et al., 2000; 
Voelker et al., 1995).  
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With respect to S. aureus, however, only RsbU, RsbV, RsbW, and SigB are 
encoded in the staphylococcal genome (Fig 1.1a). Absence of the upstream 
rsbR–rsbS–rsbT genes and the downstream rsbX gene in S. aureus may link to 
failure of SigB activation by ethanol stress and energy uncouplers which are 
both strong inductors of SigB activity in B. subtilis (Pané-Farré et al., 2006). In S. 
aureus, SigB is activated under various conditions such as heat shock, addition 
of MnCl2 or NaCl, alkaline shock, oxidation and infection, regulated by 
phosphatase RsbU, anti-anti-SigB factor RsbV and anti-SigB factor RsbW which 
apparently have the same functions as their homologues in B. subtilis (Hecker et 
al., 2007; Voelker et al., 1995; Pané-Farré et al., 2006). 
 
1.3.2 SaeRS 
The SaeRS two-component system, which is encoded by the sae (S. aureus 
exoprotein expression) locus, was identified during characterisation of a Tn551 
mutant for its defect in the production of exoproteins including α-hemolysin, β-
hemolysin, nuclease, and coagulase (Giraudo et al., 1999). Like other typical TCS, 
the signalling cascade of the SaeRS TCS starts when SaeS, the sensor histidine 
kinase, senses cognate environmental signals and autophosphorylates at the 
conserved His131 residue. The phosphoryl group is then transferred to Asp51 
of SaeR, and the resultant SaeR-P is capable of activating the transcription of the 
target genes (Novick and Jiang, 2003; Arya and Princy, 2016). The sae operon 
comprises four genes (saeP, saeQ, saeR, and saeS) and two promoters P1 and P3 
(Fig 1.1b). The P3 promoter is located inside saeQ and only responsible for saeR 
and saeS transcription. The P3 promoter is weaker than P1, but the 
transcription of saeRS from P3 is sufficient for activation of the Sae-regulated 
genes. This was shown by deletion of the sequence upstream of P3 leading to no 
significant difference in exoprotein production (Jeong et al., 2011). The P1 
promoter located in the front of the saeP directs transcription of all four genes. 
P1 is much stronger than P3 and is autoinduced by the SaeRS TCS (Novick and 
Jiang, 2003; Steinhuber et al., 2003). Induction of P1 will elevate the protein 
level of SaeRS, but the increase of SaeRS is not expected to further increase the 
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activity of the SaeRS TCS because overexpression of saeRS does not alter the 
expression pattern of the Sae-regulon (Mainiero et al., 2010). The functions of 
SaeP and SaeQ, whose encoding genes locate upstream of saeRS, are still not 
fully understood since neither shows significant homology to proteins of known 
functions. Although SaePQ are dispensable for the activation of the Sae system, 
they are essential to induce the phosphatase activity of SaeS by forming a 
SaePQS ternary complex to dephosphorylate SaeR-P facilitating resetting the 
activated systems to the pre-activation state (Jeong et al., 2012).  
To date, there are three SaeS variants identified: SaeSP, SaeSSK, and SaeSSKT (Liu 
et al., 2016). SaeSP that has a L18P substitution mutation in the first 
transmembrane helix was firstly identified in the strain Newman (Steinhuber et 
al., 2003). This polymorphism results in increased activity of kinase SaeS, and 
leading to constant expression of the auxiliary proteins SaeP and SaeQ in 
Newman strain (Sun et al., 2010; Liu et al., 2016). SaeSSK is found in the strain 
MW2, Mu50 and USA600, but this variant does not show altered enzymatic 
activity of SaeS (Olson et al., 2013). SaeSSKT is a variant of SaeSSK with one more 
amino acid substitution at the C-terminus. This variant, however, alters the time 
of SaeRS being maximally expressed. The activity of the Sae system with SaeSSKT 
is highest in the exponential growth phase and reduced in the stationary growth 
phase, while the activity of normal SaeRS reaches maximum in post-exponential 
phase (Ramundo et al., 2016). The SaeSSKT was reported in ST30 and ST36 
lineages of S. aureus (Ramundo et al., 2016). 
Sae TCS can be activated by human neutrophil peptide 1, 2, and 3 (HNP1-3), 
calprotectin, which comprises approximately 50% of neutrophil cytoplasmic 
proteins and hydrogen peroxide, but also inhibited by: silkworm apolipophorin 
protein, which is known to reduce the transcription of the hemolysin genes; 
acidic conditions (pH  5.5); and high NaCl concentrations ( 1M) (Geiger et al., 
2008; Foell et al., 2006; Kehl-Fie et al., 2011; Hanada et al., 2011; Weinrick et al., 
2004). Moreover, human skin fatty acid cis-6-hexadecenoic acid was reported to 
repress the Sae system in S. aureus, although the mechanism is not known 
(Neumann et al., 2015). 
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1.3.3 Agr 
The quorum-sensing system in S. aureus is required for the ability to colonise 
various niches within the host and cause diverse infections. This system enables 
cell-to-cell communication and regulation of a large arsenal of virulence factors 
(Yarwood, 2003). The staphylococcal accessory gene regulator (agr) quorum-
sensing system is one of the best characterised quorum-sensing systems, which 
down-regulates the expression of several surface proteins and up-regulates the 
expression of a large number of secreted virulence factors in the transition from 
late-exponential growth to stationary phase (Vuong et al., 2000; Novick, 2003). 
Inactivation of agr was found to impair staphylococcal pathogenesis in several 
infection models, including rabbit endocarditis (Cheung et al., 1994) and murine 
subcutaneous abscesses and arthritis (Bunce et al., 1992; Abdelnour et al., 
1993).  
RNAII and RNAIII are two primary transcripts expressed by the agr locus from 
the P2 and P3 promoters, respectively (Yarwood, 2003) (Fig 1.1c). AgrD is the 
precursor of the autoinducer in the agr system, processed into an octapeptide 
and secreted as the autoinducing peptide (AIP) signal by AgrB. AgrA and AgrC 
form a two-component system where the transmembrane component AgrC 
(histidine kinase), senses and binds the extracellular AIP, leading to AgrC 
autophosphorylation and activation of AgrA (the response regulator) (Novick 
and Geisinger, 2008). With increasing concentration of the AIP in the medium, 
AgrA induces increased P2 and P3 transcription, leading to up-regulation of 
down-stream genes including those encoding virulence factors such as protein A, 
α-hemolysin, adhesins, capsule, toxins, proteases, phenol soluble modulins and 
genes associated with biofilm formation (Novick and Geisinger, 2008). 
The interactions between staphylococcal global regulators were revealed by 
many studies. For example, SigB was reported to down-regulate the 
transcription of the sae operon through the P1 promoter as well as other Sae 
regulon genes, such as hla, hlgABC, nuc, and splABCDEF (Bischoff et al., 2004). 
But this interaction was not observed in a study on device-related infection of S. 
aureus (Goerke et al., 2005). In addition, it was proposed that the Sae TCS is 
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downstream of Agr in the exoprotein production pathway, since the activity of 
saeP1 promoter was decreased in Δagr strain, leading to a reduced expression 
level of saeSR (Novick and Jiang, 2003; Giraudo et al., 1999; Geiger et al., 2008). 
These effects, combined with the requirement of RNAIII for sae transcription 
from saeP1 (Novick and Jiang, 2003), suggest a positive regulation Sae by Agr. 
However, other experiments suggest that Agr and Sae are independent of one 
another, because some target genes are regulated by Agr and Sae in an opposite 
pattern. For example, the Sae regulon genes, such as hlgA, hlgB, hlgC, and lukA 
were still highly expressed in an agr mutant during murine skin infection of the 
USA300 strain (Zurek et al., 2014). 
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(a) 
 
(b) 
(c) 
 
Figure 1.1 The sigB (a), sae (b) and agr operons (c) in S. aureus. (a) Comparison of sigB 
operon structures in B. subtilis and S. aureus. The level of amino acid conservation is shown for 
SigB and regulators present in both species. (b) Organization of the sae operon. Two angled 
arrows represent the P1 and P3 promoters, respectively. (c) The P2 operon encodes (via RNAII) 
the signalling mechanism, whereas the transcript of the P3 operon, RNAIII, acts as the 
riboregulator effector molecule of the agr locus.  
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1.4 The structure of human skin 
Human skin is the largest organ of the integumentary system, which provides a 
variety of functions including maintenance of body temperature, prevention of 
excessive water loss, recognition of the outer environment, defence against 
microorganisms and protection from harmful materials in the external 
environment (Lee et al., 2006). The skin consists of layers of cells whose 
differentiation originates from migration towards the outermost layer. From 
innermost layer outwards, these layers are termed the basal (stratum basale), 
spinous (stratum spinosum), granular (stratum granulosum) and stratified 
(stratum corneum) (Candi et al., 2005; Proksch et al., 2008) (Fig 1.2). The 
keratinocyte cells in the basal layer are proliferative and function to generate 
new skin cells. In fact, every skin cell is completely replaced every 14 days that 
is more or less influenced by different metabolism rates of each individual 
(Candi et al., 2005; Roth and James, 1988). There are representative lamellar 
granules or Odland bodies in the granular layer keratinocytes. These small 
organelles consist of a collection of lipids including glucosylceramides, 
cholesterol, phospholipids and various enzymes such as acid hydrolases (Candi 
et al., 2005). 
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Figure 1.2 Structure of the skin  
(Coates et al., 2014)  
 
The major differentiation of keratinocytes occurs during cells immigrating from 
the granular layer to the stratum corneum and is accompanied with extrusion of 
the lamellar granules (Candi et al., 2005). As a result, considerable quantities of 
phospholipids and glucosylceramides are released from the lamellar granules 
followed by their hydrolysis into ceramides and free fatty acids (Madison, 2003; 
Drake et al., 2008). During this process, tight bundles are formed due to binding 
of keratin and fillagrin, leading to flattening of the keratinocytes (Candi et al., 
2005). Cornified envelope is formed beneath the plasma membrane, which is a 
protein layer self-associated by isopeptide bonds. The bonds are so tight as to 
make this layer resistant to common proteolytic enzymes (Proksch et al., 2008). 
In addition, this cornified envelope is also linked to a lipid envelope, which 
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contains ω-hydroxyceramides, due to covalent bonds (Proksch et al., 2008; 
Candi et al., 2005; Madison, 2003). Finally, the plasma membrane is replaced by 
the lipid envelope and the cell’s organelles are also lysed after apoptosis, leading 
to completion of differentiation, and these resultant cells are known as cornified 
cells or corneocytes (Candi et al., 2005).   
 
1.5 Skin surface lipids (SSLs) 
Corneocytes are covered with a lipid film that represents the actual interface 
between the viable epidermal layers and outer environment. This lipid layer 
plays a crucial role in our understanding of the colonisation of bacteria. Skin 
surface lipids (SSLs) are a mixture of mostly sebaceous lipids plus epidermal 
lipids, displaying a unique composition as compared with lipid fractions of other 
organs (Fig 1.3) (Pappas, 2009). This specificity originates from the unique 
contribution of sebum secreted from the sebaceous glands, unevenly distributed 
in all areas of the body with the exception of the palms and foot soles (De Luca & 
Valacchi, 2010). The major lipid components in human sebum include squalene, 
wax esters, and triglycerides (Nicolaides, 1974). Within this mixture there are 
multiple antimicrobial molecules including the fatty acid, sapienic acid and 
antimicrobial peptides (Pappas, 2009; Smith & Thiboutot, 2008).  
The epidermal lipids (Fig 1.3a) mainly play a role as a barrier obstructing the 
movement of electrolytes and water. This blocking effect is achieved by the 
presence of three equal proportions of ceramides, cholesterol and free fatty 
acids, originating from the lamellar bodies (Pappas, 2009). Studies revealed that 
the biosynthesis of ceramides, fatty acids and cholesterol in epidermis is very 
active. Disruption of the skin barrier leads to a significant enhancement in 
cholesterol and fatty acids synthesis. This is further confirmed by inhibition of 
these pathways resulting in delayed recovery of the barrier function (Elias et al., 
1992; Bouwstra et al., 1998).  
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(a) Epidermal lipids 
  
 
(b) Sebaceous lipids  
 
Figure 1.3 Representative structures and proportion of skin surface lipids. 
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Several unique ceramide species that are only found in the epidermal surface 
lipids but not at any other cell type were also identified and these molecules are 
believed to most importantly contribute to the skin barrier properties 
(Vasireddy et al., 2007). These lipids include the fatty acids esterified to the 
amide of the sphingosine head group, especially long chain fatty acids such as 
linoleic acid, palmitoleic acid, palmitic acid, stearic acid and oleic acid (Pappas, 
2009; Kenny et al., 2009). 
The sebaceous lipids are complex and unique (Fig 1.3b). The composition of 
human sebum is significantly different in quality and quantity from sebum of 
other species (Nicolaides and Ansari, 1968;  Stewart and Downing, 1991). 
Although the reason for this distinction is not clear, it is believed to be 
associated with the unique texture of human skin. Formation of acne, for 
example, is potential evidence for that theory as acne is unique to humans. 
Elevated sebum level plays a major role in pathophysiology of acne, suggesting 
that the unique human sebaceous lipids are closely related to this specific 
disease (Ayer and Burrows, 2006; Thiboutot, 2004; Zouboulis, 2004). 
Sapienic acid (16:1, Δ6) is the predominant fatty acid of human sebum. It 
consists of a double bond at the sixth position from the carboxyl end (Nicolaides, 
1974). As a truly unique fatty acid in sebum, sapienic acid is not obtained from 
the diet and cannot be found anywhere else in the human body (Nicolaides, 
1974). In addition, sapienic acid has high antimicrobial activity and can inhibit 
virulence determinant production (Neumann et al., 2014). 
Wax esters account for approximately 25 % of the sebaceous gland lipids and 
are also only produced in sebaceous glands but not found in any other areas of 
the body (Pappas, 2009). Wax esters play an essential role in barrier function; 
they are more resistant to oxidisation and hydrolysis than triglycerides or 
phospholipids and have higher resistance to heat (Pappas, 2009). In addition to 
their barrier function, wax esters also serve as a lubricant, preventing the 
internal moisture of tissues from excessive hydration (Pappas, 2009). 
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1.6 Squalene 
Squalene is an intriguing component of the skin surface lipids, being the 
precursor of cholesterol biosynthesis. Cholesterol is synthesised in most 
mammalian cells and is an essential molecule for membrane fluidity and 
structure (Pappas, 2009). Squalene is a unsaturated C30 hydrocarbon, which is 
quickly converted to lanosterol prior to cholesterol in most tissues. Intriguingly, 
as a component of the skin surface lipids, squalene produced in the sebaceous 
gland is not converted into lanosterol, which halts the biosynthesis of 
cholesterol (Picardo et al., 2009). The accumulation of this lipid is negligible in 
other organs of the human body and the reason for that is still unclear.  In 
humans, the greatest accumulation of squalene is in skin, where in an adult it 
normally comprises about 12% of total skin surface lipids and reach up to 60 
ug/cm2 (Pappas, 2009). A variety of roles are proposed for squalene such as 
maintaining skin moisture and acting as antioxidant (Spanova & Daum, 2011). 
In humans, squalene is synthesised via squalene synthase (hSQS), and its further 
metabolism is catalysed by squalene epoxidase and squalene monooxygenase. It 
was proposed that the relative activity of these enzymes is responsible for the 
accumulation of squalene in sebaceous cells (Pappas, 2009). 
Although significant efforts have been put into investigating the interaction 
between human skin surface components and staphylococci, especially 
antimicrobial peptides and the antimicrobial lipid sapienic acid, the effects of 
squalene on staphylococci remain poorly understood. In fact, there are very few 
studies investigating the relationship between squalene and microorganisms 
which likely correlates with squalene having no described antimicrobial 
properties. 
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1.7 Staphylococcal skin survival 
 Conditions on the human skin are extremely harsh for microbes with its low pH 
but high salt environment, along with the dry and nutrient-deficient surface, 
which all ensure that microbial reproduction is inhibited or at least largely 
restricted (Coates et al., 2014; Skaar, 2010). However, on the other hand, 
successful human skin colonisers, such as certain species of staphylococci, must 
have evolved essential mechanisms to conquer these barriers. This includes 
mechanisms for adhesion to the skin, evasion of components of the innate 
immune system, and gain of advantages during competition with other 
microbes (Cogen et al., 2008; Coates et al., 2014). Those factors are crucial for 
bacterial survival and persistence on human skin and are believed to be the 
causes for differential abilities for colonisation between S. aureus and S. 
epidermidis (McEwan et al., 2006; Cho et al., 2001; Melnik, 2006; Ong et al., 2002; 
Arikawa et al., 2002; Takigawa et al., 2005; Ishikawa et al., 2010).  
 
1.7.1 Adhesion 
Adhesion to the skin is the primary ability possessed by bacterial colonisers to 
attach so they are not pulled away by sheer forces and also ensures they can re-
adhere to the new layers before the cells are lost through desquamation every 
14 days (Candi et al., 2005). Bacteria produce adhesins that specifically target 
the receptors on the skin, resulting in a strong attachment to prevent loss. 
Although bacteria are found at both upper and lower layers of the stratum 
corneum, it is still unclear which method is better for bacterial long-term 
survival on the skin (Brooker and Fuller, 1984; Zeeuwen et al., 2012; Grice et al., 
2009).  
There are three groups of staphylococcal adhesins, microbial surface 
components recognising adhesive matrix molecules (MSCRAMMs), secretable 
expanded repertoire adhesive molecules (SERAMs), and non-proteinaceous 
adhesins (Heilmann, 2011). MSCRAMMs which are anchored to the 
staphylococcal cell wall are capable to recognise and bind to host skin factors. 
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Unlike MSCRAMMs which covalently bind to bacterial cell wall, SERAMs bind to 
the staphylococcal surface non-covalently. As well as having adhesive functions, 
SERAMs frequently have enzymatic functions such as Aae found in S. epidermidis, 
which is an autolysin with adhesive properties (Heilmann et al., 2003; Bowden 
et al., 2002). Non-proteinaceous adhesins comprise the polysaccharide PIA 
(polysaccharide intercellular adhesin) and wall teichoic acids plus lipoteichoic 
acids that are usually embedded in the membrane lipids and bind to target 
through non-covalent bonds (Heilmann, 2011). The staphylococcal adhesins 
with known receptors for human skin were summarised by Coates el al (2014). 
MSCRAMMs are the best-studied group of staphylococcal adhesins. The genome 
of S. aureus encodes 20 MSCRAMMs that enable the bacteria to colonise multiple 
niches, from anterior nares to implanted medical devices and prostheses 
(Coates et al., 2014; Mulcahy et al., 2012). Contrastingly, coagulase-negative 
staphylococci are considered to have a reduced arsenal of adhesins in their 
genome, with 12 MSCRAMMs encoded by S. epidermidis. Besides S. aureus and S. 
epidermidis, however, the MSCRAMMs in other staphylococci is poorly 
understood. In the next best studied species, the genome of S. saprophyticus only 
has three genes (sdrI, uafB and aas) encoding adhesive functions (Sakinç et al., 
2009; King et al., 2011; Hell et al., 1998). To date, the genomes of S. caprae and S. 
lugdunensis were also found to contain genes encoding adhesins (Coates et al., 
2014).     
 
1.7.2 Osmotic stress resistance 
Osmotic stress is another limiting factor for bacterial growth and survival on 
skin. Differences in either the relative ionic concentration or relative humidity 
(RH) can cause osmotic stress (Potts, 1994). Environmental conditions of the 
skin are usually low RH but high ionic concentration, such that bacterial cells 
without specific coping solutions will easily lose their function due to 
dehydration. Moreover, skin bacteria also encounter hyperosmotic stress 
caused by sudden increases of water by increased sweating or washing.    
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The primary methods of S. aureus and S. epidermidis to survive low osmotic 
pressure when RH levels approach their growth limit are to thicken their cell 
walls, enlarge their cell size and form cuboidal packs of eight cells rather than 
typical grape-like clusters (de Goffau et al., 2009, 2011). These phenomena are 
proposed to be associated with autolysis, as similar  changes were observed in 
staphylococcal autolysin mutants (de Goffau et al., 2011). As a consequence of 
alterations in morphology, the ratio of cell surface area to volume is reduced 
that may subsequently lead to reduction of water loss and maintenance of 
turgor pressure (de Goffau et al., 2011). In addition, staphylococci grown at low 
RH were found to be more hydrophilic, which may help water acquisition (de 
Goffau et al., 2011).  
Exopolysaccharide (EPS) or polysaccharide intracellular adhesin (PIA) is a cell 
wall-located macromolecule implicated in osmotic stress tolerance in 
staphylococci (McKenney et al., 1998). Study of Pseudomonas spp. revealed that 
production of EPS mitigates desiccation by acting as a buffer to slow the drying 
rate of the bacteria thus offering more time to adjust to the changing 
environment (Roberson and Firestone, 1992). Intriguingly, EPS could also 
provide similar protection upon wetting, avoiding too rapid a rehydration 
occurring (Roberson and Firestone, 1992). Similar mechanisms may also apply 
with regard PIA of staphylococci on human skin as with EPS of Pseudomonas spp. 
isolated from soil. 
A capsule of poly-γ-glutamic acid (PGA) plays an essential role in protection of S. 
epidermidis from high NaCl concentrations (2 M) (Kocianova et al., 2005). PGA 
biosynthesis genes and their homologues (pgsBCAD/capBCAD) are widely 
distributed in coagulase-negative staphylococci including S. hominis, S. capitis, S. 
haemolyticus, S. caprae, and S. warneri, but with exception of coagulase-positive 
S. aureus (Kocianova et al., 2005). 
A factor observed in various bacteria that is associated with mediation of 
osmotic stress responses is the biosynthesis of cardiolipin (CL). Increased 
salinity is often accompanied by a decrease in the amount of membrane CL and 
other zwitterionic phospholipids in both Gram-positive and Gram-negative 
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bacteria (Romantsov et al., 2009). For example, the level of CL synthase was 
shown to elevate in response to ionic stress in E. coli (Romantsov et al., 2009). 
However, levels of CL were not observed to significantly increase in S. aureus 
with higher concentration of NaCl, though mutation of CL synthase genes 
resulted in reduced long-term survival in high salinity media (Tsai et al., 2011). 
CL is considered to improve membrane tightness, hence it may contribute to 
reducing membrane permeability (Nagamachi et al., 1992).  
Ebh (extracellular matrix-binding protein homologue) which is only found in S. 
aureus and S. epidermidis and absent from S. haemolyticus and S. saprophyticus is 
a cell wall and membrane-associated protein. Invaginated vacuoles along their 
septum were observed within 30 min when ebh mutants were exposed to high 
salt conditions, suggesting that this protein contributes to initial ionic stress  
resistance (Kuroda et al., 2008 ). 
Importation of osmoprotectants is a common resistance mechanism employed 
by bacteria counteracting ionic stress (Potts, 1994). L-proline, proline betaine 
and glycine betaine all offered protection to S. aureus at 1 M NaCl where L-
proline had lowest and proline betaine the highest effects in the majority of S. 
aureus strains tested (Amin et al., 1995). Proline betaine and glycine betaine 
also offered maximal protection in S. saprophyticus and S. epidermidis (Amin et 
al., 1995).  
 
1.7.3 Acid resistance 
The acid surface of the skin facilitates innate defence by preventing microbial 
colonisation, particularly against Gram-negative bacteria due to their relatively 
more rigid cell wall by the cross-linked peptidoglycan chains (Matousek and 
Campbell, 2002). There is a gradient of acidity across the skin layers, decreasing 
from the pH of 7.4 in the stratum granulosum to pH of 4-5 at the skin surface 
(Rippke et al., 2002; Matousek and Campbell, 2002; Schmid-Wendtner and 
Korting, 2006). In addition to the direct effect of acid against microbes, such as 
damaging proteins and DNA by denaturation, acid is also revealed to enhance 
the activity of cationic AMPs and antimicrobial fatty acids (Walkenhorst et al., 
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2013; Cartron et al., 2014). The surface of human skin is more acidic than most 
other mammals. This feature is believed as an important reason for different 
microflora between human and animal skin (Matousek and Campbell, 2002).   
As well as an antimicrobial role, the acid gradient is essential for the activity of 
skin enzymes, such as regulation of β-glucocerebrosidase and serine proteases 
(Rippke et al., 2002; Schmid-Wendtner and Korting, 2006). These two enzymes 
are regulated dependent on their location within the stratum corneum, dictated 
by the pH, and this regulation ensures timely differentiation and desquamation 
of keratinocytes (Matousek and Campbell, 2002; Schmid-Wendtner and Korting, 
2006). Therefore, alteration of skin pH is usually a pathogenic factor causing 
irregular skin differentiation and desquamation, resulting in skin diseases such 
as atopic dermatitis and ichthyosis (Rippke et al., 2002; Matousek and Campbell, 
2002; Schmid-Wendtner and Korting, 2006).   
 
The acidic gradient in skin is developed by  numerous components including 
free amino acids and lactic acid from sweat, free fatty acids from sebum, 
urocanic acid and pyrrolidone carboxylic acid produced by filaggrin degradation, 
and cholesterol sulphate (Rippke et al., 2002, Matousek and Campbell, 2002). 
The concentration of most of these components increase towards the skin 
surface, whilst the only exception is cholesterol sulphate, which presents in 
higher levels towards the stratum granulosum (Rippke et al., 2002). In order to 
stabilise the skin pH, alkaline molecules such as carbon dioxide, ammonia, and 
bicarbonate are also produced in the skin to act as buffer, preventing pH from 
rapid change (Matousek and Campbell, 2002). 
Three mechanisms are usually employed by Gram-positive bacteria against acid 
stress: DNA and protein damage repair; increasing internal pH; and changing 
the cell envelope architecture (Cotter and Hill, 2003).  F1F0-ATPase is a well-
studied proton pump that mediates acid resistance by generating a proton 
motive force (PMF), leading to an increase in intracellular pH as protons are 
extruded in a ATP-fuelled process (Cotter and Hill, 2003). A similar mechanism 
is also conducted by glutamate decarboxylases, which can increase internal pH 
by exporting the proton combined with glutamate (Cotter and Hill, 2003). In S. 
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aureus, NADH dehydrogenase is believed to play a more important role than 
F1F0-ATPase in acid resistance, which moves 2H+ out of the cell, whilst 
converting NADH to NAD+ (Bore  et al., 2007). Moreover, the proteins encoded 
by the dlt operon were implicated in acid resistance as they were shown to 
reduce proton permeability in Streptococcus mutans (Cotter and Hill, 2003). 
However, no such effect of the dlt operon has been reported in S. aureus (Bore et 
al., 2007).   
Ammonia production is also involved in acid resistance in Gram-positive 
bacteria whereby ammonia binds hydrogen ions to form NH4+, resulting in 
elevation of internal pH (Cotter and Hill, 2003). Ammonia is produced via the 
activity of ureases, which convert arginine to ornithine, ammonia and carbon 
dioxide (Cotter and Hill, 2003). During acid shock, the expression of urease 
genes but not arginine deiminase genes was observed to be up-regulated in S. 
aureus, suggesting an acid resistant function of ureases (Bore et al., 2007).  
Osmotic stress resistance and acid stress resistance may link together as it was 
shown that osmoprotectant transporters were up-regulated following acid 
stress in S. aureus (Bore et al., 2007). The production of CL, which plays an 
important role in osmotic stress resistance, was altered under acid stress to 
support this theory (Ohniwa et al., 2013).  
  
1.7.4 Antimicrobial peptides and proteins resistance 
Human skin secretes a variety of antimicrobial peptides (AMPs) and 
antimicrobial proteins including cathelicidin, human beta defensins (hBD2, 
hBD3), psoriasin, dermcidin 1, RNase 7 and lysozyme (Cho et al., 2010; 
Niyonsaba and Ogawa, 2005). Cathelicidin LL-37 is expressed in the eccrine 
glands and stored in lamellar granules, with antimicrobial activity against Gram-
positive and Gram-negative bacteria and is effective to kill the yeast Candida 
albicans (Schroder and Harder, 2006). So far, LL-37 is the only AMP produced 
by humans that belongs to the cathelicidin category. The mode of action of LL-
37 is interference with biosynthesis of peptidoglycan, causing loss of turgor 
pressure and eventually inhibition of cell growth (Barns and Weisshaar, 2013). 
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The human beta defensins (hBD) hBD2 and hBD3 are produced by neutrophils 
and exhibit antimicrobial activity against Group A Streptococcus (GAS), S. aureus 
and certain viruses (Cho et al., 2010). Production of hBD2 is mainly performed 
in lamellar bodies, while hBD3 is found in tissues throughout the body 
(Schroder and Harder, 2006). 
Psoriasin was found to be effective against E. coli, and may also be involved in 
wound healing due to its function of promoting host cell growth (Glaser et al., 
2005, Shubbar et al., 2012; Anderson et al., 2009). However, overproduction of 
psoriasin is often considered as a risk factor as it may cause psoriasis and 
growth of certain cancers (Shubbar et al., 2012, Anderson et al., 2009).  
RNase 7 is highly bactericidal to E. coli, S. aureus and enterococci (Simanski et al., 
2012; Schroder and Harder, 2006). RNase7 binds to the bacterial membrane 
making it more permeable by action of clustered lysine residues, which can 
result in formation of pores and disruption of bacterial membrane (Huang et al., 
2007). 
Dermcidin 1 is produced by the eccrine glands and exhibits antimicrobial 
activity effects against S. aureus, E. faecalis, E. coli and C. albicans (Schroder and 
Harder, 2006). Dermcidin 1 inhibits bacterial biosynthesis of RNA and protein, 
which is proposed through ion channel formation (Song et al., 2013; Senyurek et 
al., 2009; Rieg et al., 2005). 
Lysozyme that is secreted from apocrine glands is a peptidoglycan N-
acetylmuramide glycanhydrolase (muramidase) that forms part of the innate 
immune system (Niyonsaba and Ogawa, 2005). The enzyme is active against 
Gram-positive cell walls by hydrolysis of 1,4-β-linkages between N-
acetylmuramic acid and N-acetyl-D-glucosamine residues in peptidoglycan. 
Hydrolysis of peptidoglycan which is the main component of Gram-positive cell 
wall compromises cell wall integrity, eventually resulting in cell lysis 
(Niyonsaba and Ogawa, 2005). 
 
MprF and DltABCD proteins were revealed to contribute to staphylococcal 
resistance to CAMPs, including cathelicidin LL-37 and defensins (Peschel et al., 
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1999). These secreted proteins share a collective mechanism against CAMPs by 
increasing the net charge of the bacterial cell surface to mitigate electrostatic 
interactions with the CAMPs. Dlt proteins achieve this by mediating the addition 
of D-alanine to wall teichoic acid, while MprF modifies anionic phospholipids 
with L-lysine and translocates the resulting lysyl-phosphatidylglycerol to the 
outer membrane (Ernst and Peschel, 2011; Peschel et al., 2001). A similar 
protective surface effect was observed from PGA, where biosynthesis mutants 
had increased susceptibility to LL-37 and hBD3, which implicated the 
exopolysaccharide PGA biosynthesis in mitigating interaction of AMPs with the 
cell membrane (Kocianova et al., 2005).  
GraRS plays a crucial role in staphylococcal resistance to CAMPs. The two-
component system is activated when the bacteria sense intra-membrane 
presence of CAMPs (Yang et al., 2012). GraRS regulates over 200 genes 
including the dlt operon (Herbert et al., 2007). Gene mutation of graRS 
increased the susceptibility of staphylococci to CAMPs and attenuated S. aureus 
virulence in a mouse infection model (Kraus et al., 2008; Herbert et al., 2007; 
Yang et al., 2012). The vraFG genes which encode an ABC efflux pump, are co-
transcribed with graRS. Mutation of vraG results in increased sensitivity to 
cationic peptides and VraG was also shown to facilitate AMP resistance (Yang et 
al., 2012). 
Proteases are a widespread method to defend against AMPs in staphylococci 
(Lai et al., 2007). It was observed in S. epidermidis that production of proteases 
was induced by challenge with AMPs (Lai et al., 2007) and the protease SepA 
efficiently inactivates the anionic AMP dermcidin under the control of sarA, agr 
and saeRS (Lai et al., 2007). A similar induction of extracellular proteases was 
also characterised in S. aureus. It was revealed that S. aureus metalloprotease 
aureolysin disables the human LL-37, which contributes to skin persistence and 
causing infections by interfering phagocytosis due to complement inhibition 
(Coates et al., 2014).  
Although lysozyme broadly exhibits activity against Gram-positive bacteria, the 
majority of staphylococci are lysozyme resistant. The counteracting activity is 
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primarily attributed to OatA, which modifies cell wall muramic acid residues by 
O-acetylation thus dramatically weakening the interaction between lysozyme 
and peptidoglycan (Bera et al., 2005). Similarly, TagO directs O-linkage to 
MurNAc of wall teichoic acid (WTA), which sterically interferes with the activity 
of lysozyme (Bera et al., 2007). 
There is also a potent mechanism against CAMPs only equipped by S. aureus but 
not S. epidermidis. The polar carotenoid staphyloxanthin modulates the fluidity 
properties of the lipid membranes and such fluidity characteristics are critical 
to the interaction of membrane-targeting host defence CAMPs with S. aureus 
(Mishra et al., 2011). 
 
1.7.5 Resistance to antimicrobial lipids 
Antimicrobial lipids are an important antimicrobial component of skin surface 
lipids. These lipids include antimicrobial fatty acids (AFAs) and sphingoid bases 
such as sphingosine. They are produced from ceramides, phospholipids, and 
glucosylceramides and released from lamellar granules (Drake et al., 2008; van 
Smeden et al., 2014). In addition to lamellar granules, the hydrolysis of 
triglycerides and bi-glycerides in sebum also produces some AFAs (Kohler et al., 
2009; Madison, 2003; Drake et al., 2008). AFAs more efficiently inhibit 
staphylococcal and micrococcal species, while sphingosines are widely active 
against not only bacteria but also fungi (Drake et al., 2008; Desbois and Smith, 
2010). Besides their antimicrobial functions, AFAs and sphingosines also play 
barrier roles as discussed in section 1.4.      
The primary resistance mechanism against antimicrobial lipids employed by 
staphylococci is the alternation of surface hydrophobicity, thus decreasing the 
ability of antimicrobial lipids to interact with the cell (Kohler et al., 2009). This 
can be achieved by production of WTA and IsdA that increase bacterial surface 
hydrophilicity, and also by thickening of the cell wall that further decreases the 
overall surface hydrophobicity, as indicated by gene expression profile in 
response to AFA challenge (Kenny et al., 2009).  
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Observation of the positive relationship between the level of pigmentation and 
the resistance to AFAs in S. aureus suggested carotenoid biosynthesis would be 
another mechanism for AFAs resistance. S. aureus strains with higher levels of 
carotenoid have greater resistance to AFAs, and carotenoid production is 
increased in response to AFAs (Chamberlain et al., 1991; Kenny et al., 2009). 
The proposed mechanism of carotenoids in AFAs resistance is the same with 
that in CAMPs resistance, which act as a membrane stiffener to reduce 
membrane fluidity (Chamberlain et al., 1991; Mishra et al., 2011). For those 
staphylococcal species that do not produce pigment, other factors such as 
cardiolipin and host-derived cholesterol are believed to have similar membrane 
reinforcement functions (Romantsov et al., 2009). 
FAME (fatty acid modifying enzyme) is an enzyme specifically targeting AFAs to 
confer resistance upon S. aureus and S. epidermidis (Chamberlain and 
Brueggemann, 1997). This exoprotein esterifies lipids with cholesterol or 
primary alcohols. Those modifications usually lead to impairment of the toxicity 
of AFAs (Chamberlain and Brueggemann, 1997; Kapral et al., 1992). FAME is 
inhibited by diglycerides and triglycerides, and hydrolysis of triglycerides and 
diglycerides conducted by lipases produces free fatty acids that FAME can act 
upon, which may explain the reason for existing strong correlation between 
FAME and lipase production in staphylococci (Long et al., 1992, Lu et al., 2012).  
The gene encoding FAME remains unidentified. 
Several cell wall anchored proteins in staphylococci were proposed to provide 
protection against AFAs, such as the S. aureus surface protein F (SasF), the S. 
saprophyticus surface protein F (SssF), and  the homologues found in other 
staphylococcal species (King et al., 2012). These proteins all belong to the 
myosin-cross reactive antigen (McrA) family (King et al., 2012). Mutation in 
SasF was shown to confer reduced survival upon exposure to linoleic acid, and 
this defect was recovered by complementation of SasF and also SssF (Kenny et 
al., 2009, King et al., 2012). S. saprophyticus clinical strains with sssF gene 
exhibited greater resistance to linoleic acid than those without (King et al., 
2012). These proteins are speculated to act as fatty acid hydratases, whose 
function is to saturate the fatty acid to form less-toxic derivatives such as 
25 
 
linoleic acid to oleic acid and stearic acid to mysteric acid (King et al., 2012; 
Campbell et al., 1983).  
The arginine catabolic mobile element (ACME) was predicted to improve 
survival of S. aureus on the skin in CA-MRSA isolates (Diep et al., 2006), which 
was supported by observation of genes encoding arginine deaminase pathway 
enzymes (such as arcABDC operon) being up-regulated in response to AFAs 
(Kenny et al., 2013).  
The ABC transporter permease VraE in S. aureus was also suggested to associate 
with staphylococcal AFAs resistance (Kenny et al., 2009). Mutation of vraE in S. 
aureus resulted in decreased survival in the presence of linoleic acid (Kenny et 
al., 2009). Export of AFAs from the bacterial cell was identified in meningococci, 
conducted by specific fatty acid efflux pumps (Schielke et al., 2010), which was 
also indicated to be present in staphylococci (Truong-Bolduc et al., 2014). 
FarRE (fatty acid resistance regulator and effector), which belongs to the 
multidrug pumps superfamily was identified as the exporter pump facilitates 
resistance to linoleic acid and arachidonic acid (Alnaseri et al., 2015). Treatment 
with linoleic and arachidonic acid strongly induce expression of farE in an farR-
dependent manner, and inactivation of farE resulted in significant increased 
susceptibility of S. aureus to linoleic and arachidonic acid (Alnaseri et al., 2015). 
 
1.7.6 Competition on human skin 
Many microbial colonisers share the same niches in the human body. For 
example, S. aureus, S. epidermidis, S.haemolyticus, Finegoldia magna, 
Corynebacterium accolens, S. hominis, and Micrococcus sp. all colonise the nasal 
cavity (Libberton et al., 2014; Wos-Oxley et al.,  2010; Iwase et al., 2010). In 
these areas, competition usually occurs such as inhibition of staphylococci by 
corynebacteria (Frank et al., 2010; Libberton et al., 2014). Moreover, 
bacteriophages also participate in the competition, with some of these capable 
of infecting particular or multiple species on the skin, also increasing the 
survival stress of staphylococcal colonisers (Aswani et al., 2011). 
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There are three well-studied mechanisms of resistance to competition 
possessed by bacteria and yeasts: limiting other’s colonisation via competitive 
interference by adhering to a range of receptors; developing resistance to 
competitor antimicrobials; and producing compounds to inhibit competitors’ 
growth (Cogen et al., 2010). A range of bacteriocins are produced by 
staphylococci, which are effective against GAS, group B Streptococcus, 
Lactobacillus spp., Enterococcus faecalis, Micrococcus luteus, Corynebacterium 
fimi and other staphylococci (Cogen et al., 2010; Gamon et al., 1999; Potter et al., 
2014). In addition, phenol-soluble modulins (PSMs) which are a group of 
amphipathic α-helical proteins, are produced by staphylococci to perform a 
range of tasks, from haemolysins (δ-toxin) to biofilm dissemination (Periasamy 
et al., 2012). The δ and γ PSMs of S. epidermidis also exhibit activity against S. 
aureus (Cogen et al., 2010).    
S. epidermidis is able to stimulate production of human defensins from the host 
such as hBD2 and hBD3, that are not active against itself but efficient in killing 
of other species, including S. aureus (Lai et al., 2010; Iwase et al., 2010). 
Secretion of Esp by S. epidermidis is an example. Esp which is a serine protease 
can disrupt biofilm formation, and can also trigger hBD2 expression to act 
against S. aureus (Iwase et al., 2010; Park et al., 2011).   
Overall, the conditions on the skin are very inhospitable for bacterial colonisers. 
Desiccation, low pH, desquamation, and presence of numerous antimicrobials 
all inhibit the growth of microbes. However, staphylococci in turn have evolved 
multiple defence mechanisms to counteract these barriers. The known 
mechanisms employed by S. aureus in order to colonise human skin are 
summarised by Coates et al (2014) in Fig 1.4.  
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Fig 1.4 Human skin survival mechanisms of S. aureus (Coates et al., 2014).  
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1.8 Staphylococcal disease 
1.8.1 Atopic dermatitis (AD) 
Atopic dermatitis (AD) is an inflammatory disease of the skin, which has a high 
prevalence in a reported 97 countries across the world indicating that it is a 
significant problem in both developing and developed countries (Kong et al., 
2012). Its symptoms include flaky lesions of the skin, infection and subsequent 
abscess formation. The disease Atopic dermatitis is associated with an increased 
production of the IgE antibody in response to environmental antigens usually 
otherwise well-tolerated. Patients with AD have high levels of S. aureus 
colonisation: up to 80% of the skin microflora may be comprised of S. aureus, 
with an associated reduction in overall microbiome diversity, in contrast with 
healthy skin where S. epidermidis comprises 90% of the resident microbiota 
(Baviera et al., 2014). It was proven that the severity of atopic dermatitis is 
linked to S. aureus abundance and the concomitant loss of microbiome diversity 
(Kong et al. 2012). Emergence of S. aureus on atopic dermatitis patients is 
believed due to dysregulation of the innate immune system, which reduced 
production of antimicrobial peptides, reduced recruitment of neutrophils to the 
skin and epidermal barrier dysfunction, resulting in alternation of the skin 
microbiome (Kong et al., 2012). 
Specifically, the level of AMPs hBD2 and hBD3 are decreased in AD patients 
comparing with the healthy people and have therefore been linked with 
susceptibility to S. aureus colonisation (Cho et al., 2011). Expression of hBD2 
and hBD3 are regulated by Th2 cytokines, where elevated level of Th2 cytokines 
leads to reduction of hBD2 and hBD3. Th2 cytokines are elevated in response to 
tissue damage and inflammation, which occurs in healthy skin when there is an 
overgrowth of S. aureus or there is an S. aureus infection (Cho et al., 2011); 
therefore, the reduced level of hBD2 and hBD3 could be a direct consequence of 
high S. aureus colonisation. 
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1.8.2 Abscess formation 
Abscess formation is one of the most common presentations of staphylococcal 
diseases and exemplifies the comprehensive abilities of S. aureus to invade the 
human body. The abscess usually develops for several days or weeks and the 
disease forming bacteria are contained within a pseudo-membrane in the centre 
of a lesion. The pseudo-membrane is formed by immune cells which infiltrate 
the abscess. This process is usually accompanied by the accumulation of pus 
(mostly dead neutrophils) as well as severe inflammation of surrounding tissues 
(Lowy, 1998). Staphylococci in pus spread onto skin surfaces or enter 
circulating lymph and blood, which leads to the formation of abscesses at new 
sites. In patients lacking protective immunity, S. aureus is a frequent cause of 
bacteraemia, as a consequence of invasive disease originating from one or more 
abscesses (Cheng et al., 2011). The formation of staphylococcal abscess after 
subcutaneous invasion is separated into four stages, with each one 
characterised based on actions of a set of distinct surface proteins and virulence 
factors (Cheng et al., 2011). 
The survival of S. aureus in the bloodstream is the first stage of disseminated 
staphylococcal abscess formation. Using a mouse model, researchers found 99.9% 
of the staphylococcal inoculum disappears from the blood within approximately 
six hours. Within three hours, however, the bacteria had reached the deep 
tissues where they could develop an abscess. Replication of these seed 
populations is measureable within 24 hours (Cheng et al., 2011). This means 
staphylococci are capable of survival in blood and circulating lymph fluids. 
Neutrophilic polymorphonuclear leukocytes, which account for 60-70 % of 
human white blood cells, are the host’s main defence against S. aureus in blood 
(Voyich et al., 2005). The reactive oxygen species produced by leukocytes are 
toxic to many bacteria. S. aureus in turn produces the antioxidant 
staphyloxanthin, secretes catalase and regulates a range of other antioxidant 
defences through the repressor activity of PerR and Fur (Horsburgh et al., 2001, 
2002; Pelz et al., 2005) to scavenge reactive oxygen species and protect S. 
aureus from neutrophil killing. In addition, PSMs are produced by S. aureus. 
These PSMs destroy human neutrophils by disrupting the cell membrane. 
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Further, S. aureus employs ClfA which binds to fibrin and fibrinogen, allowing 
agglutination of bacterial cells (McDevitt et al.,1994). This agglutination in turn, 
contributes to prolonged survival by inhibiting phagocytosis (Moreillon et al., 
1995; Palmqvist et al., 2004). Finally, adenosine synthase A (AdsA) secreted 
during early staphylococcal infection converts AMP into adenosine, which is a 
key signal to the host to prevent excessive tissue damage. Large amounts of 
adenosine will repress the inflammatory response  (Thiel et al., 2003). 
Secondly, S. aureus will establish an infectious lesion when immune cells 
accumulate in an area at very high numbers. This process can be detected 
around 48 hours post intravenous challenge (Cheng et al., 2009). The 
recruitment of immune cells to lesions is achieved by released S. aureus 
lipoproteins that are recognised by Toll-like receptors, leading to improved pro-
inflammatory signal levels that results in recruitment of immune cells (Bubeck 
Wardenburg et al., 2006). This process is believed to be facilitated by iron-
acquisition (Skaar et al., 2004) where expression of the isd operon is required to 
fulfil the need for haem-iron but prevent the haem-toxicity (Mazmanian et al., 
2003) (Torres et al., 2007).   
At stage three, S. aureus cells are found tightly associated at the centre of an 
abscess lesion, covered with a pseudocapsule of fibrin deposits, which are 
produced from cleavage of fibrinogen by the action of coagulase (Cheng et al., 
2009). This barrier keeps the immune cells away from S. aureus cells, and as a 
consequence S. aureus will replicate with less restriction. Based on mutation 
studies, two more genes play a crucial role at this stage. Staphylococcal protein 
A (SpA) prevents phagocytosis by binding a component of immunoglobulin 
(Forsgren & Sjöquist 1966) and Embp, which is expressed on the surface during 
cell growing, promotes biofilm-like growth (Cheng et al., 2009). 
The last stage of staphylococcal abscess formation is persistence, accompanied 
by rupture and release, leading to new lesions. Expression of extracellular 
adhesion proteins Eap and Ess is required in this stage. Eap is a bi-functional 
protein which acts to induce cytokines IL-6 and IFN- α from monocytes, but can 
also inhibit T-cell activation and prevent adherence from neutrophils (Scriba et 
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al., 2008; Haggar et al., 2004). Ess (ESAT-6 like secretion system) is a non-
canonical protein involved in a particular secretion pathway is reported to 
contribute to immune evasion by inhibiting phagocytosis (Davis and 
Ramakrishnan, 2009). Gene inactivation of ess results in normal abscess 
formation but failure of persistence (Burts et al., 2008) suggesting that Ess 
pathway is associated with prolonged staphylococcal survival within the 
abscess. 
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1.9 Thesis aims 
Squalene is widely present in nature, and comprises about 12% of total skin 
surface lipids. Although significant efforts have been put into investigating the 
interaction between human skin surface components and staphylococci, 
especially the antimicrobial peptides and lipids, the effects of squalene on 
staphylococci remains poorly understood. The underlying hypothesis for this 
research was that squalene, as a major skin lipid, would have activity towards 
staphylococci that acts on the cells through direct antimicrobial action or by 
modulating the action of other skin antimicrobials. 
This study therefore aimed to investigate the effects of the abundant skin lipid 
squalene upon S. aureus and S. epidermidis. The focus was on discovering the 
different impacts and responses between the two species to determine whether 
squalene may play a role in colonisation of staphylococci and thereby contribute 
to the differential skin survival and frequency of these two species.  
Initial research will aim to determine if squalene has antimicrobial effects on S. 
aureus and S. epidermidis, and investigate whether squalene modulates the 
action of selected skin-related antimicrobials. Transcriptomics will be 
conducted by RNA-Seq as a discovery tool to identify DE genes in response to 
squalene and to compare the transcriptional profiles between S. aureus and S. 
epidermidis. This approach will identify whether differences in responses and 
possible resistance determinants can explain potential antimicrobial effects of 
squalene. 
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Chapter 2 Methods and Materials 
 
2.1 Bacterial strains and growth conditions 
The strains and plasmids used in this study and their relevant properties are 
shown in Table 2.1 and Table 2.2. Todd Hewitt broth (THB) was used for RNA 
preparation and proteomic work to match the experimental conditions with 
other lipid transcriptomic studies in the Horsburgh research group at Liverpool. 
Strains Newman and Tü3298 were selected for RNA-Seq analysis. Proteomics 
and experimental evolution work both used strain Newman. Iron-deficient 
chemically defined media was used for measurement of cell growth with 
different iron concentrations. Remaining experiments were all conducted in BHI 
media. Solid medium was made by adding agar (12 g L-1) to broth.  
Agar plates were grown at 37 °C for 12-18 h unless otherwise stated. Overnight 
broth cultures were grown for 18 h at 37 °C with shaking at speeds indicated. 
Optical density (600 nm) was measured during growth using a 1 cm path length. 
For E. coli, 10 ml of Lysogeny Broth (LB; Fisher Scientific) in a 50 ml 
polypropylene tube was inoculated with a single colony from LB agar plates (LB 
broth and 1.2 % w/v agar [Thermo Scientific]). Antibiotic was added when 
necessary at the following concentrations- ampicillin (Amp; 100 μg ml-1), 
erythromycin (Ery/Erm; 10 μg ml-1), chloramphenicol (Cm; 10 μg ml-1), and 
tetracycline (Tet; 5 μg ml-1). Two different concentrations of squalene (Sigma, 
CAS: 111-02-4), 2 mM (0.1%) and 20 mM (1% v/v) were used to challenge the 
culture in the experiments unless otherwise stated. 
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Table 2.1 Bacterial strains used in this study 
Species Strain Name Reference or Source 
Staphylococcus aureus Newman (Duthie and Lorenz, 1952)  
Staphylococcus aureus SH1000 (Horsburgh et al., 2002)  
Staphylococcus aureus BH1CC (O'Neill et al., 2007) 
Staphylococcus aureus RN4220 (Nair et al., 2011) 
Staphylococcus epidermidis  Tü3298 (Allgaier et al., 1986)  
Staphylococcus capitis G390 (Kloos and Schleifer, 1975) 
Staphylococcus hominis DM122 (Kloos and Schleifer, 1975) 
Micrococcus luteus ATCC4698 (Kocur et al., 1972) 
Escherichia coli Top10 Thermo Scientific 
 
 
 
Table 2.2 Plasmids used in this study 
Plasmids Description Reference 
pMUTIN4 High copy number sub-cloning vector (Vagner et al., 1998) 
pSK5632 
High copy number in E. coli, low copy number in 
S .aureus sub-cloning vector 
(Grkovic et al., 2003) 
pDG1514 tetracycline resistance cassette containing vector (Guérout-Fleury et al., 1995) 
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2.2 Growth curves 
Overnight cultures were adjusted to an OD600 of 0.5 using BHI; 2 ml of the 
diluted culture was used to inoculate 50 ml of media in 250 ml flasks. Flasks 
were incubated in a water bath with 125 rpm linear shaking at 37 ˚C. Samples  
were taken hourly between 0 and 8 h and diluted ten-fold in phosphate buffered  
saline (PBS) before recording the OD600. This work also aimed to determine the 
concentration of squalene to be used for challenge conditions that would be 
used in future RNA-Seq work. If squalene has an antimicrobial effect, the ideal 
concentration should be the lowest concentration at which squalene could be 
added to the bacteria during the exponential phase (at OD600 0.5) and be seen to 
reduce growth rate 20 min post challenge when results were displayed 
graphically.  
 
 
2.3 H2O2, sapienic acid, nisin and LL-37 survival assays 
S. aureus Newman and S. epidermidis Tü3298 were grown in BHI with different 
concentrations of squalene for 24 h. The cell culture was centrifuged and cell 
pellets were collected and washed twice with PBS. Cells were resuspended and 
diluted to OD600 0.1 (~1.5 x 108 CFU ml-1). Hydrogen peroxide, sapienic acid, 
nisin or LL-37 were added to the diluted cells with a final concentrations of 7.5 
mM, 5 µg ml-1, 250 µg ml-1 and 10 µg ml-1, respectively. Cell suspensions were 
incubated at 37 ˚C statically. Samples were collected at time points 0 and 90 min 
into a 96-well plate and for the hydrogen peroxide treated cells catalase (10 mg 
ml-1) was added immediately to the samples to neutralise the peroxide. Serial 
dilution and viable counts were performed to measure the survival rate.  
Hydrogen peroxide, catalase, sapienic acid, nisin and LL-37 were all purchased 
from Sigma. Nisin was dissolved in 10 mM sodium citrate to a concentration of 5 
mg ml-1 as a stock. Sapienic acid was dissolved in 100 % ethanol to a 
concentration of 5 mg ml-1 for stock. LL-37 was dissolved in water for a stock 
with the concentration of 100 µg ml-1. 
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2.4 Staphyloxanthin expression and extraction 
Staphyloxanthin was extracted with methanol and an absorbance spectrum was 
determined using a Fluostar Omega (BMG Labtech) plate reader. S. aureus 
Newman, SH1000 and BH1CC, S. aureus capitis G390, S. aureus hominis DM122 
and M. luteus ATCC4698 were grown in BHI with different concentrations of 
squalene for 24 h. After growth, bacteria were centrifuged for 10 min at 4000 
rpm, and cell pellets for each sample were collected. Pigment was extracted by 
adding 1 ml of methanol to cell pellet, with mixing and incubation for 15 min at 
37 ˚C. Finally, the methanol extract was centrifuged again and 96-well 
polystyrene microtitre plates were loaded with 250 µl of extract in triplicate 
prior to absorbance measurement. 
 
 
2.5 Agarose gel electrophoresis 
Agarose gels were made to a concentration of 1 % or 2 % (w/v) agarose in TAE 
(Tris base, acetic acid and EDTA) buffer. The 1 % gels were used for gDNA 
integrity analysis whilst 2 % gels were  
used for analysis of PCR products and small plasmids. Melted agarose was 
stored at 50 °C until required. Midori green DNA stain (Nippon Genetics) was 
mixed into molten agarose using either  4 µl or 2 µl per 100 ml of agarose, 
respectively. When necessary, loading dye (containing glycerol and 
bromophenol blue) was added to samples before loading samples into the gel. 
Samples were electrophoretically separated in TAE agarose/TAE buffer at 110 v 
for between 45 min and 2 h.  
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2.6 RNA sequencing  
2.6.1 Notes  
All work with RNA was done using RNase free plasticware and RNase free filter 
tips. Benches and pipettes were cleaned with RNase Zap (Ambion). Any water 
used was incubated at 37 °C with 0.1 % (v/v) diethypyrocarbonate overnight,  
prior to sterilisation by autoclaving (DEPC-treated water).  
  
2.6.2 Growth and preparation of cells for RNA extraction  
When bacteria reached an OD600 of 0.5, squalene was added. The final 
concentration of squalene for both S. aureus Newman and S. epidermidis Tü3298 
was 1 % v/v. At 20 min after challenge with squalene, cells were harvested  
by pelleting for 5 min at 4,000 x g and 4 °C. Pellets were resuspended in 2 
volumes of RNAlater (Qiagen) and incubated overnight at 4 °C.  
  
2.6.3 Lysis of cells for RNA extraction  
Per extraction, 1 ml of the bacterial preparation was used. The bacteria were 
pelleted at 6,000 x g for 5 min at 4 °C, and resuspended in 100 µl TE (Tris base 
and EDTA) containing 6 mg ml-1 lysostaphin and 400 U ml-1 mutanolysin.  
This lysis mix was incubated at 37 °C for 15 min for S. aureus, and 30 min for S.  
epidermidis, mixing every 5 min. Bacteria were incubated for a further 30 min at 
37 °C after the addition of 25 µl of Proteinase K (Qiagen).  
 
2.6.4 RNA extraction  
RNA was extracted using the RNeasy kit (Qiagen), with slight alterations to the 
manufacturer’s protocol. Briefly the method was as follows: 350 µl buffer RLT 
containing 10 % (v/v) β-mercaptoethanol was added to the lysed cells and 
mixed before the addition of 250 ml ethanol. This suspension was centrifuged 
through the RNeasy column for 15 s at 10,000 x g. The column was then  
washed twice with 700 µl buffer RW1 for 15 s at 14,000 x g. The column was  
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then washed thrice with 500 µl buffer RPE for 15 s at 14,000 x g. Collection  
tubes were changed between buffers. The column was centrifuged in a clean  
collection tube for 1 min with the column lid off. The column was then air dried  
for 2-5 min. RNA was eluted twice with 30 µl water pre-warmed to 45 °C.  
RNasin (Promega) was added according to the manufacturer’s instructions. A 2  
µl aliquot of the sample was used for total RNA quantification using Qubit RNA  
assay kit (Invitrogen), according to manufacturer’s protocol.  
  
2.6.5 DNase treatment of RNA  
Samples with > 3 µg total RNA were DNase-treated using turbo DNase (Ambion) 
according to manufacturer’s instructions. DNase was removed using the RNeasy 
MinElute clean up kit (Qiagen) according to manufacturer’s instructions, with 
the addition of 10 % beta-mercaptoethanol to the buffer RLT and elution was in 
20 µl water. An aliquot of 4 µl was taken for quality control analysis, whilst the 
rest was frozen at -80 °C.  
  
2.6.6 RNA quality control  
Quality control analysis was conducted using a Qubit (Invitrogen) for 
quantification, 2100 Bioanalyser (Agilent technologies) to assess degradation 
levels and Nanodrop (Thermoscientific) to assess protein or solvent 
contamination. Tests were carried out according to manufacturer’s instructions 
for bacterial RNA. Samples with a paired control and test condition sample with 
the following parameters were suitable for sequencing to ensure sufficient 
quantity, good integrity and low trace of contamination: Qubit reads indicating  
3 µg RNA, Bioanalyser RIN  7.0, Nanodrop 260/280 and 260/230  1.8.  
 
 2.6.7 RNA library preparation  
Libraries preparation was performed by the Centre for Genome Research, 
University of Liverpool, UK. Total RNA samples were rRNA depleted using the 
Ribo-Zero magnetic kit for Gram-positive bacteria (Epicentre); this was 
repeated for samples with poor initial rRNA removal. Libraries were then 
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prepared using strand specific ScriptSeq kits (epicentre). Samples were 
sequenced using paired-end sequencing on the HiSeq platform (Illumina) and 
the analysis was done with single-end reads.  
 
2.6.8 RNA sequencing differential expression analysis  
Bowtie (Langmead et al., 2009) and Edge R (Robinson et al., 2010; Robinson and  
Oshlack, 2010) were used to map reads and determine the differentially  
expressed (DE) genes respectively. Genes with mapped transcripts that had a  
false discovery rate > 0.05, as determined by Benjamin and Hochberg analysis,  
and log2 fold change not ≥ ±1 were filtered out of the data set. The remaining  
gene set was considered differentially expressed between control and test  
conditions. This analysis was produced by the Centre for Genomic Research  
(CGR), Liverpool.  
Changes in gene expression in biosynthetic pathways were assessed using DE  
gene sets with KEGG mapper-search and colour (Kanehisa et al., 2012, Kanehisa  
and Goto, 2000). Gene ontology (GO) terms were attached to DE genes using  
Uniprot (UniProt, 2014).   
 
2.6.9 COG analysis  
The sequences for all genes within the genomes of S. aureus, Newman and S.  
epidermidis Tü3298 were extracted into a fasta file using the Galaxy tool  
“Extract genomic DNA” (Goecks et al., 2010; Giardine et al., 2005). A bespoke  
perl script (DNA_fasta_to_protein_fasta.pl) was then used to convert these gene  
sequences into protein sequences. These protein sequences were then  
submitted to WebMGA function annotation (COG) (Wu et al., 2011), which  
assigns a COG ID to each gene.  
Another bespoke Perl script was used to convert the names that had been  
assigned to the genes by the Galaxy extract genomic DNA tool back to their true  
gene names (replace_names.pl). The gene lists of DE genes were labelled with  
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their assigned COGs using a bespoke Perl script (label_cogs.pl). The numbers of  
genes in each COG class and the percentage of the genome accounted for by  
each COG class was then calculated using a further bespoke Perl script  
(counting_cogs.pl).  
 
2.7 Experimental evolution 
2.7.1 Evolution passaging  
The wild-type S. aureus Newman strain was passaged under selective conditions, 
by continuous repeat incubation in broth containing 6 % (v/v) ethanol or 1 % 
(v/v) squalene for 14 days. From the second day and onwards, cells that had 
been cultured for 24 h at 37 °C with ethanol or squalene were diluted to OD600 
0.02 and added into fresh broth with the same concentration of ethanol or 
squalene. A control was also conducted by passage of the parental stain in broth, 
but without ethanol or squalene for 14 days using the same method. The 
passage was performed in duplicate. 
 
2.7.2  DNA extraction  
For genomic DNA extractions, 2 ml of overnight cultures of staphylococci were 
pelleted at 4,000 x g for 2 min in sterile Eppendorf tubes. The DNeasy Blood and 
tissue kit (Qiagen) was then used according to the manufacturer’s instructions 
for Gram-positive bacteria, with the addition of lysostaphin at a final 
concentration of 25 µg ml-1.   
 
2.7.3  DNA Quality Control  
Quality control analysis of purified DNA was conducted using the Qubit (Life 
Technologies) for quantification, agarose gel electrophoresis to assess overall 
DNA integrity and Nanodrop to assess protein or solvent contamination. 
Samples used for sequencing with the TruSeq DNA sample prep kit (Illumina) 
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had Qubit reads indicating  1 µg ml-1 DNA in  55 µl volume, plus an agarose 
gel result indicating minimal fragmentation of DNA and Nanodrop 260/230 and 
260/280  1.8 verifying purity. Samples for sequencing with Nextera DNA 
sample prep kit (Illumina) had the same requirements except that DNA 
concentration was  0.1 µg ml-1. 
 
2.7.4  Pooled DNA samples  
The evolved clone DNA of S. aureus was pooled prior to library preparation. By 
the end of passage, 6 isolates (3 ethanol or squalene evolved and 3 broth 
evolved) from each duplicate were picked and their genomes were extracted 
and put into a pool for sequencing. DNA was pooled in equimolar 
concentrations based upon Qubit readings made using the same mastermix or 
using two internal control to normalise result when using a different mastermix.   
 
2.7.5  DNA library preparation  
DNA libraries for samples to be used as reference genomes for RNA sequencing 
were prepared using a Nextera DNA sample prep kit (Illumina) according to the 
manufacturer’s instructions. DNA libraries for experimental evolution clones 
were prepared using TruSeq DNA sample prep kit (Illumina). All samples were 
sequenced on the MiSeq platform (Illumina) by the CGR, Liverpool.   
 
2.7.6  Genome assembly  
The NGS QC toolkit v2.3 (Patel and Jain, 2012) was used to filter out reads with 
less than 70 % of the read with quality scores over Q20 and to trim 3’ ends with 
less than Q20 quality scores. VelvetOptimiser version 2.2.5 (Victorian 
Bioinformatics consortium), which utilises Velvet version 1.2.08 (Zerbino and 
Birney, 2008), was used to assemble genomes using k-mer lengths between 19 
and 99 bp. This produced contigs that could be used as a reference for RNA-Seq 
data.   
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2.7.7  SNP analysis  
Sequence reads were processed by the Centre for Genome Research, University 
of Liverpool (CGR) to remove adapter sequences and poor quality reads. Briefly, 
this meant trimming with cutadapt, version 1.2.1 (Martin, 2011), to remove 
adapter sequences from reads followed by a further trim with Sickle, version 
1.200, to remove bases with lower than 20 base quality score. Reads shorter 
than 10 bp after trimming were filtered from the data files, if the paired read 
was not filtered out in this process it was moved to another file designated “R0”.  
After this initial processing by the CGR, read quality was assessed using the NGS 
QC toolkit v2.3 (Patel and Jain, 2012).  If filtered reads were assessed to be of 
good quality, reads were aligned to their reference genome using the Burrows-
Wheeler aligner (BWA) aln and sampe packages (Li and Durbin, 2009, Li and 
Durbin, 2010) version 0.5.9-r16. Samtools (Li et al., 2009) version 0.1.18-r580 
was used to process sam files to create a bcf file (binary varient call format) for 
SNP calling.  SNPs were called using a bespoke Perl script (mpileup_SNPs_v2.pl) 
that utilises the SNPEFF package (Cingolani et al., 2012) version 3.4e to 
determine the effect of the SNP (e.g. synonymous, non-synonymous or 
truncation). Another bespoke Perl script was used to compare SNPs found in the 
evolved strains and parent or broth control strains (unique_SNPs_bwa.pl).  Non-
synonymous SNPs were further investigated.   
 
 
2.8 qPCR 
2.8.1  Primer design  
Primers were taken from the literature where possible or designed using 
primer-BLAST (Ye et al., 2012). Primers with a length between 15 and 25 bp, 
predicted to have only one product, a Tm of 60 ±2 °C, low level of single base 
repeats and a GC clamp towards the 3’ end were designed where possible.   
Primers were confirmed to amplify a DNA product of the expected length 
without any secondary products using standard PCR with gDNA as a template. 
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The PCR mix was made using both BioMix Red (Bioline) which is a complete 
ready-to-use 2x reaction mix containing an ultra-stable Taq DNA polymerase 
and ACCUZYME DNA polymerase (Bioline) which is a proprietary proofreading 
enzyme that offers increased-fidelity and high PCR yield to minimise fidelity 
errors from the Taq polymerase, according to the manufacturer’s instructions.  
Primer efficiency was confirmed to be within 90-100 % using a dilution curve 
with gDNA as described previously (Nolan et al., 2006). Efficiency testing was 
done using the same conditions as for qPCR reactions (described below). The 
reaction mix in a total volume of 20 µl was set up with 0.5 µM of each primer, 10 
µl SensiFAST and a dilution range of gDNA between 1x100-1x104, with a starting 
concentration of 10 million copies. Negative controls without template were 
also implemented. Efficiency values were generated by the qPCR machine 
software, and an average of at least three resulting efficiency values was taken.   
 
2.8.2  cDNA generation  
The tetro cDNA synthesis kit (Bioline) was used for cDNA synthesis according to 
the manufacturer’s instructions using random hexamer primers and 
approximately 2 µg RNA per reaction. Only RNA samples determined to have 
high integrity (described above) were used for these reactions.   
 
2.8.3  qPCR conditions  
All qPCR reactions were done using SensiFAST SYBR HiMROX kit (Bioline) with 
the ABI StepOnePlus (Life Technologies) machine. The reaction mix contained 
10 µl SensiFAST, 0.5 µM of each primer, 80 µg cDNA and DEPC-treated water up 
to a total reaction size of 20 µl. The run cycle was 95 °C for 5 min, then 40 cycles 
of 95 °C for 10 s, 62 °C for 30 s. Data analysis was done using the ABI 
StepOnePlus software. At least two technical replicates and three biological 
replicates were used to determine fold change in gene expression between 
samples.  
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2.9 Proteomics 
Overnight cultures of bacteria were diluted to OD600 0.5, and 2 ml was used to 
inoculate 50 ml fresh THB in a 250 ml flask. Bacteria were incubated at 37 °C 
with linear shaking (250 RPM). Next, 1 % (v/v) of squalene was added OD600 at 
0.5, while control cells were left untreated. Samples were grown for two more 
hours, followed by centrifuging 1ml of bacterial culture. The cell pellet was 
washed with PBS three times and diluted to OD600 0.4. 1ml of diluted cells were 
centrifuged and the supernatant was discarded. The pellet was stored at -80 °C 
until analysis.  
The following steps were performed by The Centre for Proteomics, University of 
Liverpool, Liverpool, UK. Washed pellets were suspended in 100 μl of 25 mM 
ammonium bicarbonate. To analyse for protein content, 0.05% RapiGest™ 
(Waters, Manchester) in 25 mM ammonium bicarbonate was added to the 
samples, and samples were incubated at 80 °C with 550 RPM for 10 min. The 
samples were then reduced by the addition of 10 μl 60 mM DTT (dithiothreitol) 
and incubation at 60 °C for 10 minutes, then alkylated by the addition of 10 μl of 
180 mM iodoacetamide with incubation at room temperature for 30 minutes in 
the dark. Trypsin (Promega U.K. Ltd., Southampton, proteomics grade) was 
reconstituted in 50 mM acetic acid to a concentration of 0.2 μg μl-1 and 10 μl 
added to the samples followed by overnight incubation at 37 °C. The digestion 
was terminated and RapiGest™ removed by acidification using 1 μl of TFA 
(trifluoroacetic acid) and incubation at 37 °C for 45 min and centrifugation 
(15,000 x g for 15 min).  
To check for complete digestion, each sample was analysed pre- and post-
acidification by SDS-PAGE. For LC-MS/MS analysis, a 2 μl (1 μg) injection was 
analysed using an Ultimate 3000 RSLC™nano system (Thermo Scientific, Hemel 
Hempstead) coupled to a QExactiveHF™ mass spectrometer (Thermo Scientific).  
The samples were loaded onto the trapping column (Thermo Scientific, 
PepMap100, C18, 300μm X 5 mm), using partial loop injection, for seven 
minutes at a flow rate of 4 μl min-1 with 0.1 % (v/v) FA. The samples were 
resolved on the analytical column (Easy-Spray C18 75 μm x 500 mm 2 μm 
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column) using a gradient of 97 % A (0.1% formic acid) 3% B (99.9% ACN 0.1% 
formic acid) to 70% A 30% B over 120 min at a flow rate of 300 ml min-1.  
The data-dependent program used for data acquisition consisted of a 60,000 
resolution full-scan MS scan (AGC set to 3e6 ions with a maximum fill time of 
100 ms). The 18 most abundant peaks were selected for MS/MS using a 30,000 
resolution scan (AGC set to 1e5 ions with a maximum fill time of 45ms) with an 
ion selection window of 1.2 m/z and a normalised collision energy of 28. To 
avoid repeated selection of peptides for MS/MS the program used a 30 second 
dynamic exclusion window.  
The data were used to search the S. aureus Newman protein sequence database 
using Mascot (Matrix Science, London, UK). A fixed carbamidomethyl 
modification for cysteine and variable oxidation modification for methionine 
were specified. A precursor mass tolerance of 10 ppm and a fragment ion mass 
tolerance of 0.01 Da were applied. The results were then filtered to obtain a 
peptide false discovery rate of 1 %. 
 
2.10 Growth in iron deficient media 
Iron-deficient chemical defined medium (CDM) was prepared by adding into 
one litre water: Na2HPO4 (7 g), KH2PO4 (300 mg), adenine sulfate (20 mg), 
guanine-HCl (20 mg), L-glutamic acid (2.22 g), L-aspartic acid (2.22 g), L-proline 
(2.22 g), glycine (2.22 g), L-threonine (2.22 g), L-serine (2.22 g), L-alanine (2.22 
g), L-lysine-HCl (560 mg), L-isoleucine (560 mg), L-leucine (560 mg), L-histidine 
(440 mg), L-valine (440 mg), L-arginine (330 mg), L-cysteine (220 mg), L-
phenylalanine (190 mg), L-tyrosine (170 mg), L-methionine (170 mg), L-
tryptophan (60 mg), pyridoxal (0.8 mg), pyridoxamine-2HCl (0.8 mg), D-
pantothenic acid (0.4 mg), riboflavin (0.4 mg), nicotinic acid (0.4 mg), thiamine-
2HCl (0.4 mg), and biotin (0.02 mg). Iron limited conditions were achieved by 
adding 10 g L-1 Chlex-100 (Sigma) to the solution and mixing for 4 h, followed 
by filter sterilization. Finally, sterile glucose and MgSO4 was added to obtain the 
final concentration of 10 g L-1 and 0.5 g L-1, respectively. 
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Cell growth in iron-defined media was performed and measured using a 96-well 
plate using a Fluostar Omega (BMG Labtech) plate reader. Overnight culture 
was diluted to OD600 0.02 and 200 µl aliquoted into 96 well plates. Cells were 
grown at 37 °C with double orbital shaking (200 rpm) for 12 h with the 
presence or absence of 1 % (v/v) squalene. Five concentrations of iron (0 uM, 
0.02 uM, 0.2 uM, 2 uM) were tested. Cell density was determined by 
measurement of OD600. 
 
2.11 Cellular iron concentration analysis 
Overnight cultures of bacteria were diluted to OD600 0.5, and 4 ml used to 
inoculate 50 ml fresh THB in a 250 ml flask.  Bacteria were incubated at 37 °C 
with linear shaking (250 RPM).  When OD600 reached 0.5, cells were challenged 
with 1 % (v/v) squalene (squalene-treated cells), while control cells were left 
untreated.  After 24 h, 5 ml of cell culture was harvested from each sample by 
centrifugation with washing three times with PBS. Viable counts were 
performed after washing. To lyse the cells, 0.1 mg ml-1 of lysostaphin (Sigma) 
was added and incubated for 2 h or until lysate was clear.  HCl was added to the 
lysate to a final concentration of 0.1 M in 10 ml. The lysate was then filter 
sterilised prior to Inductively Coupled Plasma optical emission spectroscopy 
(ICP-OES) analysis.  
ICP-OES analysis was performed by The Department of Chemistry, University of 
Liverpool, Liverpool, UK with an Agilent 5110 SVDV ICP-OES and the key 
parameters for the test are as follows: RF Power: 1.3kW; Wavelengths (nm): 
261.187, 240.489, 238.204, 258.588; Read Time: 10 seconds; Viewing Mode: 
Axial; Neb Flow: 0.7L min-1; Plasma Flow: 12L min-1; AuxFlow: 1L min-1. 
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Chapter 3 Influences of squalene on staphylococcal 
physiology and resistance to antimicrobials 
 
3.1 Introduction 
3.1.1 Squalene and its association with bacteria  
Squalene (SQ) is widely present in nature, and large amounts are present in 
olive oil, palm oil, wheat-germ oil, amaranth oil, and rice bran oil. The richest 
source known of squalene is shark liver oil (60 wt.%), which has been 
traditionally used as source of this lipid (Xu et al., 2004). In humans, the highest 
accumulation of squalene is associated with skin, where it normally comprises 
about 12% of total skin surface lipids that in an adult corresponds to 60 g/cm2 
(Pappas, 2009). Owing to its critical role in the biosynthesis of eukaryotic 
sterols and bacterial hopanoids, squalene is synthesised across types of cells 
and species. More specifically, squalene and its related compounds, 
oxidosqualene and bis-oxidosqualene, are precursors of nearly 200 different 
triterpenes. Several species of bacteria, metabolise SQ as a carbon source such 
as Corynebacterium sp., Rhodococcus sp., Pseudomonas sp., and Arthrobacter sp. 
(Spanova and Daum, 2011). 
As an intriguing component of the skin surface lipids, squalene produced in the 
sebaceous gland mostly accumulates on the surface, not being converted into 
lanosterol, which as the next step halts the biosynthesis of cholesterol (Picardo 
et al., 2009). The accumulation of this lipid is negligible in other organs of the 
human body and the reason for that is still unclear. A variety of hypotheses have 
been proposed for squalene accumulation on the skin, such as maintaining skin 
moisture (Luca and Valacchi, 2010) and acting as an antioxidant for UV 
protection (Ohsawa et al., 1984), but there is no study reported describing any 
antimicrobial effect of squalene. 
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3.1.2 The effects of squalene on staphylococci pigmentation and  
antimicrobial resistance 
S. aureus and many non-pathogenic species of staphylococci are able to produce 
staphyloxanthin (STX), which is an orange-red triterpenoid located in the 
membrane that is described to have a role in the environmental fitness of S. 
aureus (Clauditz et al, 2006). STX is encoded by genes of the crtOPQMN operon 
with a SigmaB-dependent promoter upstream of crtO and a terminator 
downstream of crtN (Pelz et al, 2005). In the first step of STX biosynthesis, two 
molecules of farnesyl diphosphate are condensed to form dehydrosqualene, 
catalysed by CrtM. Next the dehydrosqualene is dehydrogenated by CrtN to 
form the yellow intermediate 4,4-diaponeurosporene. Next, CrtP converts 4,4-
diaponeurosporene into 4,4-diaponeurosporenic acid by oxidising the terminal 
methyl group. In the final steps, 4,4-diaponeurosporenic acid is firstly esterified 
by CrtQ and then acylated to form STX by CrtO.  
Staphyloxanthin was revealed to have a role in antioxidation by detoxifying 
reactive oxygen species produced by phagocytes and neutrophils (Liu & Nizet, 
2009). By comparative analysis of the wild type with a crtM mutant, Götz et al 
(2006) showed staphyloxanthin contributes to resistance from hydrogen 
peroxide, superoxide radical, hydroxyl radical, hypochlorite, and neutrophil 
killing. Several reports have proposed that STX also stabilises the membrane of 
S. aureus during infection and pathogenesis in a manner similar to that observed 
for cholesterol in eukaryotes (Rohmer et al, 1979 & Mishra et al, 2011). 
Although squalene was not reported to have antimicrobial effects in previous 
studies, it remains possible that it modulates the action of skin antimicrobials 
produced by the host or other bacteria. As described in Chapter 1 general 
introduction, skin possesses a broad arsenal of antimicrobials that target 
potential colonisers. These effectors include a various types of reactive oxygen 
species (ROS), such as hydrogen peroxide, superoxide radical and hydroxyl 
radical; antimicrobial skin lipids such as sphingosine, antimicrobial fatty acids 
(AFAs) linoleic and sapienic acid; antimicrobial peptides (AMPs) such as LL-37, 
defensins and those produced by competing bacteria e.g. S. epidermidis 
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epidermin. Squalene, however, despite of its substantial amounts found on the 
skin, has not been reported to affect resistance to these antimicrobials in 
bacteria.  
 
 
  
50 
 
3. 2 Aims 
Although significant efforts have been put into investigating the interaction 
between human skin surface components and staphylococci, especially the 
antimicrobial peptides, the effects of squalene on staphylococci remain poorly 
understood. Taking account of the considerable quantity of squalene presenting 
on human skin, it was deemed valuable to determine whether squalene has 
potential to play a role in colonisation of staphylococci and determine the 
nature of any role identified. 
The main aims of this chapter were to first determine if squalene has 
antimicrobial effects on Staphylococcus aureus and Staphylococcus epidermidis. 
Additionally, investigations sought whether squalene modulates the action of 
selected antimicrobials. A minimum of two strains of each species were used to 
limit strain-specific effects. Tests based on growth rate assays and cell counts by 
Miles and Misra method were used to assess the antimicrobial activity of 
squalene. The described antimicrobials, H2O2, LL-37, nisin and sapienic acid 
were chosen to conduct antimicrobial tests to examine squalene influences. 
Overall these experiments should determine whether the role of squalene is 
more than just a precursor of cholesterol but influences the skin colonisation 
and persistence of bacteria. 
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3.3 Results 
3.3.1 The effects of squalene on the growth of Staphylococcus aureus and 
Staphylococcus epidermidis 
To determine whether squalene influenced the growth of S. aureus and S. 
epidermidis, and identify whether it had any antimicrobial properties, growth 
curves of the bacteria treated with different concentrations of squalene were 
measured by testing optical density every hour (Fig 3.1) over the first 8 hours 
and followed by viable counts determined 24 h after squalene addition (Fig 3.2). 
Briefly, bacteria were grown in fresh BHI broth for approximately 2.5 h until its 
OD600 reached 0.5. Two concentrations of squalene were added to obtain the 
final squalene concentrations from 0% to 1%. Two strains of each species 
(Newman and SH1000 for S. aureus, Tü3298 and RP62A for S. epidermidis) were 
used in these assays.   
Both growth curves and viable counts results revealed that squalene does not 
influence cell growth and does not have obvious antimicrobial effects, under the 
conditions tested. A Pearson’s correlation test supports that there was no 
significant relationship between the concentration of squalene in the medium 
and cell density (p=0.84).  The results for SH1000 and RP62A were very similar 
as those obtained using strains Newman and Tü3298, which indicated the 
absence of a strain-specific effect by squalene on staphylococcal cell growth. 
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                     S. aureus Newman                                 S. aureus SH1000         
 
 
 
                 S. epidermidis Tü3298                        S. epidermidis RP62A 
  
Figure 3.1 Growth curves of S. aureus and S. epidermidis strains  challenged with different 
concentrations of squalene.  Optical density was measured hourly. The arrow indicates 
squalene was added when OD600 reached 0.5. Squalene was added to a final concentration of  0.1% 
v/v (square), 1% v/v (triangle) or was absent (diamond). 
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Figure 3.2 Viable cell counts of S. aureus and S. epidermidis strains after 24 h growth with 
different concentrations of squalene. Viable counts were measured using Miles and Misra 
technique after 24 h culture in BHI broth in the absence (black) or presence of squalene, 0.1 % 
v/v (deep grey), and 1% v/v (light grey). 
 
 
3.3.2 The effects of squalene on staphylococcal pigmentation 
Having established that squalene had no discernible antimicrobial activity, at 
least under the conditions tested, it was noted during viable count experiments 
that the eponymous golden colour of treated S. aureus cells dramatically 
reduced. This orange-red triterpenoid located in the membrane plays an 
important role in the environmental fitness of S. aureus as discussed (Clauditz et 
al, 2006). Therefore, to investigate this phenomenon, absorbance spectrum 
tests were conducted using methanol-extracted pigment from cell pellets.  
The spectrum tests were performed using an optical spectrum analyser plate 
reader, which uses reflective techniques to separate out the wavelengths of light 
and measures the intensity of the light with an electro-optical detector. In the 
experiments, the pigment extracted from a wild-type pigmented S. aureus strain 
presents a spectrum with two peaks at 440 nm and 470 nm, which indicates the 
existence of staphyloxanthin (λmax=463 nm) and two biosynthetic precursors 
of staphyloxanthin, 4,4-diapolycopene (λmax=440,468 nm) and 4,4-
diaponeurosporene (λmax=415, 439 nm) (Furubayashi et al., 2014). 
Corresponding with Beer’s law (A=εcl), higher absorbance peak values indicate 
a greater quantity of carotenoids in the sample. 
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                                    S. aureus SH1000                                   S. aureus Newman 
 
                                          S. hominis DM122                                 S. capitis G390 
 
                                           M. luteus ATCC4698 
 
Figure 3.3 Absorbance spectra of MeOH-extracted pigment of squalene-treated cells. 
Strains S. aureus Newman and SH1000, S. capitis G390, S. hominis DM122 and Micrococcus luteus 
ATCC4698 were grown in BHI with different concentrations of squalene for 24 h. Orange: 
control; Blue: 0.1% v/v squalene; Green: 1% v/v squalene. The two peaks around a wavelength 
of 450 nm are the representative evidence for presence of the carotenoids. Readings were 
corrected based on cell amount such that a higher peak indicates a larger quantity of 
carotenoids in the sample. 
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Three pigmented staphylococci, S. aureus strains Newman and SH1000, S. 
hominis, and S. capitis G390 and a pigmented M. luteus ATCC4698 were assayed 
to determine if the effect of squalene applies more widely (Fig 3.3). Micrococcus 
luteus is a yellow-pigmented species that is part of the normal flora of 
mammalian skin and it shares similar niches with staphylococci. Although its 
pigment sarcinaxanthin differs from staphyloxanthin, the maximum absorption 
of M. luteus pigment is also around 470 nm (Netzer et al, 2010). From the 
spectral analysis, the characteristic peaks reduced indicating that levels of 
staphyloxanthin were lower with increased lipid indicating a concentration-
dependent effect of squalene on staphylococcal pigmentation. Furthermore, 
together with the similar results obtained from M. luteus, it may propose a 
widespread existence of this effect on pigmented bacteria.  
 
3.3.3 Influence of squalene on staphylococcal resistance to antimicrobials 
As described, staphyloxanthin plays an important role in resistance to oxidative 
stressors, such as H2O2. Antioxidant properties derive from multiple conjugated 
bonds of STX that enable it to eliminate singlet oxygen. Therefore, it was 
hypothesised that reduced pigmentation by treatment with squalene would 
increase the cell’s susceptibility to H2O2. In contrast, S. epidermidis lacks ability 
to produce any pigment, which theoretically would not be affected by treatment 
with squalene when applying the same test.  
Susceptibility tests of S. aureus and S. epidermidis to H2O2 were performed. Cells 
of both species were cultured with 1% v/v of squalene for 24 h and the same 
quantity of washed cells for each sample were challenged with H2O2 for 90 min. 
The results support the hypothesis (Fig 3.4). For S. aureus, cells cultured with 
the highest concentration of squalene (1 % v/v) showed the lowest survival 
levels (~40 %), compared with 0.1 % (v/v) of squalene that caused 20 % loss of 
survival relative to untreated control cells. This difference was significant 
assessed by one-way ANOVA (p<0.001). Unlike S. aureus, the results showed 
that the overall susceptibility of S. epidermidis to H2O2 was much higher. Only 
12 % of bacteria survived after 90 min compared with 68 % for S. aureus. 
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However, there was no significant difference in susceptibility across increasing 
concentrations of squalene (one-way ANOVA, p=0.98).  
To determine whether preconditioning cells with squalene also changes the 
susceptibility of S. aureus or S. epidermidis to non-oxidative substances, nisin 
was used to challenge the cells cultured with squalene (Fig 3.4).  Nisin is an 
antimicrobial peptide produced by bacteria including Lactococcus lactis that 
plays important role in the production of buttermilk and cheese. Nisin has 
relevance as a representative of one class of antimicrobial peptides i.e. type A 
lantibiotics targeting the cell membrane.  
The results showed a similar pattern to the susceptibility tests to H2O2. For S. 
aureus, cells cultured with 0.1 % (v/v) squalene exhibited a decreased survival 
(~2-fold greater killing) compared with that of the control. Moreover, there was 
a dose-dependent effect since cell culture with 1 % (v/v) squalene further 
decreased survival (~3-fold more killing) relative to untreated cells. These 
results achieved statistical significance (one-way ANOVA, p<0.005). In contrast, 
S. epidermidis cells showed no clear trend of altered survival, with 0.1 % (v/v) 
squalene exhibited slightly reduced survival (~2 %) as culture with 1 % (v/v) 
squalene slightly increased cells’ survival rate (~3 %). No statistical significance 
was achieved (one-way ANOVA, p=0.67) confirming the lack of any relationship 
between squalene concentration and survival of S. epidermidis from nisin. 
The antibacterial activity of unsaturated fatty acids has been well known for 
several decades (Kabara et al. 1972; Knapp and Melly 1986; Shin et al. 2007; 
Neumann et al., 2015). The antimicrobial lipid sapienic acid, which shares the 
same site of origin with squalene, was also chosen to preform survival tests of 
squalene-treated cells. Sapienic acid was proven having effect against 
staphylococci including S. aureus and S. epidermidis as well as being capable of 
inhibiting virulence determinant production and the induction of antibiotic 
resistance mechanisms (Kenny et al., 2009; Neumann et al., 2015). However, 
survival assays of squalene-treated cells challenged with sapienic acid revealed 
that squalene did not significantly alter the resistance for either S. aureus or S. 
epidermidis (Fig 3.4), suggesting that there may not be direct causality between 
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susceptibility of staphylococci to sapienic acid and the decreased level of 
pigmentation.  
Finally, a representative human antimicrobial peptide, LL-37, was chosen to 
perform survival tests of squalene-treated cells. The cathelicidin family member 
LL-37 is the a cationic antimicrobial peptide described in humans and is 
expressed by neutrophils and stimulated keratinocytes (Kim et al., 2005). LL-37 
shows potent antimicrobial activity against Gram-positive and Gram-negative 
bacteria, fungi, and some viruses making the peptide an important component 
of the innate immune system (Gordon et al., 2005).  
For cells cultured with increasing concentrations of squalene, the susceptibility 
of S. epidermidis to LL-37 was modestly increased (one-way ANOVA, p<0.01). 
LL-37 killed 7 % more S. epidermidis cells when they were grown with 0.1 % of 
squalene and 12 % more cells after treated with 1 % of squalene (Fig 3.4). But 
for S. aureus, no significant difference between survival from LL-37 of control 
and squalene-treated cells was observed (one-way ANOVA, p=0.92). These data 
indicate that squalene does not influence the resistance of S. aureus to LL-37.       
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Figure 3.4 Survival of S. aureus Newman and S. epidermidis Tü3298 cells cultured with 
different concentration of squalene following challenge with H2O2, sapienic acid, nisin 
and LL-37. Cells were cultured with the indicated concentrations of squalene for 24 h. Cells 
were washed twice with PBS and diluted to an OD600 of 0.1. Viable Cell counts were performed 
at time zero and 90 min after challenge with antimicrobial peptides. The final concentration of 
H2O2, nisin, sapienic acid and LL-37 is 7.5 mM, 250 µg ml-1, 5 µg ml-1, and 10 µg ml-1 respectively. 
In each experiment, three replicates were conducted. In each survival test, S. aureus Newman is 
indicated as (a), while (b) represents S. epidermidis Tü3298. Asterisks show significance as 
measured by the one-way ANOVA (** P  0.01; *** P  0.001; NS: not significant). 
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3.4 Discussion 
In this chapter, the antimicrobial properties of squalene were assessed across a 
range of squalene concentrations during bacterial growth using both growth 
curve measurement and viable counts. This study showed that at least under the 
conditions tested with rich growth medium, such as BHI, squalene does not have 
antimicrobial effects on S. aureus and S. epidermidis,. Squalene neither 
interfered with cell growth nor reduced the cell quantity after 24 hours 
treatment. The conclusion of its lack of toxicity was confirmed with three 
species and multiple strains of staphylococci. There are no previous studies that 
have reported in the literature an antimicrobial effect of squalene, despite  
numerous studies describing squalene’s role as a major component of skin 
surface lipids (Pappas, 2009; Picardo et al., 2009; Spanova & Daum, 2011). 
It was noted during culture in rich growth medium that the eponymous golden 
pigment of treated S. aureus cells was dramatically reduced. To investigate this 
phenomenon, pigment was extracted from the membranes of two strains of S. 
aureus (Newman and SH1000), two pigmented coagulase-negative 
Staphylococcus species (S. capitis G390 and S. hominis DM122) and a pigmented 
Micrococcus luteus strain ATCC4698. This experiment revealed that there was a 
negative relationship between squalene addition and bacterial pigmentation, 
and confirmed this correlation was concentration depended. Given the known 
relationships between pigmentation and defence from both antioxidants and 
certain antimicrobial peptides, the comparative effects of  squalene treatment 
on S. aureus and S. epidermidis cells were studied with respect to four distinct 
types of antimicrobial: H2O2, nisin, sapienic acid and LL-37. The results revealed 
that pre-treatment of squalene has no effect on resistance to sapienic acid, but 
increased the susceptibility of S. aureus but not S. epidermidis to H2O2 and nisin. 
However, for LL-37, pre-treatment of squalene enhanced the resistance with S. 
epidermidis but did not alter the resistance of S. aureus. 
Previous work by Bindu et al (2015) showed that squalene inhibits carotenoid 
biosynthesis in S. aureus. Their study was established after completion of the 
works shown in this chapter, but the results of two studies were highly 
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consistent. We confirmed that squalene inhibits carotenoid biosynthesis in S. 
aureus, and also in other pigmented skin colonisers S. hominis, S. capitis and M. 
luteus. The absorbance spectra of three pigmented staphylococci consistently 
demonstrated that the pigmentation levels inversely correlated with increasing 
concentrations of added squalene. From these data there is no clear explanation 
for a mechanism and further in vitro tests were deemed best after a broad 
approach to identify contributing determinants via a transcriptomic study 
presented in Chapter 4. 
The staphyloxanthin biosynthesis genes are organised in an operon, crtOPQMN, 
with a sigmaB-dependent promoter upstream of crtO and a termination region 
downstream of crtN (Pelz et al., 2005). Therefore, as the only operon 
responsible for carotenoid biosynthesis, the decreased expression of the crt 
operon is expected in transcriptomic data of S. aureus cells challenged with 
squalene. In addition, sigmaB itself and the rsb operon that regulates the 
expression of the RNA polymerase accessory factor, sigmaB, may also have 
reduced transcription after squalene challenge.  
It is known that the absence of S. aureus pigment in cells growing in anaerobic 
conditions repress production of staphyloxanthin (Hall et al., 2017). If squalene 
affects pigmentation via this pathway, then expression of contributing genes of 
anaerobic metabolism, such as srrAB, ldh1, ldh2, adhE, adh, budA1, budB and nir 
operon should be up-regulated (Fuchs et al., 2007).  
Furthermore, it was reported that the cold shock protein CspA of S. aureus is 
required for maximal production of pigment (Katzif et al., 2005). Results from 
their transcriptional studies revealed that loss of CspA decreased expression of 
crt genes needed for the biosynthesis of 4,4’–diaponeurosporene, which is an 
intermediate of staphyloxanthin biosynthesis; expression of sigmaB was also 
decreased. Therefore, cspA might also show as reduced expression level in a 
transcriptomic study. 
The observation that there was a similar effect of squalene on micrococcal 
pigmentation proposes that the action of squalene on bacterial carotenoids is 
more universal. The main carotenoid pigment in M. luteus is called 
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sarcinaxanthin, which shares  several features with staphyloxanthin. Both 
pigments are C50 carotenoids that have multiple conjugated double bonds, and 
they contain at least one hydroxyl group; both these features contribute to 
strong antioxidative properties (Netzer et al., 2010). Like staphyloxanthin, 
biosynthesis of sarcinaxanthin also starts with converting C15 farnesyl 
pyrophosphate (FPP) into a longer carbon backbone. But the product from this 
step is C40 lycopene with sarcinaxanthin biosynthesis that is different from the 
C30 dehydrosqualene produced in staphyloxanthin biosynthesis. The 
biosynthetic pathways of both staphyloxanthin and sarcinaxanthin are shown in 
Fig 3.5. The proteins participant in sarcinaxanthin production are translated 
from the crtEBIE2YgYh operon (Netzer et al., 2010). Despite the different 
structures of staphyloxanthin and sarcinaxanthin, their biosynthetic pathways 
share similar enzymatic activities that might be the target for squalene to 
produce a transcriptional feedback via competitive inhibition, for example. 
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Figure 3.5 Comparison of the biosynthetic pathways of staphyloxanthin in staphylococci 
(left) and sarcinaxanthin in M. luteus (right). (Pelz et al., 2005; Netzer et al., 2010) 
 
The susceptibility of S. aureus to H2O2 was increased after treatment of squalene, 
which fits with previous reports, because staphyloxanthin contributes to 
resistance to oxidative stress such as H2O2 by scavenging free radicals with its 
conjugated double bonds (Liu et al., 2009; Götz et al., 2006). In addition, 
staphylococci possess other mechanisms that contribute to defence against 
damage by ROS such as the activity of KatA that is transcriptionally regulated by 
SigmaB, PerR and Fur, thereby enhancing the survival of cells in response to 
oxidative stress (Horsburgh et al. 2001, 2002). Thus if down-regulated 
expression of katA or the regulator genes by treatment with squalene are 
observed, this could explain increased susceptibility of S. aureus to H2O2. Since 
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the H2O2 resistance of squalene-treated S. epidermidis cells was unchanged, 
despite expressing catalase, supports squalene having an effect on enzyme 
synthesis of carotenoids. 
The results of nisin susceptibility tests of S. aureus and S. epidermidis are similar 
to the results to H2O2, where S. aureus but not S. epidermidis cells cultured with 
squalene had increased susceptibility. To interpret this result, it is necessary to 
first understand the mechanism of the antimicrobial action of nisin. 
Nisin is a heat stable, cationic lantibiotic consisting of 34 amino acids that has 
antimicrobial activity against many species of Gram-positive bacteria, but not 
Gram-negative bacteria due to their outer membrane barrier. Nisin does not 
require a membrane receptor on its target cell. Instead, after passing through 
the target cell wall via hydrophobic or electrostatic interactions with anionic 
components in the cell wall, nisin binds to the cell wall precursor named lipid II 
which is essential for bacterial cell wall biosynthesis, thereby causing either lost 
function of lipid II or pore formation, both resulting in eventual cell death (Sahl 
et al., 1987). 
It was reported that polar carotenoids modulate the fluidity properties of lipid 
membranes and such fluidity characteristics are critical to the interaction of 
membrane-targeting host defence cationic antimicrobial peptides (CAPs) with S. 
aureus (Mishra et al., 2011). Therefore, decreased fluidity of S. aureus cells 
arisen from reduced level of pigment by treatment with squalene can be a facile 
explanation. The result of the resistance of pigmentless S. epidermidis cells to 
nisin that were not influenced by squalene also supports this conclusion. 
However, there is another possible explanation, which should not be neglected. 
Hiron et al (2011) claimed that a two-component system of staphylococci, braRS, 
is involved in resistance to bacitracin and nisin. Should this be the contributing 
effector, different expression levels of braRS system between S .aureus and S. 
epidermidis might therefore be expected in transcriptomic data. 
It was hypothesised that squalene treatment would decrease the resistance to 
LL-37 of S. aureus while having no effect on S. epidermidis on the basis of LL-37 
sharing several properties with nisin. As the only cathelicidin produced by 
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humans, LL-37 is a cationic antimicrobial peptide (CAMP) expressed by 
neutrophils and keratinocytes. LL-37 contributes to human cutaneous immune 
defences against bacterial colonisers by formation of pores in the bacterial cell 
membrane (Dürr et al., 2006). Nevertheless, the susceptibility tests of S. aureus 
and S. epidermidis to LL-37 demonstrated the opposite outcome. The 
susceptibility of S. aureus to LL-37 was unaffected by squalene while that of S. 
epidermidis increased after treatment with squalene. 
Staphylococci have a number of mechanisms to withstand the action of LL-37. 
At least four proteins have been proven to contribute to survival from LL-37 
(Barns and Weisshaar, 2013): IsdA, a cell wall MSCRAMM adhesion and haem 
uptake protein, aureolysin protease, MprF and DltABCD that catalyse 
lysinylation of phospholipid and alanine transfer to teichoic acid, respectively. 
Therefore, if squalene differentially influences the expression of these genes in S. 
aureus and S. epidermidis this would account for the observed different effects of 
squalene on LL-37 susceptibility. Among these four proteins involved in defence 
against LL-37, IsdA is the one only present in S. aureus that is absent in in S. 
epidermidis. Thus if treatment of squalene triggers the increased expression of 
IsdA, this would enhance resistance to LL-37 to produce the observed outcome.  
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Chapter 4 The responses to squalene of S. aureus and S. 
epidermidis 
 
4.1 Introduction 
Understanding changes in gene expression is critical for improving our 
knowledge of the mechanisms between stimulation and response. The need for 
reliable assessment of transcript abundance in biological samples has driven 
scientists to develop more and more technologies to meet this demand. A 
decade ago, microarrays were employed for most transcriptomic analysis using 
nucleic acid probes, typically 60-mers, covalently bound to glass slides. 
Fluorescently-labelled target sequences are hybridised to the probes and 
scanned. The images are then converted to signal intensities and these data are 
processed using software specific to the application of the array (Mantione et al., 
2014). Nowadays, the matured technique of high-throughput sequencing 
provides a more advanced method to capture all RNA transcripts. RNA-Seq has 
become the favoured technique as it has better quantitative accuracy of 
measurement and the ability to obtain absolute transcript abundance. The 
technique requires RNA fragmenting prior to reverse transcription and labelling 
with adapter sequences. The sequenced transcript fragments are typically 50–
500 bp. The read sequences are then counted and assembled into full-length 
transcripts (Marguerat and Bahler, 2010).  
One apparent diﬀerence between the capabilities of microarrays and RNA-Seq is 
whether target sequences go beyond known genomic sequences. Hybridisation-
based techniques like microarray rely on and are limited to the transcripts 
bound to the array slides. Microarrays are only as good as the bioinformatic 
data available for the model organism’s genome and transcriptome. RNA-Seq 
also detects annotated transcripts but is also able to detect novel sequences 
(Howard et al., 2013). Both RNA-Seq and microarrays can help characterise 
exon junctions, detect single nucleotide polymorphisms, and detect fusion genes. 
However, microarrays can only perform that with arrays designed for those 
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purposes. Finally, unlike RNA-Seq, microarray chips need to be updated to 
contain the most up to date sequence information.  
The applications of RNA-Seq for other bioinformatic studies besides gene 
expression are far wider than that of a microarray. RNA-Seq is useful to 
distinguish host from parasite transcripts, study symbioses, and examine 
transcripts from non-model organisms (Howard et al., 2013; Croucher et al., 
2010; Perkins et al., 2009). For example, RNA-Seq was employed to monitor 
temporal changes in transcript abundance of planktonic bacteria (Ottesen et al., 
2013), which is impossible via a microarray-based approach.  
RNA-Seq can achieve higher resolution of diﬀerentially expressed genes and has 
a much lower limit of detection than a standard whole genome microarray 
(Zhao et al. 2014). For detecting low abundance transcripts, microarrays must 
be customised to have denser probes, but there is an unlimited dynamic range 
of detection for RNA- Seq due to its digital nature (Mantione et al., 2014). 
However, the RNA-Seq method to determine diﬀerentially expressed genes does 
have an inherent bias towards longer transcripts (Oshlack and Wakefeld, 2009). 
The longer the transcript the more fragments available for sequencing, as 
samples need to be fragmented during processing. Microarrays do not have this 
length bias and expression levels are proportional to the degree of hybridisation 
to probes. The only bias that exists in microarray hybridisation would be due to 
the diﬀerences in the GC content of the probes used. Typically, validation of 
diﬀerentially expressed genes can be achieved by quantitative PCR or proteomic 
methods (Fu et al., 2009). 
Statistical tests for RNA-Seq require evaluating the null hypothesis that a gene is 
not diﬀerentially expressed between two treatment groups after calculating P 
values (Marioni et al., 2008) using a Fisher Exact Test with a great resolution, 
which can accurately measure a 1.05 fold change. For RNA-Seq, there are many 
data analysis methods available, but not one standard protocol (Trapnell et al., 
2012). Analysis of RNA-Seq data also requires extensive experience and the 
bioinformatics skills necessary to process the data files (Drewe et al., 2013).  
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A variety of transcriptional data sets from staphylococci are established so far. 
RNA-seq was used to determine the differentially-expressed (DE) genes 
between wild type and gene mutant cells (Truong-Bolduc et al.,2011), between 
treated and untreated cells (Campbell et al., 2012; Price-Whelan et al., 2013; 
Cuaron et al., 2013, Muthaiyan et al., 2012; Pietiainen et al., 2009) and between 
sensitive and resistant isolates (Song et al., 2013). Across all the transcriptome 
studies of staphylococci, investigation of DE genes between the control and cells 
treated with a given stimulant is the most common application. In this chapter, 
the DE genes were determined between control and squalene-treated cells of S. 
aureus and S. epidermidis using an RNA-Seq approach. 
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4.2 Aims 
Squalene is an underestimated component of skin surface lipids with respect to 
staphylococci. In the previous chapter, it was determined that squalene plays a 
potentially important role in skin colonisation of staphylococci by reducing 
pigmentation of staphyloxanthin-expressing staphylococci, including S. aureus, S. 
hominis and S. capitis. In addition, squalene also modulated the action of several 
skin-relevant antimicrobials. Specifically, the decreased level of pigments when 
treated with squalene enhanced susceptibility of S. aureus to H2O2 and nisin. 
Decreased resistance to LL-37 of squalene-treated S. epidermidis, but not S. 
aureus was without explanation. Therefore, in this chapter the underlying 
genetic basis for these results will be investigated by determining the 
transcriptional response of S. aureus and S. epidermidis to a challenge with 1 % 
(v/v) of squalene. Further, the prolonged effects of squalene to S. aureus will be 
assessed by proteomic approach 2 hours after squalene treatment, at the end of 
exponential phase.  
The main aim of this chapter is to identify DE genes in response to squalene and 
compare the transcriptional profiles between S. aureus and S. epidermidis. It is 
expected that this approach will find differences in responses and possible 
resistance determinants by bacteria, and explain potential antimicrobial effects 
of squalene that has the potential to influence the colonisation and persistence 
of staphylococci on human skin.  
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4.3 Results 
To determine the transcriptional response of S. aureus and S. epidermidis to 
squalene, RNA-Seq was performed on squalene challenged and control cells of S. 
aureus Newman and S. epidermidis Tü3298. Cultures were challenged with 1% 
(v/v) squalene during the mid-logarithmic phase of growth (OD600=0.5), as this 
squalene concentration caused distinct change in pigmentation level (Fig 3.4). 
After 20 min challenge, RNA was stabilised using RNAlater (Qiagen) and 
incubated overnight at 4 C. Total RNA was then purified from cells the next day 
using the method described in chapter 2 (section 2.7). 
 
4.3.1 RNA quality control 
RNA samples for RNA-Seq have strict quality criteria and these were met for 
submission to the Centre for Genome Research (CGR), University of Liverpool. 
The purified RNA preparations must have low protein, salt and solvent 
contaminations, which was assessed by NanoDrop absorbance measurements to 
ensure 260/280 and 260/230 ratios over 1.8. In addition to quality, the 
required quantity of RNA samples must be above the minimum threshold 
concentration of 30 ng µl-1 and a yield of at least 3 µg is required. These 
parameters were determined by Qubit fluorometric quantitation reads (Table 
4.1). Finally, and most importantly, because of the nature of easy degradation of 
RNA, it is critical that sufficient intact RNA is obtained. This was examined using 
an Agilent bioanalyser by verifying RNA integrity (RIN) scores >7.0 and low 
evidence of degradation on the output traces (Fig 4.1). 
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Table 4.1 RNA quality control assessment.  
Purity of purified RNA samples was measured by NanoDrop and the concentration was assessed 
by Qubit. RNA integrity was tested using a bioanalyser. RIN=RNA integrity number, C=control 
condition, S=squalene challenge condition. 
 
 
 
 
 
 
 
 
 
 
 
Species Sample 
Nanodrop 
260/280
Nanodrop 
260/230
Concentration ng 
µl-1 
Sample volume 
(µl)
RIN
C1 2.2 2.2 794 5 7.4
C2 2.1 2 421 10 7.8
C3 2.2 1.8 810 5 7.8
S1 2.2 2.2 376 10 7.1
S2 2.1 2.2 399 10 9
S3 2.2 2.3 547 6 9
C1 2.2 2.4 900 5 8.7
C2 2.2 2.4 1200 5 9.3
C3 2.2 2.4 1200 5 9.2
S1 2.2 2 565 6 8.8
S2 2.2 1.8 610 6 8.7
S3 2.2 2.1 754 6 8.6
S. aureus
S. epidermidis
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A.  B.  
C.    D.     
E.        F.   
G.    H.  
I.   J.   
K.   L.  
Figure 4.1 Bioanalyser traces of RNA samples submitted for sequencing. The visual output 
for the determined RNA integrity using the Agilent bioanalyser showed the characteristic 
profiles for purified, intact RNA with expected levels of particular sizes of RNA. The pronounced 
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two large peaks indicates the presence of 23S and 16S RNA and other small peaks suggest their 
degradation. The three bands in gel image on the right shown the presence of 23S RNA, 16S RNA 
and the assay marker. S. aureus control condition: A, B and C; S. aureus squalene challenge 
condition: D,E and F; S. epidermidis control condition: G, H and I and S. epidermidis squalene 
challenge condition: J, K and L. 
 
 
4.3.2 Overall comparison of S. aureus Newman and S. epidermidis Tü3298 
transcriptional response to squalene challenge 
After sequencing, sequence reads were analysed and processed first by the CGR 
resulting in two output tables of statistically significantly DE genes of S. aureus 
Newman and S. epidermidis Tü3298 between the control and squalene-treated 
samples. The method was outlined in the Chapter 2 Methods section. The DE 
genes for each species were then compared with each other to distinguish 
homologous genes that are DE in both species, which contributes to 
determining the similarities as well as differences between S. aureus and S. 
epidermidis in response to squalene. 
In response to squalene challenge, 414 genes of S. aureus Newman, which is 
15.8 % of total protein coding genes across the genome, were significantly DE, 
compared with 1,415 DE genes of S. epidermidis Tü3298 which accounts for 
60.7 % of total protein coding genes across its genome. While it would be 
tempting to suggest that S. epidermidis had a more pronounced response to 
squalene than S. aureus, the majority (1,127) of the S. epidermidis DE genes were 
altered by less than 1 log2 (2-fold), indicating that there was a greater breadth of 
response in the S. epidermidis data set. The degree of response to squalene 
between the species should therefore be considered as similar. 
Of the 1,415 DE S. epidermidis genes, 1271 had a homolog in S. aureus, but only 
181 genes were DE in both species, 83 were DE in S. aureus but not in S. 
epidermidis, and 1007 were DE in S. epidermidis but not in S. aureus (Fig 4.2a). 
Of the 181 genes that were DE in both species, 69 were similarly regulated in 
both species, of which 33 were up-regulated and 36 were down-regulated. This 
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means approximately 60% of the homologous genes were regulated in the 
opposite direction to their counterpart in the alternate species (Fig 4.2b). 
 
(a) 
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(b) 
 
Figure 4.2 Comparison of differentially expression between S. aureus Newman and S. 
epidermidis Tü3298 homologous genes after challenge with squalene. (a). There are 1271 
DE genes with a homolog in the alternate species, 181 genes were DE in both species, 83 were 
DE in S. aureus but not in S. epidermidis, 1007 were DE in S. epidermidis but not in S. aureus. (b). 
Among the 181 DE genes in both species, 112 were differently regulated and 69 were similarly 
regulated, of which the expression was increased for 33 genes and decreased for 36 genes. 
Tabulated details of the DE genes from both data sets are provided in Appendix 
Table 1 & 2. 
 
4.3.3 Comparison of DE COGs 
Clusters of orthologous group (COG) enrichment analysis is frequently used to 
assess the cellular pathways that are most affected. This approach was used to 
further analyse the response to squalene challenge for S. aureus and S. 
epidermidis. The most frequent COG classes that DE genes were assigned to can 
be determined by using the WebMGA and bespoke perl scripts. The detailed 
method is described in chapter 2 (section 2.7.9). Furthermore, if it is assumed 
that DE genes are evenly distributed across the genome, the theoretical number 
of DE genes in each COG class could be calculated as they should be proportional 
to the number of genes encoded by the genome in that class. Thus COGs analysis 
will reveal whether the actual numbers of DE genes in these orthologous classes 
are higher or lower than the calculated number. 
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(a)  
 
 
(b)  
 
Figure 4.3 Numbers of S. aureus Newman DE genes per COG class in response to squalene 
challenge. 
Comparison of numbers of DE genes between the theoretical (white bars) and the observed 
(black bars) per COG class for up-regulated DE genes (a) and down-regulated DE genes (b). The 
number of theoretical DE genes per class was calculated under the assumption that expression 
was uniform across the genome. Genes were assigned to a COG class using WebMGA, the 
number of DE genes in each class were then calculated using a bespoke Perl script. C: Energy 
0
10
20
30
40
50
60
C D E F G H I J K L M O P Q R S T U V
N
u
m
b
e
r 
o
f 
D
E
 g
e
n
e
s 
0
10
20
30
40
50
60
C D E F G H I J K L M O P Q R S T U V
N
u
m
b
e
r 
o
f 
D
E
 g
e
n
e
s 
79 
 
production and conversion; D: Cell cycle control, cell division, chromosome partitioning; E: 
Amino acid transport and metabolism; F: Nucleotide transport and metabolism; G: 
Carbohydrate transport and metabolism; H: Coenzyme transport and metabolism; I: Lipid 
transport and metabolism; J: Translation, ribosomal structure and biogenesis; K: Transcription; 
L: Replication, recombination and repair; M: Cell wall/membrane/envelope biogenesis; O: 
Posttranslational modification, protein turnover, chaperones; P: Inorganic ion transport and 
metabolism; Q: Secondary metabolites biosynthesis, transport and catabolism; R: General 
function prediction only; S: Function unknown; T: Signal transduction mechanisms; U: 
Intracellular trafficking, secretion, and vesicular transport; V: Defence mechanisms. 
 
COG analysis revealed that challenge with squalene of S. aureus resulted in COG 
classes F (nucleotide transport and metabolism), I (lipid transport and 
metabolism), M (cell wall/membrane/envelope biogenesis), P (inorganic ion 
transport and metabolism), R (general function prediction only), and S (function 
unknown) having more up-regulated genes than the theoretical number (Fig 
4.3). While COG classes C (energy production and conversion), E (amino acid 
transport and metabolism), G (carbohydrate transport and metabolism), H 
(coenzyme transport and metabolism), J (translation, ribosomal structure and 
biogenesis), and L (replication, recombination and repair) were found to have 
fewer up-regulated genes than the theoretical number. On the other hand, and 
as predicted for down-regulated genes, the ratio of the theoretical and observed 
DE genes for most of COG classes was opposite compared with that for up-
regulated genes. In most cases, COG classes with more up-regulated genes than 
the theoretical number showed fewer down-regulated genes than the 
theoretical number (COG classes F, I, M, P, R, S, C, E, G, and H). However, two 
classes of COG, J (translation, ribosomal structure and biogenesis) and L 
(replication, recombination and repair), were found to have less DE genes than 
the theoretical number for both up and down regulated genes. This discrepancy 
suggests that treatment with squalene has limited influence upon the 
expression of genes involved in these two classes. 
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(a) 
 
 
(b) 
 
Figure 4.4 Numbers of S. epidermidis Tü3298 DE genes per COG class in response to 
squalene challenge. 
The comparison of number of DE genes between the theoretical (white bars) and the observed 
(black bars) per COG class for up-regulated DE genes (a) and down-regulated DE genes (b). The 
number of theoretical DE genes per class was calculated under the assumption that expression 
was uniform across the genome. Genes were assigned to a COG class using WebMGA, the 
number of DE genes in each class were then calculated using a bespoke Perl script. C: Energy 
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production and conversion; D: Cell cycle control, cell division, chromosome partitioning; E: 
Amino acid transport and metabolism; F: Nucleotide transport and metabolism; G: 
Carbohydrate transport and metabolism; H: Coenzyme transport and metabolism; I: Lipid 
transport and metabolism; J: Translation, ribosomal structure and biogenesis; K: Transcription; 
L: Replication, recombination and repair; M: Cell wall/membrane/envelope biogenesis; O: 
Posttranslational modification, protein turnover, chaperones; P: Inorganic ion transport and 
metabolism; Q: Secondary metabolites biosynthesis, transport and catabolism; R: General 
function prediction only; S: Function unknown; T: Signal transduction mechanisms; U: 
Intracellular trafficking, secretion, and vesicular transport; V: Defence mechanisms. 
 
COG analysis of squalene treated S. epidermidis DE genes showed that there 
were more up-regulated genes than the theoretical number in COG classes C 
(energy production and conversion), E (amino acid transport and metabolism), 
G (carbohydrate transport and metabolism), M (cell wall/membrane/envelope 
biogenesis), P (inorganic ion transport and metabolism) and Q (secondary 
metabolites biosynthesis, transport and catabolism)(Fig. 4.4). There were less 
up-regulated genes than the theoretical number in COG classes F (nucleotide 
transport and metabolism), J (translation, ribosomal structure and biogenesis), 
K (transcription), and L (replication, recombination and repair). For down-
regulated DE genes, it showed a similar pattern as that of S. aureus, such that 
COG classes with greater (or fewer) up-regulated genes than the theoretical 
number were found to have fewer (or greater) numbers of down-regulated 
genes than the theoretical number (COG classes C, E, F, G, J, K, M, and Q) with the 
exception of COG class L (replication, recombination and repair) that had less 
DE genes than the theoretical number for both up and down regulations. 
S. aureus and S. epidermidis both up-regulate a greater number of genes than the 
theoretical number in cell wall/membrane/envelope biogenesis (M) and 
inorganic ion transport and metabolism (P). This may suggest global effects of 
treatment of squalene on staphylococcal membrane homeostasis and function 
that are not reflected in a change of growth rate. Meanwhile the ion 
transportation and metabolism-associated discrepancy might reflect loss of or 
difficulty of obtaining inorganic ions following challenge. Moreover, in both 
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species squalene challenge has a smaller effect than expected on transcription of 
genes associated with replication recombination and repair (L).  
There were differences between the numbers of S. aureus and S. epidermidis 
enriched COGs. After squalene challenge, S. epidermidis differentially expressed 
over 50 % more genes than S. aureus in energy production and conversion (C), 
amino acid transport and metabolism (E), and carbohydrate transport and 
metabolism (G). This may suggest that S. epidermidis has a greater need than S. 
aureus for energy after squalene treatment, or that S. epidermidis has a more 
rapid or effective adaptive response to squalene. Squalene could also act as a 
stimulus to which S. epidermidis has evolved to respond to as a competitive or 
adaptive strategy related to its niche. S. epidermidis showed overall down-
regulation of translation, ribosomal structure and biogenesis genes, which 
would indicate a decrease in protein biosynthesis. This down-regulation would 
seem to be at odds with such large-scale changes in the transcriptional profile of 
the cell in these conditions. 
 
4.3.4 Comparison of DE metabolic pathways 
KEGG mapper (version 2.1) search & colour is an online program that highlights 
the proteins within KEGG pathways based upon the users gene list (Kanehisa et, 
al., 2012). This program was executed using the lists of DE genes produced by 
the CGR. The S. epidermidis Tü3298 genome is not available for the KEGG 
database, so S. epidermidis gene names were converted to homologous gene 
names from strain Rp62a prior to use in KEGG mapper. During the analysis, 305 
DE genes (58.6 %) of S. aureus Newman and 313 DE genes (55.9 %) of S. 
epidermidis Tü3298 were not assigned into any pathways. This is due to 
incomplete pathway annotation for staphylococci to date together with 
unknown functions of genes. Analysis of these pathways contributes to 
detection of metabolic processes with DE genes and would help provide insight 
into the effect of squalene on metabolism. 
 
83 
 
Table 4.2 Squalene-regulated DE genes involved in energy production pathways in S. 
aureus Newman and S. epidermidis Tü3298. 
DE genes highlighted by KEGG mapper analysis and the level of log2 fold change in S. aureus 
Newman and S. epidermidis Tü3298 are listed. Genes that were not DE in one species are 
indicated by a dash in the relevant fold change column. Genes absent from one species are 
indicated with an “X” in both the relevant fold change column and gene name column. KEGG 
mapper output pathways relevant to this table were glycolysis/gluconeogenesis, pentose 
phosphate pathway, fructose and mannose metabolism, galactose metabolism, amino sugar and 
nucleotide sugar metabolism, pyruvate metabolism, propanoate metabolism, butanoate 
metabolism, and glutathione metabolism. 
          S. aureus Newman S. epidermidis Tü3298 
Gene name Fold change (log2) Gene name 
glcA -1.35 - SETU_01969 
ptsG -1.37 X X 
pgi - 0.81 pgi 
fbp - 0.83 SETU_01934 
fbaA - -1.13 fbaA 
tpi -1.07 - tpi 
gpmA -1.83 0.52 gpmA 
porA 0.91 - SETU_00859 
X X 0.64 SETU_02150 
X X 0.59 SETU_02151 
ldh -2.2 1.13 SETU_02009 
ald1 -1.09 1.23 SETU_01943 
gntK -1.53 - SETU_01917 
zwf - 0.83 SETU_01078 
NWMN_0534 - 0.51 SETU_00194 
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NWMN_0533 - 0.5 SETU_00193 
NWMN_1672 - 0.76 SETU_01333 
rbsK - 0.63 SETU_01955 
NWMN_0083 -1 0.57 SETU_01614 
mtlA -1.56 X X 
mtlD -1.43 X X 
mtlF -1.58 X X 
fruB -2.2 0.82 SETU_00319 
NWMN_0667 -1.7 1.05 SETU_00320 
lacD -2.02 0.67 SETU_01668 
gltA - 0.85 SETU_01259 
mqo - 0.68 SETU_02229 
sdhA -1.56 -0.66 sdhA 
sdhB -2.04 -0.72 sdhB 
sucA -1.57 1.00 sucA 
sucB -1.24 1.10 SETU_00989 
sucC - 1.12 sucC 
malA -1.33 1.43 SETU_01080 
lacF - 0.6 SETU_01667 
lacE - 0.52 lacE 
lacG - 0.74 lacG 
lacC - 0.55 SETU_01669 
pckA -1.41 - SETU_01340 
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NWMN_2459 - 0.6 SETU_01988 
pdhC - 0.64 SETU_02150 
NWMN_1315 - 1 SETU_00980 
leuA - 0.81 SETU_01540 
X X 1.19 gldA 
alsD -2.13 0.74 SETU_02007 
alsS - 1.03 SETU_02008 
mvaS - 0.75 SETU_01977 
X X 2.72 SETU_02044 
 
 
DE genes associated with general energy production were mainly up-regulated 
in S. epidermidis, but were relatively down-regulated in S. aureus (Table 4.3). 
There appears to be a trend in regulation to increase energy production in S. 
epidermidis. Specifically, genes associated with glycolysis and sugar uptake (pgi, 
SETU_01934, gpmA, SETU_02150, SETU_02151, SETU_00319, and SETU_00320) 
were up-regulated in S. epidermidis. Up-regulation of these genes will reduce 
biosynthesis of glycerolipid and lipoteichoic acid in favour of glycolysis. 
Furthermore, genes that allow NADPH/NADP+ recycling (SETU_02009, 
SETU_02044, and SETU_01078) and those involved in pyruvate metabolism 
(SETU_02009, SETU_00980, SETU_01943, SETU_02150, SETU_02008 and 
SETU_02007) were all up-regulated in S. epidermidis. However, an exception 
was found that two genes associated with succinate metabolism, sdhA and sdhB, 
were down-regulated in both S. aureus and S. epidermidis. Since these two genes 
are critical in TCA cycle function, and other genes involved in this cycle are 
mainly up-regulated in S. epidermidis (therefore not a global down-regulation in 
TCA cycle), the reason for their reduced expression needs to be further studied. 
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Table 4.3 Squalene-regulated DE genes involved in ammonia production pathways in S. 
aureus Newman and S. epidermidis Tü3298. 
DE genes highlighted by KEGG mapper analysis and the level of log2 fold change in S. aureus 
Newman and S. epidermidis Tü3298 are listed. Genes that were not DE in one species are 
indicated by a dash in the relevant fold change column. Genes absent from one species are 
indicated with an “X” in both the relevant fold change column and gene name column. KEGG 
mapper output pathways relevant to this table were purine metabolism, arginine and proline 
metabolism, and nitrogen metabolism. 
S. aureus Newman S. epidermidis Tü3298 
Gene name Fold change (log2) Gene name 
NWMN_0083 -1 0.57 SETU_01614 
purF -0.92 -0.79 purF 
purD - -0.94 purD 
purN -0.55 -0.68 SETU_00667 
purL -0.94 -0.56 SETU_00664 
purM - -0.94 SETU_00666 
purB - -0.95 SETU_01466 
purH -0.4 -0.9 purH 
guaC - -0.63 SETU_00914 
pnp -1.71 X X 
pnpA - -0.63 SETU_00843 
guaB 0.83 -0.68 guaB 
gmk - -0.58 gmk 
guaA - -0.83 guaA 
adk - -1.31 adk 
NWMN_0378 1.13 -0.52 SETU_00042 
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NWMN_0519 - -0.85 SETU_00180 
NWMN_0518 - -0.76 SETU_00179 
glnA - -1.35 glnA 
X X 0.8 gltD 
argH -2.34 -0.32 SETU_00508 
argG -2.52 -0.51 argG 
 
 
The expression of genes involved in ammonia production was down-regulated 
in both S. aureus and S. epidermidis, and this trend was more pronounced in S. 
epidermidis. In S. epidermidis, the entire pur operon, guaA, guaB, and 
SETU_00914 were down-regulated with each involved in purine biosynthesis. 
Down-regulation of these genes will result in decreased production of purine. In 
addition, genes associated with consumption of the ammonia pool were also 
generally down-regulated (SETU_00843, gmk, adk, SETU_00042, SETU_00180, 
SETU_00179, glnA, SETU_00508, and argG) which would indicate less 
consumption of the ammonia pool in the cell. The latter regulation may suggest 
a coordinated response due to reduced ammonia production. 
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Table 4.4 Squalene-regulated DE genes involved in amino acids production pathways in S. 
aureus Newman and S. epidermidis Tü3298.  
DE genes highlighted by KEGG mapper analysis and the level of log2 fold change in S. aureus 
Newman and S. epidermidis Tü3298 are listed. Genes that were not DE in one species are 
indicated by a dash in the relevant fold change column. Genes absent from one species are 
indicated with an “X” in both the relevant fold change column and gene name column. KEGG 
mapper output pathways relevant to this table were histidine metabolism, glycine, serine and 
threonine metabolism, cysteine and methionine metabolism, lysine biosynthesis, valine, leucine 
and isoleucine biosynthesis and alanine, aspartate and glutamate metabolism. 
S. aureus Newman S. epidermidis Tü3298 
Gene name Fold change (log2) Gene name 
hisA - 0.41 SETU_02132 
hisB - 1.04 hisB 
hisC 1.4 0.59 SETU_00345 
hisD - 0.66 SETU_02135 
hisF - 0.38 SETU_02131 
hisG - 0.87 hisG 
hisH - 0.68 hisH 
sdhA -1.56 -0.66 sdhA 
sdhB -2.04 -0.72 sdhB 
thrC -0.88 1.66 SETU_00906 
NWMN_1228 - 1.35 SETU_00894 
thrB - 0.98 SETU_00907 
pyrB 
 
-0.62 pyrB 
pyrC -2.49 - pyrC 
pyrR - -1.3 SETU_00769 
pyrG - -1.34 pyrG 
89 
 
pyrAB -1.86 - carA 
leuB - 0.6 SETU_01541 
leuD - 0.92 leuD 
ilvB -0.99 0.61 SETU_01537 
ilvC - 1.01 SETU_01539 
ilvE - 0.91 SETU_00172 
serA - 0.6 SETU_01286 
dapA -0.85 1.27 dapA 
dapB -0.79 1.25 SETU_00970 
dapD -0.68 1.13 SETU_00971 
metL - 1.54 SETU_00905 
metB 0.9 - SETU_00066 
cysM 1.64 - cysM 
cysK - 1.28 cysK 
asd -1.01 0.94 SETU_00968 
gltD - 0.8 gltD 
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There was no consistent trend between two species with respect to DE genes 
involved in amino acids biosynthesis after squalene challenge. In S. epidermidis, 
genes for the production of histidine (SETU_02132, hisB, SETU_00345, 
SETU_02135, SETU_02131, hisG, and hisH), threonine (SETU_00906, 
SETU_00894, and SETU_00907), leucine (SETU_01541 and leuD), isoleucine & 
valine (SETU_01537, SETU_01539, and SETU_00172), lysine (dapA, SETU_00970, 
and SETU_00971), cysteine (cysK), and glutamate (gltD) were up-regulated. 
While genes responsible for catabolism of amino acids into energy (sdhA, sdhB, 
pyrB, SETU_00769, and pyrG) were all down-regulated. This might indicate 
accumulation of amino acids in the S. epidermidis cell or homeostasis to a new 
threshold, consistent with  protein synthesis or proteome restructuring. In S. 
aureus, production of histidine and cysteine was increased as well, but 
biosynthesis of threonine, isoleucine and lysine was down-regulated. This 
suggests a different protein synthesis or restructuring mechanism or strategy 
towards homeostasis, which requires different amounts and types of amino 
acids. 
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Table 4.5 Squalene-regulated DE virulence factor genes in S. aureus Newman and S. 
epidermidis Tü3298. 
DE genes highlighted by KEGG mapper analysis and the level of log2 fold change in S. aureus 
Newman and S. epidermidis Tü3298 are listed. Genes that were not DE in one species are 
indicated by a dash in the relevant fold change column. Genes absent from one species are 
indicated with an “X” in both the relevant fold change column and gene name column. KEGG 
mapper output pathways relevant to this table was S. aureus infection. 
S. aureus Newman S. epidermidis Tü3298 
Gene name Fold change (log2) Gene name 
aur - -1.08 SETU_02085 
clfA -1.17 X X 
sbi 1 X X 
sdrC 0.9 X X 
sdrD 1.51 X X 
lukS 1.82 X X 
lukF 1.54 X X 
hlgB 1.81 X X 
hlgC 1.74 X X 
NWMN_1503 1.44 X X 
vraF - -0.82 SETU_00278 
vraG - -0.82 SETU_00279 
fmtC - -1.14 SETU_00936 
saeS - -2.09 SETU_00325 
saeR - -2.1 SETU_00326 
dltA - -2.75 SETU_00479 
dltB - -2.44 SETU_00480 
dltC - -2.72 dltC 
dltD - -2.4 SETU_00482 
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dltX - -2.8 dltX 
X X -2.6 SETU_02365 
ssl2nm 1.52 X X 
ssl3nm 1.35 X X 
ssl4nm 1.35 X X 
ssl5nm 1.27 X X 
ssl9nm 1.25 X X 
ssl6 1.09 X X 
isdA 1.61 X X 
fnbB 1.91 X X 
 
 
 
The regulation of expression of a subset of virulence genes showed opposite 
patterns between S. aureus and S. epidermidis. In S. aureus, the majority of these 
virulence factors were up-regulated after challenge. This includes IsdA that has 
been described to increase cell hydrophobicity independent of its role in haem 
iron acquisition (Clarke et al., 2007). In addition, these up-regulated genes 
encode toxins that target leukocytes such as lukS, lukF, hlgB, and hlgC, genes 
predicted to play a role in tissue adhesion specificity including sdrC and sdrD 
and a series of genes encoding or predicted to encode immune evasion 
determinants including NWMN_1503, ssl2nm, ssl3nm, ssl4nm, ssl5nm, ssl9nm, ssl6 
(Omoe et al., 2004; Orwin et al., 2001; Niedergang et al., 1995).  
Contrastingly, squalene repressed most of the DE virulence genes in S. 
epidermidis. This response includes down-regulation of SETU_02085 (aur) 
which encodes the aureolysin, the entire dlt operon whose products mediate 
cell surface charge, fmtC which catalyses lysinylation of phospholipid and vraF 
that co-regulates dlt. Collectively, the encoded proteins possess the ability to 
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alter cell surface hydrophobicity/charge. Moreover , the central virulence 
associated two-component regulator (TCR) in staphylococci, saeRS, was also 
repressed after squalene challenge. This TCR is proposed to have an 
overarching role in expression of virulence factors independent of the quorum-
sensing agr system. Down-regulation of SaeRS TCR may explain the reduced 
expression of other virulence genes in S. epidermidis. Due to broadly enhanced 
expression of the observed suite of virulence genes in S. aureus, it is predicted 
the saeRS-encoded TCR is activated during squalene treatment. However, no 
significant changes in expression were observed in S. aureus data, which could 
merely reflect the known genetic signature of the saeRS locus S. aureus Newman. 
Alternatively, other mechanisms affected by squalene that regulate the 
virulence factors.  
From the above analysis, it was revealed that S. aureus and S. epidermidis exhibit 
many discrete responses to squalene, despite sharing a high number of 
homologous genes. The overall trend of regulation was similar in some 
pathways, but not others. These variations of gene expression could result from 
the different lifecycles and frequency in host niches. S. aureus is a more virulent 
pathogen with a limited niche, while S. epidermidis is a ubiquitous skin coloniser.  
 
 
 
 
 
 
 
 
 
 
94 
 
4.3.5 Squalene transcriptome and S. aureus pigmentation 
 
 
Figure 4.5 DE genes in response to squalene challenge in S. aureus Newman of the 
staphyloxanthin biosynthetic pathway .  
In each box linked to the respective enzymes, the expression changes relative to the control are 
shown as fold number. Green colour indicates the respective transcript was significantly down-
regulated. CrtO, NWMN_2465; CrtI, NWMN_2464; CrtQ, NWMN_2463; CrtM, NWMN_2462; CrtN, 
NWMN_2461. 
 
The negative effects of squalene on bacterial pigmentation were reported in 
Chapter 3, where experiments with three pigmented staphylococcal species 
consistently demonstrated that their pigmentation was reduced with increasing 
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concentration of added squalene. As stated in Chapter 3, staphyloxanthin (STX) 
is produced via the crt operon in staphylococci. In the first step of STX 
biosynthesis, two molecules of farnesyl diphosphate are condensed to form 
dehydrosqualene, catalysed by CrtM. Next the dehydrosqualene is 
dehydrogenated by CrtN to form the yellow intermediate 4,4-
diaponeurosporene. Next, CrtP converts 4,4-diaponeurosporene into 4,4-
diaponeurosporenic acid by oxidising the terminal methyl group. In the final 
steps, 4,4-diaponeurosporenic acid is firstly esterified by CrtQ and then acylated 
to form STX by CrtO (Fig 3.5). From the experiments in Chapter 3, the decreased 
expression of crt operon was expected to be evident in the transcriptomic data 
of S. aureus cells challenged with squalene. It was considered that this reduction 
might occur via changes in the expression of SigmaB, which is the sole RNA 
polymerase accessory factor that regulates the crt operon via altered transcript 
levels (Katzif et al., 2005).  
As expected, the five crt operon genes concerned with staphyloxanthin 
biosynthesis, crtM, crtN, crtI, crtQ, and crtO showed a decreased level of 
expression ranging from 2.5 to 4 fold (Fig 4.5). This decline of expression 
explains the reduced cell pigmentation, however sigB expression was 
unchanged. This may reflect changes to the activity of the rsbU, rsbV and rsbW 
modulators and anti-sigma factors that control SigmaB or it could indicate there 
is another regulatory pathway modulating crt expression. 
Absence of pigment in S. aureus cells growing in anaerobic conditions is 
associated with anoxia and the consequent absence of ROS. The cold shock 
protein CspA of S. aureus is required for maximal production of pigment (Katzif 
et al., 2005). The expression of representative anaerobic metabolism genes and 
CspA could therefore participate in the phenotype and be modulated. 
Expression of the anaerobic respiration genes srrA (-2.41-fold), ldh (-2.2-fold), 
nrdD (-3.07-fold), and narI (-4.6-fold) were all down-regulated. The expression 
level of expression of adhE, adh, budA, budB, and cspA remained the same. 
Overall, these changes in gene expression rule out effects of respiration or CspA 
in the mechanism controlling squalene reduction of pigmentation. 
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4.3.6 Squalene effects on the transcriptome and iron uptake 
 
 
 
Figure 4.6 Assignment of DE genes of iron-uptake systems in response to squalene 
challenge in S. aureus Newman.  For each box linked to a DE gene, the fold changes of 
squalene-challenged cells compared with untreated control are shown. Red colour indicates the 
respective transcript was significantly up-regulated. sfaA: NWMN_2081; sfaB: NWMN_2080; sfaC: 
NWMN_2079; sfaD: NWMN_2082. 
One major correlation between the responses of both staphylococcal species is 
that genes encoding iron transport are up-regulated in both species, while the 
iron storage molecule ferritin gene is down-regulated. This, combined with the 
up-regulation of the haem-iron surface uptake system genes isdA, isdB, isdC, isdE, 
isdG and isdF in S. aureus, suggests squalene induces an iron limitation response 
in both species. There is also down-regulation of some enzymes that utilise iron, 
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such as sdhA, sdhB, SETU_01279 (nifZ), and adhE. Overall, there were 24 iron-
uptake-related genes with increased differential expression in the 100 most up-
regulated genes, in terms of fold-change, in the S. aureus DE transcriptome. S. 
aureus is remarkable for having the most numerous pathways for iron 
acquisition across those bacteria characterised to date, including production of 
siderophores (staphyloferrin A and staphyloferrin B) for extracellular iron and 
production of heme and haemoglobin receptors for heme uptake (Hammer and 
Skaar, 2011). With respect to siderophore biosynthesis, the data showed both 
genes which encode enzymes for staphyloferrin A production (sfaA and sfaC) 
and the entire sbnABCDEFGHI operon for staphyloferrin B were significantly up-
regulated (Fig 4.6). Expression of the sirABC operon whose translational 
products control staphyloferrin B import and fhuB that mediates 
xenosiderophpre transport were also enhanced over 2-fold. To obtain haem-
iron from its host, S. aureus has evolved the iron regulated surface determinant 
(Isd) system encoded by isdA, isdB, isdCDEFsrtBisdG, isdH, and orfXisdI for 
acquisition, transport and release of heme-iron. Within the transcriptome data, 
the expression of isdA, isdB, isdC, isdD, isdE, isdF, isdG and srtB were all elevated 
(Fig 4.6) indicating an activation of the Isd system after challenge with squalene. 
In contrast with S. aureus, S. epidermidis possesses considerably fewer iron 
acquisition systems (Hammer and Skaar, 2011). The transcriptional data of S. 
epidermidis revealed that the expression of four genes annotated as iron ABC 
transporters were increased over 2-fold following squalene challenge, and their 
homologs (annotated as SstABCD ferrichrome transporter) were in the DE 
transcriptome data of S. aureus (Table 4.6). Collectively, these results are 
indicative of enhanced iron uptake as a common biological response of these 
skin colonisers under squalene  challenge conditions. 
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Table 4.6 Changes in gene expression of a putative iron compound ABC transporter 
S. aureus S. epidermidis 
Gene name Fold change (log2) Gene name 
NWMN_0703 (sstB) 1.5 1.11 SETU_00357 
NWMN_0704 (sstC) 1.23 1.1 SETU_00358 
NWMN_0705 (sstD) 0.92 1.09 SETU_00359 
NWMN_0702 (sstA) 1.38 1.01 SETU_00356 
 
 
 
 
 
 
 
4.3.7 Quantitative PCR validation 
Validation of the RNA-Seq data was performed by quantification of selected DE 
genes in the squalene challenge RNA-Seq dataset using qPCR. The fold changes 
for each gene between control and squalene challenge samples were 
determined and then compared with RNA-Seq data. At least three biological and 
two technical qPCR replicates were used for each gene. RNA integrity was 
assessed by gel electrophoresis prior to conversion to cDNA for qPCR.  
The crtI, isdA, and fnbB transcript levels and SETU_00479 (dltA), SETU_00325 
(saeS), and SETU_00357 (sstB iron ABC transporter homolog) transcript levels 
were assessed for both S. aureus and S. epidermidis respectively. Collectively 
these genes are representative of carotenoid biosynthesis, iron acquisition, and 
virulence factor expression and regulation. All primers chosen had amplification 
efficiency values above 90 % and gave products of approximately 150 bp. The 
primers and their efficiency values are shown in Table 4.7. 
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Table 4.7 Primers for qPCR  
Gene name Primer sequences Efficiency (%) Reference 
crtI F- CCGGCAAGCTCAGGATATGT 92.2 This study 
  R-TACTGGCGCTTGTGTGTGAT 
 
  
isdA F- CAATCAAGCTGTAAGTG 94.6 This study 
  R- CCTAAAAGGGCAAGTGTTGCG 
 
  
fnbB F- CTCATGGTATCTCAACACTGC 90.4 This study 
  R- TGCGTCACTGTTGTAGGATC 
 
  
SETU_00479  F- GGAACAGACAAATGCACAAG 90.6 This study 
  R- ATACCATCCATTCTGCGA 
 
  
SETU_00325  F- GGATGGCGTCATTAGTGAT 91.0 This study 
  R- CAAGTAATTGATCGAGCTG 
 
  
SETU_00357  F- GGTGAACAAGCAACTGTTG 90.5 This study 
  R- CCTAATATTACACCAACTAGT     
 
 
The fold-level changes in expression that were determined from the qPCR data 
were consistent with RNA-Seq, where down-regulation of genes crtI, 
SETU_00479, and SETU_00325, as well as up-regulation of genes isdA, fnbB, and 
SETU_00357 were also observed in qPCR results  (Fig 4.7). All the fold-level 
changes showed broadly similar regulation that was in the same direction as the 
RNA-Seq data. However, results of qPCR data showed different absolute values 
compared with RNA-Seq data. The fold-level changes in the expression of genes 
crtI, isdA, SETU_00479 and SETU_00357 were lower. This phenomenon may be 
due to different methods of testing between two technologies. Overall, the data 
from qPCR supports the changes in the RNAseq dataset. 
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Fig 4.7 Differential expression of crtI, isdA, and fnbB in S. aureus and SETU_00479, 
SETU_00325, and SETU_00357 in S. epidermidis after challenge with squalene, assessed by 
qPCR.  Black bars indicate the fold change in gene expression from RNA-Seq data while white 
bars indicate those values from qPCR data. 
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4.3.8 Quantitative Proteomics analysis 
While the bacterial responses to squalene was determined by transcriptomics 
after 20 min challenge, investigation of a prolonged exposure was also deemed 
to be valuable. Changes in protein expression during late exponential growth 
phase, due to the presence of squalene was investigated using quantitative 
methods.  The aim was not to directly confirm transcriptional data from 
challenge at 20 min, but to glean insights into expression at another growth 
stage that might associate with the described squalene-associated phenomena.  
Therefore, protein expression differences between squalene-treated and 
untreated S. aureus  were determined 2 h after squalene treatment, when cells 
were at the end of exponential phase.  
In the proteomics experiment data, of the 1240 identified proteins identified 
with at least one peptide (47.3 % of the total proteins in S. aureus), there were 
133 proteins with significantly changed abundance in squalene conditions. 
These proteins were further analysed based on the identified unique peptides. 
Proteins with less than 2 unique peptides were filtered out due to low validation 
of identification. Consequently, 21 proteins were selected from the proteomics 
experiment with > 1.5-fold change (Table 4.8). 
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Table 4.8 Differential protein expression compared with RNAseq expression data. S. 
aureus cells were challenged with 1% (v/v) squalene during the mid-logarithmic phase of 
growth (OD600=0.5). Proteins were identified 2 h after squalene challenge, at the end of 
exponential growth phase. For comparison, corresponding transcripts 20 min after squalene 
challenge are shown.  Expression of proteins listed was >1.5 fold changed relative to untreated 
control. A dash indicates that a protein or its cognate gene was not altered in expression.  
Name Description 
 Fold 
change in 
Proteomics 
Fold change in 
Transcriptomics 
Chp Chemotaxis inhibitory protein 18.28 - 
HlgB Gamma hemolysin component B 4.25 3.51 
HlgC Gamma-hemolysin component C 4.24 3.47 
NWMN_1076 Uncharacterised protein 3.5 4.29 
FnbA Fibronectin binding protein A 3.4 - 
FnbB Fibronectin binding protein B precursor - 3.76 
NWMN_2543 
N-acetylmuramoyl-L-alanine amidase domain 
protein 
3.2 - 
LukF Leukocidin/hemolysin toxin family F subunit 2.81 2.9 
Coa Coagulase 2.49 - 
NWMN_0757  Secreted von Willebrand factor-binding protein 2.44 - 
LukS Leukocidin/hemolysin toxin family S subunit  2.37 3.53 
HlgA Gamma-hemolysin component A 2.22 - 
CtpA Carboxyl-terminal protease 2.17 - 
NWMN_0429 N-acetylmuramoyl-L-alanine amidase aaa 1.88 - 
NWMN_1831 Ferritin -1.52 -2.53 
PckA Phosphoenolpyruvate carboxykinase 1.5 - 
AldA Aldehyde dehydrogenase homolog 1.5 -2.41 
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MsrA Peptide methionine sulfoxide reductase MsrA 1.5 - 
Fib Fibrinogen-binding protein 1.5 - 
SpxA Regulatory protein Spx  -1.5 - 
AdhE Aldehyde-alcohol dehydrogenase -1.68 -9.85 
 
 
 
Although not intended as a direct comparison, there was agreement between 
most of the proteins with altered expression and their transcripts in the RNA-
Seq data of squalene challenge.  Six up-regulated proteins, that were also DE in 
squalene challenge transcriptome, included known virulence factors, such as 
gamma hemolysin components HlgB and HlgC, leukocidin proteins LukF and 
LukS, and fibronectin binding proteins FnbA (Table 4.8).  Additional virulence 
factors were also up-regulated in the proteomics data such as the chemotaxis 
inhibitory protein CHIPS, γ-hemolysin component HlgA, and coagulase protein 
Coa. These data further support that squalene activates the SaeRS TCS and 
induces an invasive phenotype in S. aureus.  
In further agreement with the RNA-Seq data, ferritin and the iron-containing 
alcohol dehydrogenase AdhE were both down-regulated. S. aureus uses ferritin 
to safely store iron intracellulary without risking inducing oxidative stress 
(Theil, 1987), and biosynthesis of AdhE requires iron. The down-regulation of 
ferritin and AdhE, combined with the up-regulation of iron-acquisition genes, 
strongly indicates that squalene induces iron limitation in staphylococci. 
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4.3.9 Experimental evolution of S. aureus with squalene selection 
On the basis that squalene challenge triggered the derepression of iron 
acquisition mechanisms and reduced pigmentation of S. aureus, it was 
hypothesised that squalene might act as a selective pressure due to reduced 
iron levels and increased susceptibility to oxidative stress.  Experimentally, the 
selection of mutations that confer adaptation of S. aureus to these phenotype-
driving effects of squalene might identify genetic variation that enhances 
growth and determinants targeted by squalene. Therefore, experimental 
evolution of S. aureus with squalene as a selective agent was performed. Since 
squalene does not exhibit antimicrobial effects on S. aureus in rich medium 
(chapter 3), broth supplemented with squalene was used as growth medium in 
serial passages at a concentration that was consistent with previous RNA-Seq 
experiments. After passages, the purification and pooling DNA from end-point 
and untreated control isolates for sequencing, will enable more isolates to be 
sequenced without additional costs to reveal contributing Single Nucleotide 
Polymorphisms (SNPs) and Insertions and Deletions (INDELs). A high frequency 
of variance at a particular sequence might indicate the SNP contributes to 
improved growth fitness under selection. It was expected such variation 
compared with the parental strain would be a strategy to reveal the actions of 
squalene upon S. aureus.  
The wild-type strain, S. aureus Newman was passaged by repeated incubations 
in broth containing 1 % (v/v) squalene in 24 h batch cultures for 14 d. From the 
second day forward, cells that were cultured for 24 h with squalene were 
diluted to OD600 reading of 0.02 and added into fresh broth with the same 
concentration of squalene. A control culture was also grown using the same 
method with passage of the parental stain for 14 days in broth without squalene. 
Any genetic variance in the control culture would help to filter out mutations 
selected during continuous culture in the broth over 14 d. The passages were 
performed in duplicate experiments. By the end of the 14 passages, 6 isolates (3 
from squalene passage, 3 from broth passage) from each duplicate experiment 
were randomly picked and their genomic DNA was extracted and equal amounts 
of each clone was added to make a DNA pool for sequencing.  
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Prior to sequencing, DNA samples were assessed to ensure these were of 
sufficient quality and quantity for sequencing as judged  by 260/280 & 260/230 
ratios greater than 1.8 (Table 4.9) and suitable integrity (Fig 4.8), using 
procedures described in earlier chapters.  
DNA from the chosen isolates was sequenced and the reads were aligned to the 
reference Newman genome using Burrows-Wheeler aligner (BWA) aln and 
sampe packages (Li and Durbin, 2009, Li and Durbin, 2010) version 0.5.9-r16.  
After alignment, SNPs and INDELs were called and filtered using a bespoke perl 
script, which utilised the SNPEff version 3.4e open source software. SNPs and 
INDELs that were synonymous or intergenic and more than 200 bp upstream of 
a transcriptional start site were filtered out. A second bespoke perl script was 
used to filter SNPs or INDELs identical to any found in either of the controls of 
the parental strain or the pool of no squalene passage isolates. After filtering 
twice, the remaining SNPs and INDELs were considered candidates for loci 
contributing to adaptation.  
However, there were no non-synonymous SNPs identified from the evolution 
experiment. The most plausible reason for this outcome is a lack of selective 
pressure, thereby preventing increases in variants. The outcome also implies 
that although the expression of genes for iron acquisition was elevated, the 
cellular iron availability did not fall below the limit for survival and 
reproduction. The experimental evolution experiment was conducted in rich 
medium which was iron replete. Therefore, future experimental evolution could 
be performed in iron-limited CDM medium used in previous experiments to 
produce a growth selection due to additional iron limitation. In that case, 
genetic variants that overcome the effects of squalene might be selected 
successfully. 
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Table 4.9 Quality control analysis results for DNA samples of S. aureus Newman 
submitted for sequencing. Data of the quality checks performed prior to DNA sequencing. 
Concentrations and 260/280 and 260/230 absorbance reading were assessed by Qubit and 
Nanodrop, respectively. C0: parental S. aureus Newman strain without passage; C1: passage 
without squalene; S: passage with squalene. C1 and S were made as pools consisting of 6 
genomes from selected isolates with the same amount of DNA. 
Strain Sample  
Nanodrop 
260/280 
Nanodrop 
260/230 
Concentration ng 
µl-1  
Sample 
volume (µl) 
S. aureus Newman 
C0 1.9 2.3 102.6 19.5 
C1 2.0 2.2 95.7 21.0 
S 2.1 2.2 110.0 18.0 
 
                              
 
Figure 4.8 Gel electrophoresis of purified genomic DNA of pooled isolates. No apparent 
sign of degradation was observed, indicating the genomes of these isolates were intact. C0: 
parental S. aureus Newman strain without passage; C1: passage without squalene; S: passage 
with squalene. C1 and S were made as pools consisting of 6 genomes from selected isolates with 
the same amount of DNA.  
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4.4 Discussion 
In Chapter 3, the experiments identified a concentration dependent negative 
relationship between squalene treatment and bacterial pigmentation. In 
addition, the comparative results of growth in the presence of squalene with S. 
aureus and S. epidermidis cells demonstrated that squalene modulates the 
function of three distinct antimicrobials, H2O2, nisin and LL-37. In this chapter, 
the transcriptional responses of S. aureus Newman and S. epidermidis Tü3298 to 
squalene were determined. The main aims in this chapter were to compare the 
DE genes of S. aureus and S. epidermidis challenged with squalene to find the 
potential for a transcriptional basis to this phenomenon observed in Chapter 3, 
and determine the extent to which squalene could impact upon staphylococcal 
skin colonisation.  
Overall, it was revealed that there are considerable overlaps as well as 
significant differences between both species in their transcriptional responses 
to squalene. A greater number of DE genes were found for S. epidermidis, 
however the extent of the response to squalene between the species could be 
considered mostly similar because the majority of S. epidermidis DE genes had a 
<2 fold change. 
The similarities of transcriptional response between S. aureus and S. epidermidis 
after squalene challenge were revealed by interrogation with COG and KEGG 
metabolic pathways. Both S. aureus and S. epidermidis transcriptomes revealed a 
greater number of up-regulated genes than the theoretical numbers for 
categories ‘cell wall/membrane/envelope biogenesis’ and ‘inorganic ion 
transport and metabolism’. This discrepancy  might indicate global effects of 
treatment of squalene on the staphylococcal cell surface which may also lead to 
loss of or difficulty of obtaining inorganic ions. It is coincident with the up-
regulation of genes involved with iron acquisition in both species. Moreover, 
both species revealed less active genes than the theoretical number involved in 
DNA repair which may be suggestive of innocuousness of squalene towards 
bacterial genome integrity. The KEGG maps data indicates that the expression of 
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representative genes associated with this pathway, ruvAB, rec and holAB, were 
not significantly altered, which supports the COG result. 
Another pathway sharing the same trend of regulation in response to squalene 
challenge between both species is the ammonia metabolic pathway. The overall 
expression of genes involved in ammonia production was down-regulated in 
both S. aureus and S. epidermidis. Down-regulation of the genes associated with 
consumption of ammonia pool including SETU_00843, gmk, adk, SETU_00042, 
SETU_00180, SETU_00179, glnA, SETU_00508, and argG may suggest a 
consequential compensation due to reduced ammonia production.  
It was confirmed from the RNA-Seq data that the reduction in pigmentation 
level of S. aureus after culture with squalene was most likely due to decreased 
expression of the crt operon. Although the expression level of the crt operon 
was low during exponential growth as carotenoid is a secondary metabolite, the 
whole operon was over two-fold down-regulated. This finding rejected the 
hypothesis that the effect of squalene on staphylococcal pigmentation was due 
to competitive inhibition with dehydrosqualene in the CrtN catalysed 
dehydrogenation to form the yellow intermediate 4,4-diaponeurosporene .  
Instead, but equally complex, the data supports an effector through which 
squalene interferes with pigment production by reducing transcription. 
Nevertheless, the mechanism for that is still unclear and requires future 
experiments targeting such an effector.  
At present, it is known that the crt operon is dependent on activation of the RNA 
polymerase alternative SigmaB factor. Notably sigB is not a DE gene in the RNA-
Seq data which suggests the expression of sigB was not relevant. It brings two 
hypotheses that are not necessarily independent: there is an unknown 
regulatory pathway controlling expression of crt operon, or squalene somehow 
interferes with the activity of SigmaB, but not reduces its transcription.   
Examination of the first hypothesis could be straightforward. The suite of 
transcriptional regulators in S. aureus were broadly determined (Shaw et al., 
2013) and the availability of an ordered gene inactivation library (The Nebraska 
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library) means that each regulator mutant could be targeted in a squalene-
dependent pigment assay.  
One candidate for a regulator is rsbUVW-sigB regulatory system where RsbU 
dephosphorylates the anti-anti-sigmaB factor RsbV and thus leads to the release 
of SigB from its inhibitory complex with RsbW (Pané-Farré et al., 2009).  
Inactivation of RsbU activity due to a 9 bp gene deletion in its gene renders S. 
aureus almost colourless and is a key phenotypic attribute of lab strain 8325/4 
compared with the abundant pigment expression of strain SH1000 (Horsburgh 
et al., 2002). As the RsbUVW-mediated regulation of SigB is at the protein level, 
it was conceivable that the expression of sigB could remain unchanged and 
thereby was not indicated in RNA-Seq data. Notably, the transcriptional data 
showed that the expression level of rsbV, but not rsbU and rsbW slightly 
decreased (-1.8-fold) after squalene challenge. As the anti-anti-sigB factor, 
decreased level of RsbV leads to less release of SigB from SigB-RsbW complex, in 
turns resulting in impairing the overall SigB activity. However, this transcript 
difference might not be expression level since all the other genes on the same 
transcript were not DE, and how squalene challenge solely influences the 
transcriptional level of rsbV is unclear. 
If SigB activity was abated by squalene challenge, then reduced expression of 
other genes coordinately regulated in the SigB regulon would also be expected. 
To investigate this regulation further, genes reported as members of the SigmaB 
regulon or impacted by sigB deletion (Bischoff et al., 2004) were compared with 
the DE genes in RNA-Seq data to determine if there was any overlap (Table 4.8 
& Table 4.9). 
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Table 4.10 DE genes that are positively regulated by SigmaB in S. aureus 
Gene name Description 
Up or down regulated after 
squalene challenge 
clfA clumping factor A Down 
crtM squalene desaturase Down 
crtN squalene synthase Down 
hutG formimidoylglutamase Down 
mtlA mannitol-specific IIA component Down 
mtlD mannitol-1-phosphate 5-dehydrogenase Down 
rbsR ribose transcriptional repressor RbsR Down 
 
 
 
Table 4.11 DE genes that are negatively regulated by SigmaB in S. aureus 
Gene name Description 
Up or down regulated after 
squalene challenge 
hlgB gamma-hemolysin component B Up 
hlgC gamma-hemolysin component C Up 
lip lipase precursor Down 
lrgB antiholin-like protein LrgB Down 
lukF leukocidin/hemolysin toxin family F subunit Up 
ssa secretory antigen precursor SsaA Up 
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Seven genes positively regulated by sigB were DE in the RNA-Seq data (Table 
4.10) and their expression was regulated in the same direction with that in the 
squalene challenge transcriptome. All seven DE genes were down-regulated, 
implicating that an impaired activity of SigB due to squalene challenge. 
Furthermore, six genes negatively regulated by sigB were DE in the RNA-Seq 
data (Table 4.11) with four of six shown the same direction of regulation but 
with only two exceptions. Overall, the results support the hypothesis that SigB 
activity was interrupted directly or indirectly by squalene challenge.  
Decline of pigmentation level is one explanation for increased susceptibility of S. 
aureus to H2O2 after treatment of squalene, since staphyloxanthin contributes to 
oxidant resistance, including peroxide, by scavenging free radicals with its 
conjugated double bonds (Daum 2008; Liu et al., 2008; Götz et al., 2006). 
However, transcriptional data revealed that it maybe not the only case. 
Transcription of katA, which encodes the sole catalase was down-regulated in S. 
aureus but remains unchanged in S. epidermidis. The decrease in gene 
expression of katA in S. aureus potentially exacerbates the difference in 
susceptibility between two species. Catalase expression is regulated by several 
determinants (PerR, Fur; Horsburgh et al., 2001a,b) in S. aureus, in addition to 
SigmaB; regulation by the latter is owing to an upstream SigB promoter 
(Horsburgh et al., 2002) 
As discussed in Chapter 3, polar carotenoids modulate the fluidity properties of 
lipid membranes and such fluidity characteristics are critical to the interaction 
of membrane-targeting host defence cationic antimicrobial peptides (CAPs) 
with S. aureus (Mishra et al., 2011). Therefore, decreased fluidity of the S. aureus 
cell membrane caused by reduced level of pigment due to treatment of squalene 
may lead to increased susceptibility of S. aureus cells to nisin. Moreover, it was 
reported that a two-component system of staphylococci, BraSR, is involved in 
resistance to bacitracin and nisin (Hiron et al., 2011). However, different 
expression levels of the BraSR between S. aureus and S. epidermidis was not 
observed in transcriptional data, thus whether BraSR plays a role in the 
observed nisin results cannot be confirmed . 
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In Chapter 3, it was noted that the susceptibility of S. aureus to LL-37 was 
unchanged while with S. epidermidis it increased after treatment of squalene. A 
hypothesis was proposed that differences in expression levels of isdA, aur, mprF, 
and the dltABCD operon between S. aureus and S. epidermidis may lead to this 
result as these genes were proven to contribute to defence against action of host 
LL-37 (Ryu et al., 2014). Expression of these genes was investigated in the 
current study to examine whether any differential expression might explain the 
observed phenotypes. Transcriptome data revealed mprF was not a DE gene in 
either species, while isdA was up-regulated in S. aureus, but does not have a 
homolog in S. epidermidis. Both aur and the entire dlt operon were down-
regulated in S. epidermidis but were not DE loci in S. aureus.  
The dlt operon in Gram-positive bacteria encodes proteins that catalyse the 
addition of D-alanine to wall-associated teichoic acid. The addition of this amino 
acid to the cell wall reduces negative charge on the bacterial cell surface and, as 
a consequence, reduces the interaction with cationic antimicrobial peptides 
(CAMPs) such as LL-37 (Neuhaus & Baddiley, 2003). The expression of dlt 
operon is regulated by the TCS GraRS that requires VraFG, whereby GraS senses 
CAMPs resulting in its autophosphorylation, which then phosphorylates GraR, 
driving dlt operon expression. VraFG affects expression of dlt via a positive 
feedback mechanism (Yang et al., 2011). Within the transcriptome data sets in 
this study, expression of the GraRS TCS was not altered in S. epidermidis, while 
vraFG was down-regulated (Table 4.5). This decrease in expression of vraFG 
could explain the reduced expression level of the dlt operon, and suggest that 
the expression of GraSR was unchanged. As a signal transduction system, the 
transcriptional level of GraSR does not have to decrease to reduce its 
downstream operon expression, instead, the switch from inactivation to 
activation or opposite is most critical. Therefore, absence of GraSR in 
transcriptional DE gene list does not mean the decrease in gene expression of 
dlt was not mediated by this system. Collectively, these gene expression data 
indicate that the resistance of S. aureus to LL-37 increased while that of S. 
epidermidis reduced, which explains the in vitro experimental results obtained 
in Chapter 3.  
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Overall, the reason remains unclear for the observed different regulation with 
respect to direction of virulence factor expression between S. aureus and S. 
epidermidis, as highlighted in KEGG pathway maps (Table 4.5) which was 
further confirmed in S. aureus proteomic data (Table 4.8). This difference could 
simply reflect distinct strategies possessed by the two species, particularly the 
aggressiveness of S. aureus and the relatively benign relationship that S. 
epidermidis has with its host. Both lifecycles are successful and enable the 
species to survive and spread but the less virulent species has greater 
advantages for persistence on its host (Massey et al., 2006).  The S. epidermidis 
approach consists of a series of passive mechanisms to evade host defences, 
with production of protective matrix polymers instead of the production of 
aggressive toxins. This notion was recently supported with the increasing 
investigation of S. epidermidis virulence mechanisms (Otto, 2012).  With respect 
to the study here, one possibility is that S. epidermidis has evolved to recognise 
squalene as a lipid that is a signature of its major niche, and thus decrease its 
virulence expression level for fitness purposes. In contrast, S. aureus may regard 
squalene as the sign of arrival upon host skin therefore up-regulates its 
virulence factors preparing for invasion.  S. aureus is the major skin bacterial 
pathogen of humans and it was proposed that skin infection is a key to its 
transmission (Massey et al., 2006) that discriminates it from S. epidermidis. 
Iron acquisition is a critical mechanism required for bacteria to colonise 
vertebrate hosts. This requirement is due to hosts are effectively devoid of free 
iron, with concentrations normally lower than 10-15, that ensures that all 
bacteria encounter a barrier of iron starvation to impede its invasion. Therefore, 
bacterial pathogens have evolved powerful mechanisms to sense and acquire 
iron. S. aureus is renowned for its numerous and diverse pathways for iron 
acquisition, including production of siderophores (staphyloferrin A and 
staphyloferrin B), haem and haemoglobin receptors, combined its ability to lyse 
erythrocytes through the secretion of haemolysins (Hammer and Skaar, 2011). 
The expression profile of proteins involved in iron acquisition is regulated by 
the iron-dependent ferric uptake regulator (fur) (Xiong et al, 2000; Horsburgh 
et al, 2001). Fur binds a consensus DNA motif to repress the expression of 
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downstream genes in the presence of its iron corepressor. Fur binding is non-
productive when iron limitation alters the intracellular iron corepressor 
concentration, which derepresses the expression of iron uptake genes (Hammer 
and Skaar, 2011). Inactivation of fur in S. aureus resulted in a growth defect due 
to oxidative stress caused by the unrestrained import of iron combined with 
alterations in reduced catalase expression (Horsburgh et al., 2001).  
In this study, challenge with squalene triggered the derepression of the iron 
acquisition mechanisms in both S. aureus and S. epidermidis (Fig 5). And down-
regulation of ferritin and iron-containing alcohol dehydrogenase AdhE was 
further confirmed in proteomic data of S. aureus. However, little can be stated at 
present as to why this would be an outcome pertaining to a long chain lipid with 
no functional side groups. The failure of selecting SNPs from experimental 
evolution of S. aureus indicates that the squalene treatment in rich medium 
cannot induce sufficient stress, at least under the conditions that were 
established. As the key and most intriguing finding of the transcriptomics work 
in this chapter, the effects of squalene on staphylococcal iron acquisition will be 
further investigated in Chapter 5. 
 
  
115 
 
Chapter 5 Squalene induced iron-starvation in S. aureus 
and S. epidermidis 
 
5.1 Introduction 
Numerous and diverse functions of iron have been studied in bacterial cells. 
Iron plays important roles in cell composition, intermediary metabolism, 
secondary metabolism, enzyme activity and host cell interactions associated 
with pathogenicity (Symeonidis and Marangos, 2012). Deficiency of iron can 
cause growth inhibition, decrease in RNA and DNA synthesis, inhibition of 
sporulation, and changes in morphology of cells (Symeonidis and Marangos, 
2012).  Iron contributes to intermediary metabolism processes including: 
tricarboxylic acid cycle; electron transport; oxidative phosphorylation; nitrogen 
fixation; and aromatic biosynthesis (Messenger and Barclay, 1983). Moreover, 
certain proteins and enzymes require iron such as peroxidase, superoxide 
dismutase, nitrogenase, hydrogenase, glutamate synthase, cytochromes, 
ferridoxins, and flavoproteins (Messenger and Barclay, 1983; Skaar, 2010; 
Schaible and Kaufmann, 2004; Symeonidis and Marangos, 2012). 
Humans possess several defences against bacterial infection, where the very 
first line is the withholding of nutrients including iron to prevent bacterial 
outgrowth; a process termed nutritional immunity. Greater than 90 % of iron in 
the host is intracellular, sequestered by the iron storage protein ferritin or 
bound with the haem cofactor of haemoglobin or myoglobin. Moreover, neutral 
pH and the aerobic environment of serum ensures that extracellular iron is in its 
insoluble Fe3+ form and thereby more difficult to be sequestered by invading 
pathogens. A serum protein, transferrin, even enhances this difficulty by binding 
iron with an association constant of approximately 1036 (Skaar, 2010; Schaible 
and Kaufmann, 2004). Altogether, these factors ensure that the level of free iron 
available to invading bacteria is far lower than the minimal requirement for 
most with respect to bacterial replication and causing disease. 
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The arms race for nutrient iron never ends for both host and bacterial 
pathogens. Bacterial pathogens have evolved abilities to sense iron depletion 
and this may serve as a signal that they have arrived on host tissue (Skaar, 2010; 
Symeonidis and Marangos, 2012). This sensing typically involves transcriptional 
control mediated by the iron-dependent repressor known as Fur (ferric uptake 
regulator) (Hantke, 1981; Xiong et al, 2000; Horsburgh et al, 2001). Fur binds a 
consensus DNA sequence termed ‘fur box’ to repress the expression of down-
stream Fur-regulated genes in the presence of iron cofactor. Fur releases from 
the DNA when iron is limited as cofactor and this derepresses the expression of 
iron uptake genes. The orthologs of Fur have been identified in a wide range of 
genera from both Gram-negative and Gram-positive bacteria and contributes to 
the virulence of both animal and plant pathogens (Ratledge and Dover, 2000). 
In  S. aureus, Fur also regulates the expression of staphylococcal virulence, 
including adhesins, biofilm formation, and manipulation of host wound healing 
(Athanasopoulos et al., 2006; Chavakis et al., 2002; Johnson et al., 2008). It was 
reported that Fur regulates the expression of secreted cytolytic and 
immunomodulatory toxins, which play critical roles in decreasing the host 
immune response that contributes to bacterial survival (Nizet, 2007). In 
addition to controlling iron acquisition mechanisms, Fur also positively 
regulates  glycolytic and fermentative enzymes, indicating S. aureus modulates 
its metabolism in order to adapt to the iron-starved environment by increasing 
fermentative metabolism. Increased fermentative metabolism leads to elevated 
production of lactate, and secretion of lactate in turns lowers the pH of the 
microenvironment thus impairing the affinity of transferrin for iron (Friedman 
et al., 2006). Collectively, these studies suggest the ability possessed by S. aureus 
to alter the host environment in a way that promotes the release of iron from 
host proteins presumably increasing iron availability. 
Production of siderophores is one of the key mechanisms for S. aureus to 
scavenge iron from host extracellular iron-binding proteins, such as transferrin 
and lactoferrin (Hammer and Skaar, 2011). Siderophores are small molecules  
secreted by bacteria and have an exceptionally high affinity for iron. 
Staphyloferrin A and staphyloferrin B are two distinct siderophores produced 
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by S. aureus that share many properties (Hammer and Skaar, 2011). The genes 
involved in the biosynthesis and import of both staphyloferrin A and B are 
regulated by Fur and are therefore maximally expressed in iron-limiting 
environments (Friedman et al., 2006; Lindsay and Riley, 1994). In addition to 
staphyloferrin A and B, the presence of a third S. aureus siderophore named 
aureochelin was suggested, but it is still not characterised (Courcol et al., 1997).  
A further important mechanism possessed by S. aureus for iron acquisition is 
capture of host haem that represents the primary reservoir of iron within 
vertebrates (Drabkin, 1951). Studies revealed the utilisation of haem-iron is 
preferential when S. aureus grows in the presence of both transferrin and either 
haem or haemoglobin, suggesting that haem-iron is the preferred source of iron 
during infection (Torres et al., 2006; Skaar et al., 2004). Haemoglobin is 
obtained by lysis of erythrocytes by hemolysins, and subsequent trapping, 
transportation and lysis of haem is executed by proteins expressed from the 
iron regulated surface determinant (Isd) system encoded by isdA, isdB, 
isdCDEFsrtBisdG, isdH, and orfXisdI (Hammer and Skaar, 2011). Taken together, 
S. aureus utilises a remarkable arsenal of pathways to obtain iron during 
infection.  
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5.2 Aims 
In the previous chapter, transcriptional data showed that S. aureus and S. 
epidermidis genes involved in iron acquisition were up-regulated, accompanied 
by the iron storage ferritin being down-regulated in both species. Overall, there 
were 24 iron-uptake-related genes with increased differential expression in the 
100 most up-regulated genes in terms of fold-change in the S. aureus DE 
transcriptome. The transcriptional data of S. epidermidis also revealed that the 
expression of four genes annotated as iron ABC transporters were increased 
over 2-fold following squalene challenge.  
Therefore, the primary aim of this chapter is to determine whether the 
transcriptional profile in response to iron limitation is driven by actual iron-
deficiency or inactivation of Fur but independent to iron availability. To achieve 
this, a negative relationship between iron availability in medium and expression 
of the iron-uptake genes was assessed. In addition, growth of cells in iron-
defined media was performed in the presence or absence of squalene to 
examine whether squalene could induce a further iron-limited situation thus 
inhibiting bacterial growth. Finally, intracellular iron concentration will be 
determined through ICP-OES for both squalene treated and control sample to 
provide direct evidence for whether squalene actually reduces the iron 
concentration in staphylococci. 
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5.3 Results 
5.3.1 The transcriptional profile in response to iron-limitation were 
revealed by RNA-Seq data of squalene challenge for both S. aureus and S. 
epidermidis 
As observed in chapter 4, both S. aureus and S. epidermidis significantly up-
regulated the genes associated with iron acquisition as well as down-regulated 
several genes for iron storage and utilisation. These DE genes revealed by RNA-
Seq data were summarised in Table 5.1. 
 
Table 5.1 Genes associated with iron metabolism revealed by the transcriptional data in 
response to squalene challenge. 
Gene name Description Fold change 
Found in S. aureus 
or S. epidermidis 
Genes involved in iron acquisition 
 
  
isdG cytoplasmic heme-iron binding protein 4.08 S. aureus 
NWMN_2081 biosynthesis of staphyloferrinA 3.81 S. aureus 
sbnD membrane transporter protein 3.58 S. aureus 
isdC iron-regulated cell surface protein 3.48 S. aureus 
sbnI SbnI protein 3.41 S. aureus 
sbnH diaminopimelate decarboxylase 3.36 S. aureus 
sirA siderophore compound ABC transporter 3.20 S. aureus 
srtB NPQTN-specific sortase B 3.12 S. aureus 
isdF iron/heme permease 3.07 S. aureus 
isdA iron-regulated heme-iron binding protein 3.05 S. aureus 
NWMN_2076 FecCD iron compound ABC transporter 3.03 S. aureus 
sbnG 2-dehydro-3-deoxyglucarate aldolase 2.97 S. aureus 
NWMN_2185 iron compound ABC transporter 2.83 S. aureus 
sstB iron compound ABC transporter 2.81 S. aureus 
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sbnE siderophore biosynthesis 2.81 S. aureus 
fhuB ferrichrome transport permease 2.77 S. aureus 
sbnC siderophore biosynthesis 2.69 S. aureus 
isdE iron compound ABC transporter 2.66 S. aureus 
sstA ferrichrome ABC transporter permease 2.58 S. aureus 
NWMN_2078 ferrichrome ABC transporter lipoprotein 2.51 S. aureus 
sbnF siderophore biosynthesis 2.50 S. aureus 
sstC Iron ABC transporter ATP-binding protein 2.35 S. aureus 
sirB siderophore compound ABC transporter 2.17 S. aureus 
isdB iron-regulated heme-iron binding protein 2.14 S. aureus 
fhuG ferrichrome transport permease fhuG 1.96 S. aureus 
sstD ferrichrome ABC transporter lipoprotein 1.88 S. aureus 
SETU_00357 
iron compound ABC transporter sstB 
homolog 
2.16 S. epidermidis 
SETU_00358 
iron compound ABC transporter sstC 
homolog 
2.14 S. epidermidis 
SETU_00359 
iron compound ABC transporter sstD 
homolog 
2.13 S. epidermidis 
SETU_00356 
iron compound ABC transporter sstA 
homolog 
2.01 S. epidermidis 
  
  
  
Genes involved in iron storage or utilisation 
 
  
NWMN_1831 ferritin -2.54 S. aureus 
SETU_01451 ferritin -1.26 S. epidermidis 
sdhA succinate dehydrogenase flavoprotein  -2.93 S. aureus 
sdhB succinate dehydrogenase iron-sulfur  -4.08 S. aureus 
SETU_01279  iron-sulfur cofactor synthesis protein nifZ -1.49 S. epidermidis 
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5.3.2 Iron-concentration-dependent expression of iron-uptake genes, sirA 
& sbnE 
It was known there is a negative relationship between iron availability in 
growth medium and expression level of the iron-uptake genes in S. aureus 
(Friedman et al., 2006). Confirmation of this relationship and establishment of a 
gene expression measure was achieved by quantifying the expression levels of 
two representative genes associated with siderophore production and 
transportation, sbnE and sirA, in chemically-defined medium (CDM) with 
different iron concentrations via qPCR. The primer sequences are listed in Table 
5.2. RNA integrity was assessed by gel electrophoresis prior to conversion to 
cDNA for qPCR.  
 
 
 
Table 5.2 Primers for qPCR  
Gene name Primer sequences Efficiency (%) Reference 
sirA F- GCCACTGACGTCGCTGTATC 95.2 This study 
  R- GACGCGACAATTAAGTCCGG 
 
  
sbnE F- CGATGCCTGATTCACCGATG 94.1 This study 
  R- CATACGTCGGGTATGCCATC 
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Figure 5.1 Decreased expression levels of sirA and sbnE in iron-depleted CDM with 
increasing added iron. Black bars indicate S. aureus cells cultured with 0.02 μM of iron, and 
white bars represent culture  with 0.2 μM of iron. S. aureus cells were cultured in CDM with two 
iron concentrations (0.02 μM 0.2 μM). Cells were harvested 20 min later after OD600 reached 0.5 
and cDNA was made for qPCR test. Fe(NH4)(SO4)2 was added into iron-depleted CDM to obtain the 
desired iron concentration. 
 
 
S. aureus cells were cultured in CDM with two iron concentrations, 0.02 μM, and 
0.2 μM (Fe(NH4)(SO4)2). The level of gene expression for samples cultured with 
0.02 μM and 0.2 μM of iron were compared with samples grown in iron-
deficient medium (0 μM) (Fig 5.1). The expectation was that the expression of 
sirA and sbnE would be at their maximum level in the iron-deficient condition, 
then the expression level would decrease with increasing iron concentration. As 
expected, the expression of both sirA and sbnE exhibited the same pattern that 
when iron concentration was elevated from 0 to 0.02 μM and 0.2 μM, the 
expression of both sirA and sbnE diminished. Collectively, these data confirmed 
the negative relationship between iron availability and the expression of sirA 
and sbnE. When less iron was available in broth, S. aureus cells express more 
SbnE and SirA to chelate and import iron. Since sirA and sbnE are two 
representative genes involved in staphylococcal iron acquisition and both of 
-7
-6
-5
-4
-3
-2
-1
0
sirA sbnE
F
o
ld
 c
h
a
n
g
e
 
123 
 
them are regulated by Fur, this result should apply to the rest of the Fur regulon 
identified in the RNA-Seq data that also regulated by. 
After confirmation of this inverse relationship, squalene challenge was 
performed on the basis of above experiment. In this case, squalene was added to 
a final concentration of 1 % (v/v) when OD600 reached 0.5, then the samples 
were cultured for a further 20 min, prior to cDNA preparation (Fig 5.2). Results 
revealed that the expression of both sirA and sbnE was increased after squalene 
challenge in each iron concentration. Although this increase was minor, the 
consistency of the change suggests squalene might further exacerbate the iron 
starvation of S. aureus cells.  
 
 
 
 
Figure 5.2 Comparative expression of sirA and sbnE in cells grown with increasing added 
iron, with or without 1 % (v/v) squalene challenge.  Cells were cultured in iron deficient 
CDM with either none, 0.02 μM or 0. 2 μM supplemented iron in the absence (black bars) or 
presence (white bars) of 1 % (v/v) squalene. The level of gene expression for samples cultured 
with 0.02 μM and 0.2 μM of iron were compared with samples grown in iron-deficient medium 
(0 μM). Squalene challenge was conducted when OD600 reached 0.5 and grew the samples for 
further 20 min and cDNA was made after challenge for qPCR test. Fe(NH4)(SO4)2 was added into 
no iron CDM to obtain desired iron concentration.  
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5.3.3 Squalene caused a growth defect in iron-limited media 
Having established that the derepression of iron acquisition genes in 
staphylococci was induced by squalene challenge in iron replete conditions, it 
was hypothesized that staphylococci may be iron limited following squalene 
challenge, and that this would affect their growth in iron-limited conditions. 
Hence, S. aureus and S. epidermidis were grown in CDM with and without 
Fe(NH4)(SO4)2 supplementation to generate iron concentrations in the range 0–
2 µM and also in an iron replete, rich medium  control THB medium.  Cells were 
cultured in the presence or absence of 1 % (v/v) squalene, and growth yield was 
measured by spectrophotometry after 12 hours (Fig 5.3).  
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S. aureus Newman 
 
 
S. epidermidis Tü3298 
 
Figure 5.3 Growth yield of S. aureus and S. epidermidis after 12 h growth with or without 
1 % (v/v) squalene in iron-deficient CDM with or without iron supplementation.   
Overnight culture was diluted to an OD600 of 0.02, and grown at 37°C with shaking for 12 h in the 
presence or absence of 1% (v/v) squalene in iron deficient CDM supplemented with the 
indicated concentrations of iron. Growth yield was determined by measurement of OD600. 
Shaded bars: untreated; grey: cultured with 1% (v/v) squalene. Asterisks show significance as 
measured by the Student’s T-test (** P  0.01; *** P  0.001). 
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S. aureus and S. epidermidis growth yields in iron-deficient media were lower 
than cells cultured in iron-sufficient THB medium.  In CDM that was iron-
deficient supplementation with iron (0.02 µM and 0.2 µM) progressively 
improved yield with increasing concentrations. The yield of cells in iron-
depleted media decreased in the presence of 1% (v/v) squalene, while there 
was no significant difference in yield when the medium was supplemented to an 
iron concentration at 0.2 µM and above .For S. aureus the difference in growth 
yield in the presence of squalene is statistically significant (paired t-test, 
p=0.001 and p=0.005) for cells cultured in CDM in the absence or presence of 
0.02 µM iron, respectively, while there was no significant difference (paired t-
test, p=0.27, p=0.71 and p=0.6) for cells cultured in CDM with 0.2 µM and 2 µM 
iron and in THB. Similar growth yield reductions caused by squalene were 
observed for S. epidermidis when cells were cultured in iron-depleted CDM in 
the absence of iron supplementation or with 0.02 µM iron added;  paired t-test, 
p=0.002 and p=0.003, respectively. Growth yield was not different  in the 
presence of squalene when cells were cultured in iron sufficient culture media 
(CDM with 0.2 µM, 2 µM iron, and THB), where differences were not statistically 
significant (paired t-test, p=0.3, p=0.41 and p=0.39). Altogether, these results 
revealed a growth defect of S. aureus and S. epidermidis in iron-limited media 
caused by squalene treatment, but this defect was iron concentration dependent, 
which supports the previous hypothesis that iron-limitation is induced by 
squalene challenge in both staphylococci. 
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5.3.4 Measurement of cellular iron concentration by ICP-OES 
To determine whether squalene reduces the iron uptake of staphylococci, the 
cellular iron concentration of squalene-treated cells was compared with control 
cells. To achieve this, S. aureus Newman and S. epidermidis Tü3298 were grown 
in THB in the presence or absence of 1% (v/v) squalene for 24 h.  
Approximately 108 cells of each sample was lysed by treatment with lysostaphin 
for 2 h and then analysed by ICP-OES. For analysis of iron concentration, the 
bacterial lysates were diluted 1:10 in 0.1 M HCL. Lysates were compared with 
an equivalent sample of 0.1 M HCL to determine additional iron in HCL. 
Additionally, to determine whether cellular iron was depleted as a result of 
squalene chelating iron extracellularly, a broth only control with or without 
squalene treatment was also analysed by ICP-OES. The broth only sample was 
also treated with or without 1 % (v/v) squalene for 24 h, followed by 
centrifuging and only broth was extracted for analysis as squalene forms a layer 
away from the media. Values were corrected based on CFU counts and the 
results are shown in Figure 5.4. 
 
 
 
 
 
 
128 
 
 
Figure 5.4 The cellular iron concentrations of S. aureus Newman and S. epidermidis 
Tü3298 with or without 1% (v/v) squalene treatment after 24 h.  The cellular iron 
concentration of S. aureus and S. epidermidis in the absence (black bars) or presence of 1 % (v/v) 
squalene (grey bars). A broth only (THB) control was with the absence or presence or absence 
of 1% (v/v) squalene was assayed. Bacteria were lysed using lysostaphin and diluted in 0.1 M 
HCL prior to ICP-OES tests. The final iron concentration was corrected using viable cell counts. 
Asterisks show significance as measured by the Student’s T-test (** P  0.01). 
 
 
 
Figure 5.5 Growth of S. aureus Newman in THB or squalene-extracted THB. Squalene-
extracted THB was prepared by adding 1% (v/v) squalene into fresh THB with vigorously 
shaking for 24 h, the mixture was then centrifuged and squalene was removed from the top 
layer. Yellow line: THB; green line: squalene extracted THB. 
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Staphylococcal cellular iron levels were significantly decreased in squalene-
treated cells compared with those cultured in the absence of squalene (S. aureus: 
46 % reduction, p = 0.005; S. epidermidis: 24 % reduction, p = 0.008). The THB 
control with or without squalene treatment had the same iron concentration 
(11.2 µM, p = 1). The results prove that squalene causes the decline of cellular 
iron levels and revealed that this effect was not brought about by a reduced iron 
concentration in the broth. In addition, to determine whether squalene might 
extract iron from the medium in a manner that restricts growth rate, THB 
extracted with squalene was used to culture S. aureus Newman in comparison 
with cells cultured in untreated THB (Fig 5.5). There was no evidence of growth 
differences indicating that squalene does not sufficiently influence THB to  alter 
growth kinetics, at least under the conditions tested here. 
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5.4 Discussion 
In the previous chapter, a typical bacterial response to iron-limitation was 
observed after squalene challenge as determined from transcriptomic data for 
both S. aureus and S. epidermidis. These data suggested that squalene may 
induce the iron-starvation response of staphylococci. Therefore, further 
experiments were performed in this chapter to determine if this iron limited 
response is caused by actual iron-deficiency or via an indirect route such as 
interference with Fur, but independent to iron availability. Confirmation of an 
inverse relationship between iron availability and the expression of genes 
associated with iron acquisition was conducted by using qPCR to measure the 
expression levels of two representative genes, sirA and sbnE,  associated with 
siderophore transport and biosynthesis during culture in chemically-defined 
media with different iron concentrations. Squalene challenge was also studied 
using these qPCR tests. The expression of both sirA and sbnE was further 
increased after squalene challenge in each iron concentration tested that caused 
derepression of these Fur-regulated genes. This result combined with the 
finding that squalene caused a growth defect in iron-limited media for both S. 
aureus and S. epidermidis, was strongly suggestive that iron-limitation was  
direct consequence of squalene treatment for staphylococci. The cellular iron 
concentration was then quantified using ICP-OES, showing that the cellular iron 
levels for both species of staphylococci were significantly decreased in 
squalene-treated samples, but remained unchanged for the control squalene-
treated THB. Assays using both ICP-OES and growth in squalene-extracted THB 
rule out the possibility that iron starvation in broth was brought about by 
reduced iron availability from sequestration by squalene. Collectively, the 
results in this chapter can be interpreted to propose that squalene induces iron 
limitation in staphylococci, which results in the differential expression of iron-
related genes observed in the transcriptomic data.  
However, the mechanism for how squalene treatment lowers intracellular iron 
concentration remains to be identified. Since expression of genes for iron 
acquisition were elevated in rich medium (THB) where iron is sufficient, it 
seems unlikely that squalene impedes iron-uptake pathways by reducing iron 
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affinity of siderophores or lowering the efficiency of siderophore transport, 
because very low levels of proteins for iron acquisition are required in an iron-
sufficient environment.  Squalene interfering with an iron efflux mechanism 
such that it leads to a net deficit of intracellular iron as a plausible explanation 
that requires interference with less cellular components. However, efflux 
pathways are not characterised. 
Although it is clear that access to sufficient iron is crucial for successful 
microbial persistence within the host, during the course of infection, pathogens 
may encounter stress conditions that raise intracellular free iron levels and 
promote the Fenton reaction (shown below), presenting an entirely different 
challenge to survival. The Fenton reaction proceeds rapidly at physiological pH 
and temperature, and small alterations in the concentrations of H2O2 or free 
iron can have a dramatic impact on the amount of radical production and 
resulting damage (Park et al., 2005). DNA is the most critical target of hydroxyl 
radical damage, although proteins and lipids can be affected as well. It is 
therefore required that bacterial pathogens adapt to mediate iron uptake thus 
avoiding the oxidative damage caused by overload of iron. 
  
 
 
A mechanism for iron efflux is still uncharacterized in staphylococci, but has 
been well studied in other species such as Streptococcus and Salmonella 
(VanderWal et al., 2017; Frawley et al., 2014). In Streptococcus, the PerR-
controlled metal transporter A (PmtA) which was previously implicated in 
antioxidant defences and suggested to protect against zinc toxicity was reported 
as a P1B4-type ATPase that functions as an Fe(II) exporter and contributes to 
defences against iron intoxication and oxidative stress (VanderWal et al., 2017). 
An excess of intracellular iron directly derepresses expression of pmtA and this 
induction requires action of PerR. The inactivation of pmtA resulted in increased 
sensitivity to iron toxicity and oxidative stress due to an elevated intracellular 
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accumulation of iron. In Salmonella, two proteins were identified with the 
function of reducing levels of total intracellular iron. STM3944 and IceT are both 
expressed under stress conditions and appear to aid against reactive oxygen 
species (ROS) and reactive nitrogen species (RNS) (Frawley et al., 2014). 
Therefore, if iron efflux mechanisms were also employed by staphylococci, and 
squalene interferes with this process by enhancing its action, it could result in 
reduced intracellular iron that presents in transcriptomic data and in vitro 
experiments as iron starvation. 
A separate study revealed a similar profile of up-regulated genes for iron 
acquisition in E. coli (Varghese et al., 2007). In that study, H2O2 was found to 
disrupt the activity of Fur protein, thus altering the free iron levels in E. coli. The 
mutants that cannot produce peroxidase and catalase exhibited an elevated 
expression level for genes normally repressed by Fur suggesting the repression 
function of Fur is impaired by oxidising the Fur:Fe2+ complex. However, the 
OxyR H2O2-response system restored Fur repression in iron-replete medium by 
up-regulating the synthesis of Fur protein. This co-regulation was also identified 
in S. aureus, where Fur and PerR, a functional ortholog to OxyR, was mutually 
regulated and co-regulate various genes involved in antioxidant, virulence 
factors and iron homeostasis (Horsburgh et al., 2001). As an unsaturated linear 
lipid, squalene can be partially oxidized into squalene-peroxide under culturing 
condition, which may induce the same alternation of gene expression as shown 
in the study of E. coli. But this still cannot explain why the actual total iron was 
reduced after squalene treatment. A discrete mechanism would be expected. 
Fur was also shown to be capable of modulating the expression of a variety of 
virulence factors, especially those that target host neutrophils (Torres et al., 
2010). The study reported that in an iron-deficient environment or Δfur strain 
of S. aureus, α-hemolysin (Hla), γ-hemolysin (HlgC), and leukocidin ED (LukED) 
were up-regulated, while the expression of protein A (SpA), staphylococcal 
immunoglobulin G-binding protein (Sbi), Ssl proteins (Ssl 1, Ssl 2, Ssl 3, Ssl 4, Ssl 
6, Ssl 7, Ssl 8, Ssl 9, Ssl 10, and Ssl 11), Coa, FLIPr, SCIN, extracellular fibrinogen-
binding protein (Efb), SEA, and CHIP were down-regulated (Torres et al., 2010). 
These results share similarities with the transcriptional data obtained in this 
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study. In the RNA-Seq data, the expression of hlgC, lukS, and lukF was elevated 
as well, suggesting the regulation of the genes associated with leukocytes killing 
was not solely undertaken by the saeRS two-component system. Moreover, in 
their study (Torres et al., 2010), up-regulation of hemolysin genes and down-
regulation of staphylococcal toxins were altogether interpreted as that when S. 
aureus becomes iron starved, it must acquire iron in order to survive, and thus 
Fur coordinates a gene expression profile that leads to significant host cell lysis 
and iron uptake using considerable energy, but this comes at the expense of 
decreased production of factors involved in escaping from cells of the immune 
system, which in turn results in increased susceptibility to immune cell 
clearance. But in the current study, genes involved in biosynthesis of hemolysin 
and toxin such as hlg, luk, ssl and sbi were all up-regulated by squalene challenge, 
which suggests the energy theory is less likely to be true. S. aureus is able to up-
regulate both hemolysin genes and staphylococcal toxins in response to a single 
stimulant without regard to energy consumption. 
In summary, challenge with squalene triggered derepressed transcription of the 
main iron acquisition mechanisms as well as decreased expression levels for 
genes involved in iron storage and utilisation in both S. aureus and S. epidermidis.    
These species showed growth defects in iron-limited media.  ICP-OES analysis 
revealed decreased intracellular iron following squalene treatment. ICP-OES 
analysis of squalene extracted broth and growth of S. aureus in squalene treated 
broth ruled out the possibility that squalene altered the iron concentration of 
the medium by sequestration. Taken together, these data shows that squalene 
causes iron starvation in staphylococci. 
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Chapter 6 Transcriptional response and experimental 
evolution of S. aureus to ethanol 
 
6.1 Introduction 
Ethanol is one of the most common stabilisers, solvents, and disinfectants 
employed by numerous applications. A large variety of medicines, especially 
liquids for oral application, contain ethanol, such as cough suppressants, 
expectorants and oral tranquiliser suspensions. Most alcohol-based 
disinfectants contain ethanol, typically at a concentration of 70 to 85%. As an 
example, ethanol is utilised for disinfection of medical instruments and 
implantation materials and is widely applied. As a solvent, ethanol is used in 
biological experiments to dissolve organic compounds with intermediate 
polarity or non-polar nature, such as lipids, vitamins and various antimicrobials. 
For a general dissolution purpose, ethanol is usually the first choice if water is 
not suitable.  
Ethanol possesses several bactericidal modes of action: disruption of membrane 
structure or function (Chatterjee et al., 2006; Barker and Park, 2001; Silveira et 
al., 2004); interference with cell division, affecting stationary phase growth 
(Fried and Novick, 1973); alteration of fatty acid composition and protein 
synthesis (Chiou et al., 2004); inhibition of nutrient transport via membrane-
bound ATPases (Bowles and Ellefson, 1985); alteration of membrane pH and 
membrane potential (Terracciano and Kashket 1986); and a decrease in 
intracellular pH (Huang et al., 1986). In addition, ethanol influences bacterial 
morphology, growth, and viability even at a very low concentration (<0.1%) 
(Chatterjee et al., 2006). This latter study revealed that cells treated with 0. 1 % 
of ethanol displayed alterations of cell integrity in late-stationary phase growth, 
and a profound delay of post-stationary phase recovery (>48 h) was observed 
even if ethanol in the medium was completely metabolized during exponential 
phase (Chatterjee et al., 2006). These data suggest that a much lower than 
previously reported ethanol concentration is capable of altering bacterial 
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physiology thus leading to changes in gene expression profile (Fried and Novick, 
1973; Bowles and Ellefson, 1985).  
Although the effects of various ethanol concentrations on bacteria have been 
well-established (Fried and Novick, 1973; Bowles and Ellefson, 1985; Chatterjee 
et al., 2006; Barker and Park, 2001; Silveira et al., 2004), less is known about 
how different bacteria respond to ethanol at the transcriptional level. In this 
chapter, the transcriptional responses of S. aureus to challenge with a low 
ethanol concentration (1 % v/v) were recorded through RNA-Seq approach. In 
addition, a sub-bactericidal concentration (6 %) was used as a selection to 
experimentally evolve S. aureus cells. By analysing the transcriptional response 
and the single nucleotide polymorphisms (SNPs) from evolution, these data will 
facilitate our understanding of the underlying genetic basis for the responses of 
S. aureus to ethanol.  
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6.2 Aims 
Previous work from our lab has revealed a reduction in pigmentation of S. 
aureus due to 1~5 % of ethanol treatment that is similar to the phenomenon 
identified with squalene. Thus, it was of interest to determine whether squalene 
and ethanol employ the same mechanism to affect carotenoid production. To 
investigate this further, the absorbance spectrum assay of pigmentation level of 
ethanol-treated S. aureus would firstly be confirmed. Next, characterisation of 
the transcriptional response to ethanol challenge would be obtained using RNA-
Seq and these data would be compared with that for squalene challenge. In this 
way it will be possible to investigate if the responses to these organic 
compounds share similar genetic regulation. Finally, an experimental evolution 
approach would be used to investigate genetic selection of S. aureus to a sub-
bactericidal concentration of ethanol. This research programme was expected to 
identify genes or alleles that contribute to ethanol resistance by analysis of SNPs 
and insertions and deletions (INDELs). 
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6.3 Results 
6.3.1 The effects of ethanol on pigmentation of S. aureus 
In preliminary work performed by others in the laboratory, it was noted that 
the golden colour of S. aureus cells was dramatically reduced when cells were 
treated with ethanol. The orange-red triterpenoid pigment, staphyloxanthin, 
located in the membrane has an important role in the environmental fitness of S. 
aureus, as discussed previously (Clauditz et al, 2006).  Since this phenomenon 
was similar with that characterised for squalene treatment, it was decided to 
investigate this phenomenon, firstly with absorbance spectrum tests conducted 
using methanol-extracted pigment from cell pellets.  
As covered in chapter 3, absorbance spectrum tests were performed using an 
optical spectrum analyser plate reader, which uses reflective techniques to 
separate the wavelengths of light and measures the intensity of the light with an 
electro-optical detector. In the experiments, the pigment extracted from a wild-
type pigmented S. aureus strain presents a spectrum with two peaks at 440 nm 
and 470 nm, which indicates the existence of staphyloxanthin (λmax=463 nm) 
and two biosynthetic precursors of staphyloxanthin, 4,4-diapolycopene 
(λmax=440,468 nm) and 4,4-diaponeurosporene (λmax=415, 439 nm) 
(Furubayashi et al., 2014). Corresponding with Beer’s law (A=εcl), higher 
absorbance peak values indicate a greater quantity of carotenoids in the sample. 
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                            Treated with ethanol                                            Treated with squalene 
 
Figure 6.1 Absorbance spectra of extracted pigment of S. aureus Newman cells cultured 
with either ethanol or squalene. S. aureus Newman was grown in BHI with different 
concentrations of squalene or ethanol for 24 h. Orange: control; Blue: treated with 0.1% (v/v) of 
ethanol or squalene; Green: treated with 1% (v/v) of ethanol or squalene. The two peaks around 
wavelength of 450 nm are characteristic of the carotenoid staphyloxanthin. Readings were 
corrected based on viable cell numbers. 
 
 
S. aureus Newman was used in the pigment extraction absorbance assay (Fig 6.1) 
to compare the relative effect of squalene and ethanol. From the spectral 
analysis, the characteristic peaks of absorbance due to staphyloxanthin reduced 
with increasing ethanol indicating a concentration-dependent effect of ethanol 
on staphylococcal pigmentation. The spectra for ethanol treatment was 
remarkably consistent with the spectra for squalene, suggesting they may share 
similar mechanisms to influence the pigment level of S. aureus, although the 
molar equivalents of each organic compound differed in the assay 
As described, staphyloxanthin plays an important role in resistance to oxidative 
stressors, such as H2O2. Antioxidant properties derive from multiple conjugated 
bonds of STX that enable it to eliminate singlet oxygen. Therefore, it was 
hypothesised that reduced pigmentation by treatment with ethanol would 
increase the cell’s susceptibility to H2O2. In contrast, S. epidermidis lacks the 
ability to produce any pigment, which would leave resistance unaffected by 
treatment with ethanol, when applying the same test.  
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(a) 
 
 
(b) 
 
Figure 6.2 Survival of S. aureus Newman and S. epidermidis Tü3298 cells cultured with 
different concentrations of ethanol prior to challenge with H2O2. Cells were cultured with 
the indicated concentrations of ethanol for 24 h. Cells were washed twice with PBS and diluted 
to an OD600 of 0.1. Viable Cell counts were performed at time zero and 90 min after challenge 
with of 7.5 mM. H2O2. S. aureus Newman is indicated as (a), while (b) represents S. epidermidis 
Tü3298. Three replicate experiments were performed. 
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The susceptibility of S. aureus and S. epidermidis to challenge with H2O2 was 
assayed. Cells of both species were left untreated or treated with 0.1 or 1% v/v 
of ethanol for 24 h and equal numbers of washed cells for each sample were 
challenged with H2O2 for 90 min. The results support the hypothesis and were 
almost identical to the results gained from squalene survival limitation to 
peroxide in chapter 3 (Fig 6.2). For S. aureus, cells treated with the highest 
concentration of ethanol (1 % v/v) showed lowest survival levels (~40 %), 
compared with 0.1 % (v/v) of ethanol, which caused 20 % loss of survival 
relative to untreated control. This difference was significant assessed by 
student’s t-test (p<0.001). However, there was no significant difference in 
susceptibility across increasing concentrations of ethanol of S. epidermidis, 
whose resistance to peroxide was unaffected by ethanol at either concentration 
(student’s t-test, p>0.5).  
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6.3.2 RNA quality control 
Having confirmed the ethanol induced reduction in S. aureus pigmentation, 
RNA-Seq was performed on ethanol challenged and control cultures of S. aureus 
Newman to determine the transcriptional response of S. aureus to ethanol. 
Cultures were challenged with 1% (v/v) ethanol during the mid-logarithmic 
phase of growth (OD600=0.5), as this ethanol concentration caused distinct 
change in pigmentation level (Fig 6.1) but without inducing large survival 
pressure (Fried and Novick, 1973; Bowles and Ellefson, 1985; Chatterjee et al., 
2006). After 20 min challenge, RNA was stabilised using RNAlater (Qiagen) and 
incubated overnight at 4 C. Total RNA was then purified from cells the next day 
using the method described in chapter 2 (section 2.7). 
RNA samples for RNA-Seq met the strict quality criteria for submission to the 
Centre for Genome Research (CGR), University of Liverpool. The required 
quality and quantity of the RNA samples were above the minimum threshold 
concentration of 30 ng µl-1 and the yields greater than the 3 µg required. These 
parameters were determined by Qubit fluorometric quantitation reads (Table 
6.1). Sufficient intact RNA was confirmed using an Agilent bioanalyser by 
verifying RNA integrity (RIN) scores >7.0 and low evidence of degradation on 
the output traces (Fig 6.3). 
 
Table 6.1 Quality control assessment.  
Purity of samples was measured by NanoDrop and concentration was assessed by Qubit. RNA 
integrity was tested via bioanalyser. RIN=RNA integrity number, C=control condition, E=ethanol 
challenge condition. 
 
Species Sample 
Nanodrop 
260/280
Nanodrop 
260/230
Concentration ng 
µl-1 
Sample volume 
(µl)
RIN
C1 2.2 2.2 794.0 5.0 7.4
C2 2.1 2.0 421.0 10.0 7.8
C3 2.2 1.8 810.0 5.0 7.8
E1 2.3 1.8 770.0 7.0 8.7
E2 2.2 2.4 554.0 7.0 8.6
E3 2.2 2.0 632.0 7.0 8.8
S. aureus
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A.  B.  
C.    D.    
E.     F.  
 
Figure 6.3 Bioanalyser traces of RNA samples submitted for sequencing. The visual output 
for the determined RNA integrity using the Agilent bioanalyser showed the characteristic 
profiles for purified, intact RNA with expected levels of particular sizes of RNA. The pronounced 
two large peaks indicates the presence of 23S and 16S RNA and other small peaks suggest their 
degradation. The three bands in the gel images on the right show the presence of 23S RNA, 16S 
RNA and the assay marker. S. aureus control condition: A, B and C; S. aureus ethanol challenge 
condition: D, E and F. 
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6.3.3  The transcriptional response to ethanol of S. aureus Newman and its 
comparison with the response to squalene 
After RNA sequencing, sequence reads were analysed and processed first by the 
CGR resulting in an output table of statistically significantly DE genes of S. 
aureus Newman between the control and ethanol-treated samples. The method 
was outlined in Chapter 2. These DE genes for ethanol challenge were then 
compared with the DE genes identified in transcriptional data for squalene 
challenge, which enabled identification of the similarities and differences 
between the two treatments.  
In response to ethanol challenge, 368 genes of S. aureus Newman were 
significantly DE, which is 14 % of total protein coding genes across the genome. 
The majority of the DE genes (303 genes) were altered by more than 1 log2 (2 
fold), indicating that there was a major response to ethanol challenge. Of the 
368 DE genes, 108 (29.3 %) were found up-regulated and 260 (70.7 %) were 
down-regulated. 
When comparing these ethanol data with the transcriptional data for squalene 
challenge, there were 305 DE genes presented in both datasets (Fig 6.2). 
Surprisingly, of these 305 DE genes in both treatments, only 5 were regulated in 
the opposite direction (conserved hypothetical protein NWMN_2545, drug 
resistance transporter NWMN_2253, ferrichrome ABC transporter sstD, 
conserved hypothetical protein NWMN_2254 and conserved hypothetical 
protein NWMN_0048), which indicated the responses to squalene and ethanol 
of S. aureus shared spectacular consistency. Of note, this includes the genes for 
pigment biosynthesis, however it did exclude the up-regulation of genes 
associated with Fur-iron uptake regulon observed in the squalene challenge 
dataset.  
Tabulated details of the DE genes are provided in Appendix Table 3. 
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Figure 6.4 Comparison of DE genes in S. aureus Newman between squalene challenge and 
ethanol challenge. 
There were 414 DE genes found in transcriptional data for squalene challenge, while 368 DE 
genes were found for ethanol challenge, and 305 genes shared DE in both treatments. 
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6.3.4 Comparison of DE COGs 
Clusters of orthologous group (COG) enrichment analysis was performed to 
assess the cellular pathways that were most affected in response to ethanol 
challenge for S. aureus. The most frequent COG classes that DE genes were 
assigned to was determined by using the WebMGA, bespoke perl scripts and the 
IMG database as detailed in chapter 2 (section 2.7.9). if it is assumed that DE 
genes are evenly distributed across the genome, the theoretical number of DE 
genes in each COG class could be calculated as they should be proportional to 
the number of genes encoded by the genome in that class. Thus COGs analysis 
will reveal whether the actual numbers of DE genes in these orthologous classes 
are higher or lower than the calculated number. 
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(a)  
 
(b) 
 
Figure 6.5 Numbers of S. aureus Newman DE genes in response to ethanol challenge per 
COG class. Comparison of numbers of DE genes between the theoretical (white bars) and the 
observed (black bars) per COG class for up-regulated DE genes (a) and down-regulated DE 
genes (b). The number of the theoretical DE genes per class was calculated with an assumption 
that expression was uniform across the genome. Genes were assigned to a COG class using 
WebMGA, the number of DE genes in each class were then calculated using a bespoke Perl script. 
C: Energy production and conversion; D: Cell cycle control, cell division, chromosome 
partitioning; E: Amino acid transport and metabolism; F: Nucleotide transport and metabolism; 
G: Carbohydrate transport and metabolism; H: Coenzyme transport and metabolism; I: Lipid 
transport and metabolism; J: Translation, ribosomal structure and biogenesis; K: Transcription; 
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L: Replication, recombination and repair; M: Cell wall/membrane/envelope biogenesis; O: 
Posttranslational modification, protein turnover, chaperones; P: Inorganic ion transport and 
metabolism; Q: Secondary metabolites biosynthesis, transport and catabolism; R: General 
function prediction only; S: Function unknown; T: Signal transduction mechanisms; U: 
Intracellular trafficking, secretion, and vesicular transport; V: Defence mechanisms. 
 
COG analysis revealed that challenge with ethanol of S. aureus resulted in COG 
classes K (transcription), R (general function prediction only), S (function 
unknown), T (signal transduction mechanisms) and U (intracellular trafficking, 
secretion, and vesicular transport) with greater numbers of up-regulated genes 
than the theoretical number (Fig 6.5). While COG classes C (energy production 
and conversion), E (amino acid transport and metabolism), G (carbohydrate 
transport and metabolism), H (coenzyme transport and metabolism), J 
(translation, ribosomal structure and biogenesis), I (lipid transport and 
metabolism), L (replication, recombination and repair), O (posttranslational 
modification, protein turnover, chaperones), and Q (secondary metabolites 
biosynthesis, transport and catabolism) were found to have fewer up-regulated 
genes than the theoretical number. For down-regulated genes, COG classes C, E, 
F (nucleotide transport and metabolism), G, and H were found to have more 
down-regulated genes than expected, and COG classes D (cell cycle control, cell 
division, chromosome partitioning), J, K, L, M (cell wall/membrane/envelope 
biogenesis), O, and S exhibited fewer down-regulated genes than the theoretical 
number. In most cases, COG classes having more up-regulated genes than 
expected were shown to have less down-regulated genes than the theoretical 
number. However, COG classes J (translation, ribosomal structure and 
biogenesis) and L (replication, recombination and repair) revealed fewer DE 
genes than the theoretical number for both up- and down-regulated genes, 
which exhibited the same transcription pattern observed in DE COGs of the 
squalene challenge transcriptome. This suggests that treatment with both 
squalene and ethanol has limited influence upon the expression of genes 
involved in these two functional classes.  
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When comparing with DE COGs for squalene challenge (Fig 4.3), greater 
numbers of genes in general function prediction only (R), and function unknown 
(S) were up-regulated for both treatments, indicating there is likely to be a 
common global response to ethanol and squalene. This response remains 
uncharacterised in S. aureus. Both treatments resulted in greater numbers of 
down-regulated genes in energy production and conversion (C), amino acid 
transport and metabolism (E), carbohydrate transport and metabolism (G), and 
coenzyme transport and metabolism (H), suggesting challenge with both 
ethanol and squalene lowers the metabolism level of S. aureus. 
To compare the effects between two treatments on each COG class, the 
percentage of the DE genes per COG class was calculated (Fig 6.6). For up-
regulated DE genes, squalene challenge resulted in more DE genes than ethanol 
challenge in almost all COG classes except L (replication, recombination and 
repair) and T (Signal transduction mechanisms). On the contrary, ethanol 
challenge resulted in more down regulated DE genes than squalene challenge in 
most COG class except K (transcription) and L. The differences in the number of 
DE genes in COG class of replication, recombination and repair and signal 
transduction mechanisms between two treatments may suggest the sensing 
pathways in S. aureus in response to ethanol and squalene are different.  
  
149 
 
(a) 
 
(b) 
 
Figure 6.6 Comparison of the percentage of the DE genes in response to squalene (black 
bars) or ethanol challenge (white bars) per COG class for up-regulated DE genes (a) and 
down-regulated DE genes (b). Genes were assigned to a COG class using WebMGA, the number 
of DE genes in each class were then calculated using a bespoke Perl script. C: Energy production 
and conversion; D: Cell cycle control, cell division, chromosome partitioning; E: Amino acid 
transport and metabolism; F: Nucleotide transport and metabolism; G: Carbohydrate transport 
and metabolism; H: Coenzyme transport and metabolism; I: Lipid transport and metabolism; J: 
Translation, ribosomal structure and biogenesis; K: Transcription; L: Replication, recombination 
and repair; M: Cell wall/membrane/envelope biogenesis; O: Posttranslational modification, 
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protein turnover, chaperones; P: Inorganic ion transport and metabolism; Q: Secondary 
metabolites biosynthesis, transport and catabolism; R: General function prediction only; S: 
Function unknown; T: Signal transduction mechanisms; U: Intracellular trafficking, secretion, 
and vesicular transport; V: Defence mechanisms. 
 
 
6.3.5 Comparison of DE metabolic pathways 
KEGG mapper (version 2.1) search & colour was also applied to the ethanol 
challenge transcriptome data. This program was executed using the lists of DE 
genes produced by the CGR. From the analysis, 238 DE genes (54.6 %) of S. 
aureus Newman were not assigned into any pathways. This is due to incomplete 
pathway annotation for staphylococci to date, together with unknown functions 
of genes. The annotated metabolic pathway genes within the ethanol challenge 
transcriptome were compared with those of the squalene challenge 
transcriptome generated in chapter 4. The hypothesis was that analysis of these 
DE genes and pathways that contribute to known metabolic processes would 
reveal speculative mechanisms for the effect of ethanol on S. aureus metabolism. 
Both treatments exhibited great consistency of down-regulation of genes 
involved in energy production (Table 6.2). This consistency is not only reflected 
in the directional trend of regulation, but also the extent (fold-level) of 
differential expression. The clear stand out pathways and trends with this 
overlap include: reduced level of glycolysis (glcA, tpi, gapA, pgk, gpmA, pckA and 
aldA); decreased pentose, fructose, mannose, and galactose metabolism (gntK, 
NWMN_0083, mtlF, mtlA, mtlD, fruB, fruA, and malA), and declined pyruvate, 
propanoate, and butanoate metabolism (NWMN_2459, poxB, fumC, alsD, ilvB, 
sdhA, sdhB, sucA, and sucB). Overall, a trend in regulation is observed that 
reveals decreased energy production in response to both ethanol and squalene 
challenge. 
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Table 6.2 Ethanol and squalene regulated DE genes involved in energy production 
pathways in S. aureus Newman. 
DE genes highlighted by KEGG mapper analysis and their level of log2 fold change in S. aureus 
Newman are shown. Genes that were not DE in one treatment are indicated by a dash in the 
relevant fold change column. KEGG mapper output pathways relevant to this table were 
glycolysis/gluconeogenesis, pentose phosphate pathway, fructose and mannose metabolism, 
galactose metabolism, amino sugar and nucleotide sugar metabolism, pyruvate metabolism, 
propanoate metabolism, and butanoate metabolism. 
Gene name 
Fold change (log2) 
Ethanol challenge Squalene challenge 
Glycolysis 
 
glcA 
 
 
-0.72 
 
 
-1.35 
ptsG - -1.37 
tpi -0.85 -1.07 
gapA -1.21 -1.08 
pgk -1.55 -0.89 
gpmA -1.52 -1.83 
pckA -1.11 -1.41 
aldA -1.52 -1.28 
 
Pentose, fructose, mannose, 
and galactose metabolism  
 
gntK 
 
 
 
 
-1.21 
 
 
 
 
-1.53 
NWMN_0083 -1.09 -1.01 
mtlF -1.38 -1.58 
mtlA -1.90 -1.56 
mtlD -1.45 -1.43 
fruB -2.07 -2.19 
fruA -2.05 -2.64 
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malA -1.16 -1.33 
lacA -1.33 -1.89 
mnaA -1.05 -0.87 
 
Pyruvate, propanoate, and 
butanoate metabolism  
 
NWMN_2459 
 
 
 
 
 
-0.99 
 
 
 
 
 
- 
poxB -1.63 -1.43 
fumC -0.75 -0.94 
alsD -2.19 -2.13 
ilvB -1.71 -0.99 
sdhA -1.14 -1.55 
sdhB -0.65 -2.04 
sucA -1.59 -1.57 
sucB -1.07 -1.24 
 
 
Overall, the expression of genes involved in ammonia production was down-
regulated in both treatments, and it was more pronounced with ethanol 
challenge (Table 6.3). In the ethanol challenge transcriptome, down-regulation 
of the nrdG, narI, purF, purD, purN, purQ, purL, purM, and purH genes associated 
with purine biosynthesis is indicative that S .aureus cells reduced their 
production of purine and ammonia. This response together with the down-
regulation of genes that would reduce the pool of ammonia, including 
argininosuccinate synthase (argG) and argininosuccinate lyase (argH) suggest a 
homeostatic mechanism due to reduced ammonia production, which was also 
observed in the squalene challenge transcriptomic data (Table 4.3). 
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Table 6.3 Ethanol and squalene regulated DE genes involved in ammonia production 
pathways in S. aureus Newman. 
DE genes highlighted by KEGG mapper analysis and the level of log2 fold change in S. aureus 
Newman are shown. Genes that were not DE in one treatment are indicated by a dash in the 
relevant fold change column. KEGG mapper output pathways relevant to this table were purine 
metabolism, arginine and proline metabolism, and nitrogen metabolism. 
Gene name 
Fold change (log2) 
Ethanol  Squalene 
nrdG -1.98 -2.09 
narI -2.47 -2.27 
narJ -4.10 -4.33 
narH -4.22 -4.67 
purF -2.20 -0.92 
purD -1.39 - 
purN -1.51 - 
purQ -1.45 -0.72 
purL -1.84 -0.94 
purM -1.78 - 
purH -1.38 - 
nrdD -1.28 -1.62 
NWMN_2454 -1.36 -1.04 
putA -2.58 -2.82 
argH -2.19 -2.14 
argG -2.28 -2.52 
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Table 6.4 Ethanol and squalene regulated DE genes involved in amino acids metabolism 
pathways in S. aureus Newman. 
DE genes highlighted by KEGG mapper analysis and the level of log2 fold change in S. aureus 
Newman are shown. Genes that were not DE in one treatment are indicated by a dash in the 
relevant fold change column. KEGG mapper output pathways relevant to this table were 
histidine metabolism, glycine, serine and threonine metabolism, cysteine and methionine 
metabolism, lysine biosynthesis, valine, leucine and isoleucine biosynthesis and alanine, 
aspartate and glutamate metabolism. 
Gene name 
Fold change (log2) 
Ethanol Squalene 
hisIE -1.16 - 
hisH -1.57 - 
hisB -1.35 - 
hisD -1.10 - 
hutG -0.92 -1.52 
sdhA -1.14 -1.55 
sdhB -0.65 -2.04 
leuD -1.34 - 
leuC -1.12 - 
leuB -1.35 - 
leuA -1.55 - 
ilvA -0.98 - 
trpB -1.93 - 
metB 0.78 0.90 
metL -1.36 -0.79 
thrA -1.75 -1.40 
155 
 
thrB -1.39 - 
thrC -1.08 -0.88 
lysC -2.87 - 
asd -2.42 -1.02 
cysM 1.23 1.64 
dapA -2.45 - 
dapB -1.98 - 
dapD -1.82 - 
pyrAA -2.21 -2.47 
pyrB -2.21 -2.54 
argH -2.14 -2.19 
argG -2.52 -2.28 
gltB -0.98 - 
NWMN_2454 -1.36 -1.04 
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The overall expression of genes involved in amino acid metabolism was down-
regulated, but with the exceptions of metB and cysM (Table 6.4). Both genes are 
associated with cysteine biosynthesis, which indicates that challenge with either 
ethanol or squalene elevates cysteine/sulphur metabolism. A reduction in 
transcription of biosynthetic genes of other amino acids was more apparent in 
the ethanol challenge dataset. Down-regulated expression of genes involved in 
production of histidine (hisIE, hisH, hisB, hisD), leucine (leuD, leuC, leuB, leuA), 
isoleucine and valine (ilvA), lysine (dapA, dapB, dapD) and glutamate (gltB) was 
only determined after ethanol challenge. Furthermore, although no up-
regulated genes associated with serine biosynthesis were identified, genes 
facilitating serine degradation (sdhA, sdhB) were down-regulated, indicating 
potential for conservation of serine levels in S. aureus cells. 
The overlap of both stimuli was also observed with expression of virulence 
genes, whereby ethanol challenge exhibited the same trend as squalene 
challenge, although it was more pronounced after squalene challenge (Table 
6.5). The majority of DE virulence factor genes were up-regulated after both 
challenges, including: isdA that has been described to increase cell 
hydrophobicity independent of its role in haem iron acquisition (Clarke et al., 
2007); those encoding enzymes that specifically target leukocytes, such as lukS, 
lukF, hlgB, and hlgC; and fnbB encoding a cell surface-associated protein                         
with a role in tissue adhesion specificity,. plus a series of genes encoding or 
predicted to encode immune evasion determinants including ssl2nm, ssl3nm, 
ssl4nm, ssl5nm, ssl9nm, ssl6 (Omoe et al., 2004; Orwin et al., 2001; Niedergang et 
al., 1995).  This suggests that both ethanol and squalene challenges induce 
survival/invasion responses of S. aureus.  
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Table 6.5 Ethanol and squalene regulated DE virulence factor genes involved in amino 
acids metabolism pathways in S. aureus Newman.DE genes highlighted by KEGG mapper 
analysis and the level of log2 fold change in S. aureus Newman are shown. Genes that were not 
DE in one treatment are indicated by a dash in the relevant fold change column. KEGG mapper 
output pathways relevant to this table was S. aureus infection. 
Gene name 
Fold change (log2) 
Ethanol Squalene 
clfA -1.14 -1.17 
sbi 1.19 1.00 
sdrC - 0.90 
sdrD - 1.51 
lukS 1.07 1.82 
lukF - 1.54 
hlgB 1.02 1.81 
hlgC 1.00 1.74 
NWMN_1503 - 1.44 
ssl2nm 2.09 1.52 
ssl3nm 2.11 1.35 
ssl4nm 1.88 1.35 
ssl5nm 1.60 1.27 
ssl9nm 1.31 1.25 
ssl6 1.33 1.09 
isdA - 1.61 
NWMN_0165 1.23 - 
fnbB 1.42 1.91 
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6.3.6 Ethanol transcriptome and S. aureus pigmentation 
 
 
 
Figure 6.7 DE genes of the staphyloxanthin biosynthetic pathway in response to squalene 
or ethanol challenge in S. aureus Newman. In each box linked to the respective enzymes, the 
transcription changes relative to the control are shown as fold number. Green boxes represent 
the respective transcript was significantly down-regulated. Ethanol transcriptome data values 
are labelled E with S for the squalene transcriptome data. CrtO, NWMN_2465; CrtI, NWMN_2464; 
CrtQ, NWMN_2463; CrtM, NWMN_2462; CrtN, NWMN_2461. 
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In this chapter, it was confirmed that ethanol has a negative effect on pigment 
expression of S. aureus (Fig 6.1). And further investigation determined that this 
reduced level of pigmentation resulted in increased susceptibility of S. aureus to 
H2O2 (Fig 6.2). Since staphyloxanthin (STX) is produced via the crt operon in 
most staphylococci, the decreased expression of crt genes was expected to be 
evident in the transcriptomic data of S. aureus cells challenged with squalene.  
As predicted, five genes in crt operon encoding enzymes in staphyloxanthin 
biosynthesis, crtM, crtN, crtI, crtQ, and crtO exhibited a decreased level of 
expression with the same trend as that observed after squalene challenge (Fig 
6.7). This decline of expression explains the reduced cell pigmentation. Just as 
observed with squalene challenge, the gene expression of sigB remains 
unchanged, such that expression changes must either reflect changes to the 
activity of the RsbU, RsbV and RsbW modulators and anti-sigma factors that 
control the ability of SigmaB to direct transcription or it indicates there is 
another regulatory pathway modulating crt expression. 
 
6.3.7 Quantitative PCR validation 
Validation of the RNA-Seq data was performed by transcript quantification 
using qPCR for selected DE genes in the ethanol challenge RNA-Seq dataset. For 
each selected gene, the fold-changes in relative transcript abundance  between 
control and ethanol challenge samples were determined and then compared 
with RNA-Seq data. At least three biological and two technical qPCR replicates 
were used for each gene. RNA integrity was assessed by gel electrophoresis 
prior to conversion to cDNA for qPCR.  
The S. aureus crtM, crtI, lytR, and fnbB transcript levels were assessed for 
comparison. Collectively these genes are representative of carotenoid 
biosynthesis, autolysin regulation and virulence factors. All primers chosen 
were determined to have amplification efficiency values above 90 % and gave 
products of approximately 150 bp. The primers and their efficiency values are 
shown in Table 6.6. 
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Table 6.6 Primers for qPCR  
Gene name Primer sequences Efficiency (%) Reference 
crtI F- CCGGCAAGCTCAGGATATGT 92.2 This study 
  R-TACTGGCGCTTGTGTGTGAT 
 
  
crtM F- CGTAGAATCATGATGGCGCTTC 91.3 This study 
  R- CCGAATAATTCAGCGTCCGT 
 
  
fnbB F- CTCATGGTATCTCAACACTGC 90.4 This study 
  R- TGCGTCACTGTTGTAGGATC 
 
  
lytR  F- GCAACTGCACATGACCAATAC 90.2 This study 
  R- TCGCCGACATATCATTCGC 
 
  
 
 
The fold changes determined from the qPCR data showed good agreement with 
RNA-Seq (Fig 6.8), where the down-regulation of crtM and crtI and up-
regulation of fnbB and lytR were both observed in qPCR results. All fold changes 
showed broadly similar values as those determined in RNA-Seq data. However, 
values of qPCR data were consistently lower than the fold changes from RNA-
Seq. This phenomenon may reflect the different methods of testing between the 
two technologies and underestimation of gene expression by qPCR. Overall, the 
data from qPCR supports the differential expression changes in the RNAseq 
dataset. 
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Figure 6.8 Differential expression of crtI, crtM, fnbB and lytR in S. aureus after challenge 
with ethanol, assessed by qPCR. Black bars indicate the fold change in gene expression from 
RNA-Seq data while white bars indicate fold change in gene expression from qPCR data.  Error 
bars were determined from three replicate experiments. 
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6.3.8 Experimental evolution of S. aureus with ethanol selection 
The selection of genetic mutations that confer an increased resistance of S. 
aureus to ethanol was achieved through passage in broth containing 6 % (v/v) 
ethanol as this concentration of ethanol induced a sub-bactericidal effect on S. 
aureus allowing limited growth. Use of pooled samples containing the genomes 
from selected isolates with increased resistance was applied in this study. The 
pool and their parental strain were sequenced to identify Single Nucleotide 
Polymorphisms (SNPs) and Insertions and Deletions (INDELs) associated with 
the increased resistance. Sequencing of pools enables more isolates to be 
sequenced without additional costs, and may reveal more SNPs and INDELs. In 
addition, high frequency of a SNP in multiple isolates within the pool is 
identified by a high proportion of variance at a particular position and this 
indicates the SNP is more likely to be involved in resistance.  
The wild-type strain, S. aureus Newman was passaged by repeated incubations 
in broth containing 6 % (v/v) ethanol in 24 h batch cultures for 14 d. From the 
second day forward, cells that were cultured for 24 h with ethanol were diluted 
to OD600 reading of 0.02 and added into fresh broth with the same concentration 
of ethanol. A control culture was also conducted using the same method with 
passage of the parental stain for 14 days in broth without ethanol. Any genetic 
variance, such as SNPs in the control culture would help to rule out any 
mutations selected during continuous culture in the broth over 14 d. The 
passages were performed in duplicate experiments. By the end of the 14 
passages, 6 isolates (3 from squalene passage, 3 from broth passage) from each 
duplicate experiment were picked and their genomic DNA was extracted and 
equal amounts of each clone was added to make a DNA pool for sequencing.  
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6.3.9 Susceptibility of experimentally evolved isolates to ethanol  
At the end of the passages, the growth curves of selected isolates were 
measured to verify that resistance to ethanol was elevated after experimental 
evolution. To achieve this, 3 isolates from the ethanol passage and 3 isolates of 
control passage (no ethanol) were selected from each duplicate and these 
isolates together with a parental Newman control were cultured in BHI with 6 % 
(v/v) ethanol and their growth was recorded by absorbance measurement (Fig 
6.9). 
(a) 
 
(b) 
 
Figure 6.9 Growth curves of selected isolates cultured in BHI with 6 % (v/v) ethanol for 
first (a) and second (b) duplicate experiments. Open diamond, square and triangle:  three 
isolates from ethanol passage. Closed diamond, square and triangle: three isolates of control 
passage (no ethanol). Cross: parental S. aureus Newman strain that has not undergone any 
passages.  
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The growth curve data confirmed that the isolates from ethanol selection 
cultures exhibited greatly increased growth rates and yield compared with 
isolates chosen from cultures without ethanol selection. The growth yield values 
of ethanol selection isolates (open diamond, square and triangle) after 8 h of 
culture was over four times greater than broth only control isolates (closed 
diamond, square and triangle) and the parental strain. These differences in 
growth support that increased resistance was due to evolution of fixed genetic 
changes in response to sub-bactericidal ethanol and not caused by selection to 
the BHI broth. 
 
6.3.10 Sequencing QC and alignment 
Sequencing of selected isolates was performed to determine SNPs and INDELs 
that account for changes in growth in the presence of ethanol. Prior to 
sequencing, DNA samples were assessed to ensure these were of sufficient 
quality and quantity for sequencing. All genome DNA samples used for 
sequencing should have minimal protein, salt and solvent contamination, and 
sufficient purity was indicated by 260/280 & 260/230 ratios greater than 1.8 
(Table 6.7). DNA samples were also visualised by gel electrophoresis to confirm 
the integrity of the DNA was suitable (Fig 6.10).  
DNA from the chosen isolates was sequenced and the reads were aligned to the 
reference Newman genome. After alignment, SNPs and INDELs were called and 
filtered using a bespoke perl script, which utilised the SNPEff version 3.4e open 
source software. SNPs and INDELs that were synonymous or intergenic and 
more than 200 bp upstream of a transcriptional start site were filtered out. A 
second bespoke perl script was used to filter SNPs or INDELs identical to any 
found in either of the controls of the parental strain or the pool of no ethanol 
passage isolates. After filtering twice, the remaining SNPs and INDELs were 
considered candidates for loci affecting resistance.  
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Table 6.7 Quality control analysis results for DNA samples of S. aureus Newman 
submitted for sequencing. 
Data of the quality checks performed prior to DNA sequencing. Concentrations and 260/280 and 
260/230 absorbance reading were assessed by Qubit and Nanodrop, respectively. C0: parental S. 
aureus Newman strain without passage; C1: passage without ethanol; E: passage with ethanol. 
C1 and E were made as pools consisting of 6 genomes from selected isolates with the same 
amount of DNA. 
Strain Sample  
Nanodrop 
260/280 
Nanodrop 
260/230 
Concentration ng 
µl-1  
Sample 
volume (µl) 
S. aureus Newman 
C0 1.9 2.3 102.6 19.5 
C1 1.9 2.2 83.9 23.8 
E 2.1 2.3 99.5 20.0 
 
 
 
                                   (a)                                                                             (b)                 
 
Figure 6.10 Gel electrophoresis of purified genome DNA of selected isolates from the first 
(a) and replicate (b) passage. 
Isolates 1-3 (a) and isolates 1’-3’ (b) selected from ethanol passage. Isolates 4-6 (and isolates 4’-
6’) were picked from broth only passage (without ethanol). No apparent sign of degradation was 
observed, indicating the genomes of these isolates were intact. 
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6.3.11 S. aureus Newman ethanol selected SNPs  
As described above, S. aureus Newman isolates experimentally evolved with 
ethanol exhibited increase ability to grow at elevated ethanol concentration 
compared with isolates cultured in the absence of ethanol or the parental isolate. 
Filtering was done that would remove any DNA sequences identified by SNPEff 
that were synonymous or intergenic (more than 200 bp upstream of a 
transcriptional start site), or identical to the parental strain or no ethanol 
isolates. As a result, it revealed three non-synonymous SNPs that includes one 
coding SNP, and two SNPs within the upstream regulatory region of a gene 
(Table 6.8). The SNP in dapD presents in all the reads of the pool, while the 
other two  intergenic SNPs present approximately 83 % of the reads of the pool, 
indicating approximately 5 of the 6 pooled isolates had these SNPs. 
The genic SNP is located in dapD (DapD A219E), leading to the non-conservative 
amino acid replacement of the non-polar aliphatic alanine with the acidic, polar 
glutamic acid. DapD is a tetrahydrodipicolinate acetyltransferase that catalyses 
L-2,3,4,5-tetrahydrodipcolinate into N-Acetyl-L-2-amino-6-oxopimelate during 
L-lysine biosynthesis. This amino acid serves a wide variety of functions in the 
bacterial cell and lysine has a crucial role in biosynthesis of cell wall 
peptidoglycan (Jang et al., 2008).  
 
Table 6.8 Non-synonymous SNPs from S. aureus Newman ethanol evolved isolates.  
SNPs from ethanol selection of S. aureus Newman isolates were identified using a bespoke perl 
script. All mutations were confirmed by at least 6x coverage. Intergenic SNPs were included if 
they were less than 200 bases upstream of the predicted translational start site.   
Gene name Gene function 
Position of 
change 
Base 
change 
Change 
Position 
in protein 
dapD 
tetrahydrodipicolinate 
acetyltransferase 
1441331 C->A 
Substitution 
A/E 
219/239 
aa 
NWMN_1774 
conserved hypothetical 
protein 
1986628 C->T 
Upstream 
substitution 
-10bp 
NWMN_1774 
conserved hypothetical 
protein 
1986634 T->G 
Upstream 
substitution 
-16bp 
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Since DapD A219E potentially contributes to enhanced growth in the presence 
of ethanol resistance, protein modelling was attempted to examine the influence 
of the amino acid substitution. However, the structure of this protein is poorly 
understood. Only the first 87 residues have been assigned into secondary 
structure and the remainder of the residues remain uncharacterised. Since the 
SNP alters the protein sequence near the carboxyl end  the amino acid 
substitution cannot be shown in a 3D model. Therefore it is very difficult to 
predict if DapD A219E lies within a domain and the effects it might cause. 
Should the substitution alter the catalytic efficiency of the enzyme this might 
alter pathway flux to counteract effects of ethanol on the cell.  
If the amino acid substitution DapD A219E does not facilitate the increased 
growth of isolates in the presence of ethanol, the two intergenic SNPs upstream 
of NWMN_1774 would be the sole explanation. These two SNPs are 10 bp and 16 
bp upstream of the translational start site. Protein NWMN_1774 is annotated as 
being of unknown function containing the domain DUF2951 and has 99 amino 
acids. The protein appears to be specific to S. aureus and is phage-derived. 
NWMN_1774 is annotated as a transmembrane protein because of the presence 
of both alpha-helical transmembrane region and a membrane spanning region. 
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6.4 Discussion 
Previous unpublished studies from the Horsburgh laboratory at Liverpool  
indicated that ethanol treatment caused a reduction in S. aureus pigmentation.  
Since a similar phenotype was revealed as a phenomenon caused by squalene 
treatment in this study, comparative investigation of the effects of ethanol and 
squalene on S. aureus was performed using transcriptomics. Firstly, in this 
chapter, pigment was extracted from S. aureus cells cultured in the presence or 
absence of ethanol. This experiment revealed that there was a negative 
relationship between ethanol treatment and bacterial pigmentation, and 
confirmed this correlation was concentration dependent. Like the experiment 
conducted on squalene, S. aureus cells cultured in the presence of ethanol 
showed susceptibility to H2O2 challenge was increased.  These data matched the 
observation with squalene in chapter 3 and similarly fits with the hypothesis 
that staphyloxanthin contributes to resistance from oxidative stressors, such as 
H2O2, by scavenging free radicals with its conjugated double bonds (Liu et al., 
2008; Götz et al., 2006). 
Having established the similar effects of ethanol and squalene on S. aureus 
pigmentation, the transcriptional responses of S. aureus Newman to ethanol 
were determined and the results were compared with the squalene challenge 
transcriptional data obtained in chapter 4. The main aims were to compare the 
DE genes of S. aureus between ethanol and squalene challenge datasets to find 
potential clues for whether squalene and ethanol cause common transcriptional 
responses and what the mechanisms are in S. aureus.  
Overall, it was revealed that there were more overlaps than divergence in 
transcriptional responses between ethanol and squalene. Approximately 80 % 
of DE genes found in ethanol challenge data were also DE in squalene challenge 
results, and the majority of them (90 %) also showed the same trend of 
regulation. This suggests ethanol and squalene, despite having different 
molecular structure and properties, is recognised as having underlying stimulus 
similarities which result in an analogous response from the bacteria. 
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The similarities of transcriptional response between ethanol and squalene 
challenge of S. aureus were revealed by analysis of both COG and KEGG 
metabolic pathways. Both treatments up-regulated more genes in general 
function prediction only, and function unknown categories, indicating there may 
be global responses that remaining uncharacterised in S. aureus, at least at the 
stimulus level. Both treatments down-regulated more genes in energy 
production and conversion, carbohydrate transport and metabolism, and 
coenzyme transport and metabolism, suggesting challenge with either ethanol 
or squalene induces decreased metabolism in S. aureus. 
Analysis of the ethanol challenge transcription data overlaid to KEGG 
pathways revealed that the expression of DE genes ascribed to energy 
production, ammonia production, amino acid metabolism, and virulence 
factors all showed remarkable consistency with the expression profile of the 
squalene challenge transcriptome. These overlaps suggests that ethanol and 
squalene may largely trigger a common stimulus response of S. aureus, and this 
mechanism acts to manage bacterial energy levels.  Neither stimulus appears to 
cause DNA or cell membrane damage, at least at the concentration used, since 
these processes almost remain unchanged.   
Although most of the DE genes exhibited a consistent trend of regulation, 
there were still some differences, most likely due to the distinct molecular 
properties of ethanol and squalene. The largest difference in gene expression 
profile between ethanol and squalene challenge is the regulation of genes 
involved in iron acquisition. In chapter 4 and 5, both transcriptional data and 
in vitro experiments revealed that squalene caused iron starvation in S. aureus 
and S. epidermidis as determined by reduced intracellular iron concentration, 
leading to up-regulation of the numerous genes associated with iron uptake. 
However, such a large-scale trigger of derepression of iron uptake genes was 
absent in the ethanol transcriptome (Table 6.9). Among all the 28 DE genes 
identified in squalene transcriptional data, only two (isdG and sdhB) were DE 
with the same direction of regulation after ethanol challenge. This suggests 
that the cellular iron availability was not likely affected by ethanol treatment 
and distinguishes the cellular responses .  
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Table 6.9 Genes associated with iron metabolism revealed by the transcriptional data of 
squalene challenge and ethanol challenge. Among all the 28 DE genes identified in squalene 
transcriptional data, only 2 (isdG and sdhB) were DE with the same direction of regulation 
after ethanol challenge, indicating the intracellular iron availability was not affected by 
ethanol treatment. 
Gene name Description 
Fold change in 
squalene 
transcriptome 
Fold change in 
ethanol 
transcriptome 
Genes involved in iron acquisition 
 
  
isdG cytoplasmic heme-iron binding protein 4.08 2.05 
NWMN_2081 biosynthesis of staphyloferrin A 3.81 Not DE 
sbnD membrane transporter protein 3.58 Not DE 
isdC iron-regulated cell surface protein 3.48 Not DE 
sbnI SbnI protein 3.41 Not DE 
sbnH diaminopimelate decarboxylase 3.36 Not DE 
sirA siderophore compound ABC transporter 3.20 Not DE 
srtB NPQTN-specific sortase B 3.12 Not DE 
isdF iron/heme permease 3.07 Not DE 
isdA iron-regulated heme-iron binding protein 3.05 Not DE 
NWMN_2076 FecCD iron compound ABC transporter 3.03 Not DE 
sbnG 2-dehydro-3-deoxyglucarate aldolase 2.97 Not DE 
NWMN_2185 iron compound ABC transporter 2.83 Not DE 
NWMN_0703 iron compound ABC transporter sstB 2.81 Not DE 
sbnE siderophore biosynthesis 2.81 Not DE 
fhuB ferrichrome transport permease 2.77 Not DE 
sbnC siderophore biosynthesis 2.69 Not DE 
isdE iron compound ABC transporter 2.66 Not DE 
NWMN_0702 
ferrichrome ABC transporter permease 
sstA 
2.58 Not DE 
NWMN_2078 ferrichrome ABC transporter lipoprotein 2.51 Not DE 
sbnF siderophore biosynthesis 2.50 Not DE 
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NWMN_0704 
Iron ABC transporter ATP-binding 
protein sstC 
2.35 Not DE 
sirB siderophore compound ABC transporter 2.17 Not DE 
isdB iron-regulated heme-iron binding protein 2.14 Not DE 
fhuG ferrichrome transport permease  1.96 Not DE 
NWMN_0705 
ferrichrome ABC transporter lipoprotein 
sstD 
1.88 -1.97 
  
  
  
Genes involved in iron storage and utilisation 
 
  
NWMN_1831 ferritin -2.54 Not DE 
sdhB succinate dehydrogenase iron-sulfur  -4.08 -1.51 
 
 
The RNA-Seq data confirmed that the reduction in pigmentation level of S. 
aureus after ethanol treatment was likely due to decreased expression of the crt 
operon. As was observed in squalene challenge, the gene expression of sigB, 
which is the sole accessory RNA polymerase factor that regulates the crt operon 
via altered transcript levels remains unchanged.  Ethanol may be perceived 
through the activities of RsbUVW regulator and anti-sigma factor proteins that 
release SigB for engagement with the RNA polymerase complex.  The role of 
RsbU in S. aureus is very poorly understood compared with the many studies in 
the model Gram-positive bacterium, B. subtilis, where the protein acts as a 
stimulus sentinel (Voelker et al., 1995; Delumeau et al., 2004). Alternatively,  
ethanol may activate other regulatory pathways that influence SigB, though this 
is likely to exclude SrrAB, which was described to modulate pigment expression, 
since there was an absence of the hypoxia regulon also controlled by this two-
component system (Yarwood et al., 2001; Mashruwala and Boyd, 2017).  
Recently, Pando et al. (2017) published a study of the effects of ethanol-
induced stress (EIS) on S. aureus. The transcriptional data were obtained from 
two unrelated clinical MRSA isolates challenged with 10 % (v/v) ethanol for 
15 min using microarray hybridisation. Their study provides excellent 
comparative material for the study in this thesis. Although the concentration 
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of ethanol challenge in their study (10 % v/v) was much higher than that was 
used in the current study (1 % v/v) and different strains were used, 
identification of the DE genes showing a consistent trend of expression 
contributes to our understanding of the primary and fundamental responses 
of S. aureus to ethanol. 
Overall, in the study by Pando et al., (2017),10 % EIS resulted in differential 
gene expression of 1091 genes. This compares with 368 DE genes identified 
with 1% v/v in the current study, and this large difference in number of DE 
genes is most likely due to the more critical survival pressure caused by 10 % 
(v/v) ethanol, while 1 % (v/v) ethanol was shown here to produce negligible 
effects on growth and survival. This large difference in stress will explain the 
extensive and greater expression responses in the other study. However, it 
was noted that 73.3 % of DE genes in the 10% ethanol study were down-
regulated, comparing with 70.7 % of down-regulated DE genes observed with 
1% ethanol. This suggests that regardless of the concentration, ethanol seems 
to consistently induce more negative responses. Similarly, genes involved in 
transcription, translation and nucleotide biosynthesis were down-regulated 
in the 10% ethanol study, matching the trend described in  this chapter. 
The common DE genes shown in both studies involved in amino acid 
metabolism, central intermediary metabolism, cofactors and secondary 
metabolites, nucleotide metabolism, stress response, and virulence factor are 
listed in Table 6.10. This comparison shows that different concentrations of 
ethanol modulated the expression of these common DE genes with 
remarkable consistency. There is no DE gene regulated in opposite direction. 
The reduced expression of crt operon was observed even with 10 % ethanol 
challenge, indicating a large effective range of ethanol concentration affecting 
pigmentation at least from 0.1 % to 10 % (v/v).  
As proposed in chapter 4 and this chapter, squalene and ethanol both induced 
an invasion-like response with the increased expression of a suite of virulence 
genes such as hlg, luk, and sbi. One possible explanation for that was based on 
the inherent genetic differences in the sae locus possessed by strain Newman. 
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The saeS gene in Newman has several SNPs leading to activation of the TCS 
with increased expression level. The two-component system SaeSR regulates 
expression of a large amount of virulence factors. Because of that, it is not 
reasonable to claim the increased expression of virulence genes was solely 
induced by squalene or ethanol treatment. However, confirmation of the same 
regulation of virulent factors in 10 % ethanol study (Pando et al., 2017) 
suggests the genetic variations in saeS are irrelevant as two un-related MRSA 
strains were used in the EIS study but obtained the same results. 
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Table 6.10 Comparison of 10% and 1% ethanol challenge transcriptomes. DE genes 
listed here are involved in amino acid metabolism, central intermediary metabolism, 
cofactors and secondary metabolites, nucleotide metabolism, stress response, and virulence 
factor. 
Gene function 
category 
Gene 
name 
Description 
UP OR DOWN 
REGULATED 
10% EtOH 
study 
1% EtOH 
study 
Amino Acid 
Metabolism  
cysK  cysteine synthase  ↑ ↑ 
hisC histidinol-phosphate aminotransferase ↓ ↓ 
dhoM  homoserine dehydrogenase  ↓ ↓ 
dapA  dihydrodipicolinate synthase  ↓ ↓ 
dapB  dihydrodipicolinate reductase  ↓ ↓ 
dapD  tetrahydrodipicolinate acetyltransferase  ↓ ↓ 
ilvA threonine dehydratase  ↓ ↓ 
Central 
Intermediary 
Metabolism 
adh1 alcohol dehydrogenase ↓ ↓ 
alsS alpha-acetolactate synthase ↓ ↓ 
Cofactors and 
Secondary 
Metabolites 
ribH riboflavin synthase, beta subunit ↓ ↓ 
ribA riboflavin biosynthesis protein ↓ ↓ 
ribD riboflavin specific deaminase ↓ ↓ 
Nucleotide 
Metabolism 
purC  
phosphoribosylaminoimidazole- 
succinocarboxamide synthase ↓ ↓ 
purQ  
phosphoribosylformylglycinamidine  
synthase I ↓ ↓ 
purL 
phosphoribosylformylglycinamidine 
synthetase ↓ ↓ 
purF  
phosphoribosylpyrophosphate 
amidotransferase ↓ ↓ 
purM  phosphoribosylaminoimidazole synthetase ↓ ↓ 
purN  
phosphoribosylglycinamide 
formyltransferase ↓ ↓ 
purH  
phosphoribosylaminoimidazolecarboxamide 
formyltransferase/IMP cyclohydrolase ↓ ↓ 
purD  phosphoribosylamine-glycine ligase ↓ ↓ 
pyrB  
aspartate carbamoyltransferase catalytic 
subunit ↓ ↓ 
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pyrAA  carbamoyl-phosphate synthase small subunit ↓ ↓ 
pyrE  orotate phosphoribosyltransferase ↓ ↓ 
Stress Response 
mnhF  Na+/H+ antiporter subunit ↓ ↓ 
mnhC  Na+/H+ antiporter subunit ↓ ↓ 
mnhB  Na+/H+ antiporter, MnhB component ↓ ↓ 
crtN  squalene synthase ↓ ↓ 
crtM  squalene desaturase ↓ ↓ 
crtQ  glycosyl transferase, group 2 family protein ↓ ↓ 
crtP  4,4'-diaponeurosporene oxidase ↓ ↓ 
ilvD  dihydroxy-acid dehydratase ↓ ↓ 
ilvA  threonine dehydratase ↓ ↓ 
Virulence Factor 
sbi  IgG-binding protein SBI ↑ ↑ 
hla alpha-hemolysin precursor ↓ ↓ 
lukF putative leukocidin F subunit ↑ ↑ 
lukS putative leukocidin S subunit ↑ ↑ 
hlgA  gamma-hemolysin chain II precursor ↑ ↑ 
hlgB  gamma hemolysin, component B ↑ ↑ 
hlgC  gamma hemolysin, component C ↑ ↑ 
spoVG  regulatory protein SpoVG ↑ ↑ 
agrA  accessory gene regulator protein A ↓ ↓ 
agrC  accessory gene regulator C ↓ ↓ 
agrD  accessory gene regulator protein D ↓ ↓ 
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In chapter 4 one candidate for a regulator of SigB is the rsbUVW-sigB 
regulatory system. As the RsbUVW-mediated regulation of SigB is in protein 
level,  it was conceivable that the expression of sigB could remain unchanged 
and thereby was not indicated in RNA-Seq data. The transcriptional data of 
squalene challenge revealed the expression level of rsbV was slightly decreased 
(-1.8-fold). Considering the rsbV gene is in an operon with rsbUVW-sigB, this 
transcript difference might not be expression level since all the other genes on 
the same transcript was not DE. This together with the fact that none of rsbUVW 
were DE in ethanol challenge transcriptome, suggesting a different mechanism 
possessed by ethanol to affect the activity of SigB. 
Whole genome comparisons of antimicrobial-resistant strains and susceptible  
strains have been previously proven as a powerful tool to identify resistance  
determinants. Some of these studies have used isogenic clinical isolates 
(Mwangi et al., 2007; Howden et al., 2011 ) whilst others have used laboratory-
evolved isolates (Renzoni et al., 2011; Song et al., 2013).  The use of laboratory-
evolved isolates has the advantage that selection for resistance is specific to the 
antimicrobial used. However, antimicrobial specific evolution could also be 
considered a disadvantage, as complex interactions of the antimicrobial with 
host factors may require different or multiple resistance determinants due to 
possible synergistic interactions. In addition, horizontal gene transfer from 
other members of the host microflora is a frequent and critical mechanism for 
clinically-evolved isolates to gain resistance determinants, whilst this cannot 
happen in typical experiments that generate laboratory-evolved isolates. 
In this chapter, increased growth in the presence of ethanol was selected for in S. 
aureus Newman. Three SNPs were identified as the result of selective pressure 
from 6 % (v/v) ethanol. Considering the greatly increased growth after ethanol 
passage (Fig 6.9) only one non-synonymous SNP, causing the non-conservative 
replacement DapD A219E, was located in a coding region. 
DapD is a tetrahydrodipicolinate acetyltransferase that catalyses L-2,3,4,5-
tetrahydrodipcolinate into N-Acetyl-L-2-amino-6-oxopimelate which is a step in 
L-lysine biosynthesis.  The specific step is required for biosynthesis of meso-
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diaminopimelic acid which is an essential component of cell wall peptidoglycan 
in staphylococci and many other bacterial species.  Enzymes of the meso-
diaminopimelic acid/lysine pathway are potential targets for the development 
of antibacterial agents (Chapot-Chartier and Kulakauskas, 2014). The A219E 
amino acid replacement might alter catalytic activity that mediates changes in L-
lysine pathway flux. It is difficult to predict the impact of the amino acid change 
on the C-terminal DapD domain as the structure of the protein in staphylococci 
is incomplete. Although tetrahydrodipicolinate acetyltransferase is widely 
distributed in bacteria, the closest protein YkuQ from Bacillus subtilis with 
known structure only has 60 % identity, which makes it less reliable applying 
this SNP into that model. 
By searching for the dapD gene in other S. aureus transcriptional studies and 
including the squalene and ethanol transcriptomes derived in the current 
study, it was found that dapD may be regulated in response to various kinds 
of antimicrobials. Treatments with ethanol, vancomycin, and ortho-
phenylphenol (Brackman et al., 2016; Jang et al., 2008; Pando et al., 2017) all 
caused down-regulation of dapD, whilst squalene did not alter transcription. 
Notably, there was a 5.45 fold decrease in the 1% ethanol transcriptional data 
in the current study and a 4.28 fold decrease revealed in the 10% ethanol 
challenge study (Pando et al., 2017). In view of the knowledge that DapD has a 
crucial role in biosynthesis of cell peptidoglycan (Jang et al., 2008), it is 
possible that decreased expression of this protein is part of a coordinated 
defence mechanisms possessed by S. aureus in response to certain types of 
antimicrobials. If so, the SNP in dapD is a reasonable candidate for the observed 
enhanced resistance in evolved isolates which may help to maintain flux in the 
L-Lysine pathway to maintain cell wall integrity. 
The other candidates that might contribute are two SNPs in the upstream 
control region of NWMN_1774. Both SNPs, 10 bp and 16 bp upstream of the 
translational start site, respectively might alter the abundance of the protein, 
especially if these are located around the Shine-Dalgarno ribosome binding site. 
NWMN_1774 is a small, hypothetical protein of unknown function, that appears 
to be a transmembrane protein based on the presence of both alpha-helical 
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transmembrane region and the membrane spanning region.  The potential 
involvement of the protein in enhancing growth in ethanol is difficult to predict 
and will require construction of isogenic gene inactivation and SNP variant 
strains together with further study in the future. 
Since selection of SNPs in the genome of S. aureus appears facile in a 
laboratory, it brings into question why antimicrobials produced on human 
skin are still functional against S. aureus after thousands of years of evolution. 
One explanation is that it is possible that the combination of components found 
on the skin prevent antimicrobial lipid resistance developing to any one of these 
without a major loss of fitness. This is supported by studies where increasing 
antimicrobial lipid resistance simultaneously decreased resistance to other 
antimicrobials found on the skin such as the “seesaw effect” between 
daptomycin nonsusceptibility and beta-lactam susceptibility in S. haemolyticus 
(Sieradzki and Tomasz, 1997; Vignaroli et al., 2011).  
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Chapter 7 General discussion 
 
7.1 Summary of this study 
The aims of this thesis were to determine if squalene potentially plays a role in 
the colonisation and persistence of staphylococci on skin and comparatively 
investigate the effects of squalene upon S. aureus and S. epidermidis. To 
complete these aims, firstly experiments were undertaken to determine 
whether squalene has antimicrobial effects on staphylococci. The conclusion of 
its lack of toxicity in rich medium was made while quantifying that the 
eponymous golden colour of S. aureus cells was dramatically reduced by 
squalene. Next, taking into consideration the known relationships between 
pigment level and resistance to certain antimicrobials, experiments were 
performed to investigate if squalene treatment is capable of modulating the 
activities of four distinct antimicrobials, H2O2, nisin, sapienic acid and LL-37, 
with respect to S. aureus and S. epidermidis. These studies showed that pre-
treatment with squalene has no effect on resistance to sapienic acid, but 
lowered the susceptibility of S. aureus but not S. epidermidis to H2O2 and nisin. 
However, The opposite pattern was observed for LL-37, where pre-treatment of 
squalene enhanced the resistance of S. epidermidis but did not alter the 
resistance of S. aureus. Thirdly, to gain insights into the overall gene expression 
profiles after squalene challenge, the transcriptional response of S. aureus and S. 
epidermidis was recorded by RNA-Seq and a further prolonged effects of 
squalene to S. aureus was assessed using a quantitative proteomics approach. 
The results of RNA-Seq analysis revealed numerous overlaps as well as 
significant differences between both species in their transcriptional responses 
to squalene, and possible genetic bases for previous experiments were also 
found and proposed. Of note, challenge with squalene triggered the 
derepression of the iron acquisition mechanisms in both S. aureus and S. 
epidermidis, and down-regulation of ferritin was further confirmed in proteomic 
data of S. aureus. The unexpected effect of squalene with respect to iron 
transport systems, lead to quantification of its effects on cellular iron level. ICP-
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OES confirmed that the intracellular iron level was significantly decreased in 
squalene-treated cells and revealed that squalene treatment caused a 
pronounced growth defect in iron-limited defined growth medium. Squalene 
was found to have no ability to sequester iron from broth suggesting simple 
chelation could not explain the phenomenon.   
Ethanol treatment was observed to produce a similar reduction in S. aureus 
pigment level during culture. Consequently, a transcriptomics approach was 
used to enable comparison with the squalene data that had been generated 
previously. Analysis of RNA-Seq data for ethanol challenge was compared with 
that for squalene challenge to determine whether squalene and ethanol might 
act via a common mechanism to affect staphyloxanthin production. The similar 
extent of crt operon down-regulation after ethanol challenge supports shared 
responses by squalene and ethanol that extended beyond staphylococcal 
pigment genes to metabolic and virulence pathways. Finally, the experimental 
evolution of S. aureus to sub-bactericidal concentration of ethanol was 
conducted to identify SNPs in genes that might act as resistance determinants to 
ethanol. Three SNPs were identified as the result of selective pressure from 6 % 
(v/v)  ethanol.  Two SNPs were in the leader sequence of a gene for a 
hypothetical protein and could not be explained.  One non-synonymous SNP in a 
gene (dapD, producing DapD A219E) of the lysine biosynthesis pathway 
responsible for production of meso-diaminopimelic acid could affect flux in cell 
wall peptidoglycan biosynthesis. 
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7.2 Unanswered questions and future research 
Although considerable progress has been made in understanding the role of 
squalene on colonisation and persistence of S. aureus and S. epidermidis, several 
questions remain unanswered. Of these, two questions with the highest 
importance are: 
 How squalene (and ethanol) acts via transcription to reduce the pigment 
biosynthesis of S. aureus? 
 What is the mechanism by which squalene lowers staphylococcal cellular 
iron levels? 
Squalene and ethanol may employ the same or two distinct mechanisms 
affecting the pigmentation of S. aureus, but both end up with the decreased 
expression level of the crt operon. Therefore, factors that are capable of 
regulating the crt operon become the most likely susceptible targets for 
squalene and ethanol. Currently, it is known that the stress response alternative 
sigma factor SigB regulates STX production; the SigB deletion mutant is white 
and lacks STX (Kullik et al., 1998). Direct SigB regulation was proposed, and a 
consensus SigB DNA binding motif was identified in the crt promoter, but direct 
interaction was not confirmed (Hall et al., 2017). SigB activity is mediated by the 
upstream sigB operon genes encoding the RsbUVW regulatory system, where 
RsbU dephosphorylates the anti-anti-sigmaB factor RsbV and thus leads to the 
release of SigB from its inhibitory complex with RsbW (Pané-Farré et al., 2009). 
With respect to this study, the down-regulation of rsbV revealed in the squalene 
challenge transcriptome might indicate that squalene acts indirectly to lower 
pigment production through interfering with SigB activity. While this would 
require complex regulation, neither rsbV, nor any other genes within the rsb 
operon was DE in the ethanol challenge transcriptome, suggesting both ethanol 
and squalene may directly, though more likely indirectly, act via RsbU (the 
stimulus modulator) or there exists an alternative regulation system of the crt 
operon. 
Recently, it was reported the oxygen-sensing and redox-signalling AirSR TCS 
transcriptionally regulates the STX-biosynthetic crt operon (Hall et al., 2017). 
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Overexpression of the AirR response regulator increased colony pigmentation, 
and the ΔairSR mutant exhibited an over 4.5-fold decrease in expression level of 
crt operon compared with the parental wild-type strain (Hall et al., 2017). 
Unlike the ΔsigB mutant, a gene knockout of airSR did not result in complete 
shutdown of STX biosynthesis, indicating that airSR is epistatic to sigB, as AirSR 
regulation of crt is dependent on the presence of SigB (Hall et al., 2017). 
Moreover, it was identified that there is a specific AirR binding region upstream 
of crtOPQMN indicating direct regulation of the biosynthetic operon via the DNA 
recognition motif (G/T)AA(C/A)ATNNA(C/A)AAAT, which was present in all 11 
AirSR-regulated promoters (Hall et al., 2017). In further agreement with the 
current study, their microarray data revealed that two STX-biosynthetic genes, 
crtM and crtN, to be down-regulated 2- to 3-fold at the mid-exponential phase of 
growth during airS antisense RNA induction (Hall et al., 2017). This combined 
with the decreased expression level of the crt operon in an airSR mutant, 
suggests AirSR TCS could be an alternative target besides RsbUVW for the 
actions of squalene and ethanol. 
Therefore, to answer the question of how squalene/ethanol transcriptionally 
reduces expression level of crt operon, future studies should primarily focus on 
a determination of whether squalene and ethanol have effects on AirSR TCS or 
the RsbUVW regulatory system. Firstly, although transcriptional data in this 
study showed the expression level of airSR, rsbU, and rsbW remained unchanged 
after squalene or ethanol challenge, this result can be double checked by 
examining the expression level of both treated and untreated samples via qPCR. 
If the qPCR results confirm the expressions of airSR and rsbU(V)W are not 
influenced by squalene or ethanol challenge, a protein activity-level interference 
from squalene or ethanol with AirSR and RsbUVW will be expected. 
Determination of whether squalene or ethanol are affecting the crt operon 
through AirSR can be conducted by assessing the pigment level of a ΔairSR 
mutant with or without squalene or ethanol treatment. As shown in the study 
(Hall et al., 2017), the expression of the crt operon was uninterrupted but at a 
lower level in ΔairSR mutant, meaning the pigment level should be still 
measurable. Consequently, if there is no difference in pigment level of an airSR 
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mutant between the two treatments, it can be confirmed that the ability of 
squalene or ethanol to lower crt expression is via impairing the function of 
AirSR. Otherwise, if squalene or ethanol treatment causes a further decreased 
level of pigmentation for an ΔairSR mutant, it can be concluded that AirSR is 
irrelevant to the squalene or ethanol-induced reduction in staphylococcal 
pigmentation.  
A similar experiment could also be applied to determine whether activity of 
RsbUVW is influenced by squalene or ethanol treatment. Inactivation of RsbU 
activity in S. aureus 8325-4 shuts down the majority of pigment biosynthesis 
(Horsburgh et al., 2002), but the remaining pigment should be measurable using 
a more precise method. Construction of an entire rsbUVW knockout strain or 
separately inactivation of rsbU, rsbV and rsbW are both theoretically feasible, 
and whether there is a difference in pigment level between two treatments will 
be the key determinant.      
Iron acquisition is a critical mechanism that is required for bacteria to colonise 
vertebrate hosts, and humans possess several mechanisms that minimises free 
iron to <10-18 M to prevent bacterial outgrowth. In this study, challenge with 
squalene triggered the derepression of the iron acquisition mechanisms in both 
S. aureus and S. epidermidis, and further investigations revealed that this change 
in gene expression profile was due to a significant reduction in cellular iron. To 
answer the question of how this long chain lipid without functional side groups 
is able to lower cellular iron level, molecular tracking of both squalene and iron 
ions could be performed using isotope labelling method in future research 
studies.  
Biological studies based on isotope labelling have been widely established, 
especially investigating metabolic fluxes and determining the structure of 
metabolic pathways and networks including the studies determining carbon 
and iron metabolisms (Dunn et al., 2013; Klein et al., 2012; Skaar et al, 2004). 
This technique is particularly powerful in biochemical pathway analysis 
allowing scientists to trace the conversion of one chemical to another following 
incorporation of heavy atoms from precursor substrates into different 
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metabolic products (Chokkathukalam et al., 2014; Fan et al., 2012). Usage of 
radioactive isotope is a common method in isotope labelling research due to its 
high sensitivity. But the amount of radioactive isotope used in the study should 
be strictly controlled within the limits of what an experimental organism can 
support, as excess amount of radiation could induce mutations thus affecting the 
results. Alternatively, usage of stable isotopes does not have the mutagenic 
effect. Stable isotopes have the same number of protons as common elements, 
and consequently share the same physicochemical properties, but differ in mass 
due to a difference in the number of neutrons, which enables MS-based 
analytical tools to easily separate isotopically labelled compounds based on 
mass difference. Skaar et al (2004) used stable isotope labelling to detect 
source-specific iron by mass spectrometry, and revealed that haem-iron is the 
preferred source of iron in the presence of both transferrin and either haem or 
haemoglobin during infection for S. aureus, which indicates using isotope 
labelling method to study metabolic pathway in S. aureus is feasible.  
Therefore, to determine if squalene interferes with an iron efflux mechanism 
that leads to a net deficit of intracellular iron, S. aureus cells can be pre-cultured 
in an iron-deficient medium with supplement of stable iron-isotope to create a 
saturated heavy isotope-labelled metabolome. Then transferring the pre-
cultured cells into a new medium without iron-isotope and culturing with or 
without squalene for several hours. By comparing the amount of iron-isotope 
found in the supernatant of the new media between two treatments, a squalene-
induced iron efflux could be assured if observing a higher level of iron-isotope 
in squalene treated sample than the untreated. Moreover, if applying the 
radioactive isotope of iron in the above experiment, it would allow a more 
dynamic in vivo tracking to examine whether there are differences in the 
passage of iron through bacteria between squalene treated and untreated 
samples. In addition, isotope labelled iron-containing proteins such as 
transferrin, lactoferrin, and haem could replace isotope-iron ions to obtain the 
more in vivo like results.  
Using an isotope labelling method could also facilitate our understanding of the 
relationship between squalene and staphylococcal pigment biosynthesis. By 
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treatment of staphylococci with a customised isotope-labelled squalene then 
tracking  its flux in bacterial metabolic pathways, it will be determined whether 
squalene enters the cell membrane; whether bacteria consume squalene as a 
carbon source, and if so, which metabolic pathways squalene passes through.   
Although squalene did not exhibit antimicrobial effects on staphylococci in rich 
media as shown in chapter 3 (Fig 3.2), a squalene-induced growth defect was 
observed in low iron media (chapter 5, Fig 5.3). This suggests the experimental 
evolution of S. aureus to squalene is feasible in low iron (0-0.02 µM) media as 
squalene induces enough survival pressure for selection of mutations. The 
methods for experimental evolution of S. aureus to ethanol (chapter 2.8) could 
apply to conduct the experiment by changing culture media from BHI to iron-
deficient CDM. 
In this study, increased growth yield of S. aureus Newman was achieved by 
selection using 6% (v/v) ethanol and experimental evolution. Three non-
synonymous SNPs were identified as the result of the ethanol selective pressure. 
They include a non-synonymous SNP in dapD (producing DapD.A219E) and two 
intergenic SNPs in the leader sequence of NWMN_1774. Due to poor 
understanding of the functions of the latter gene, the role of these leader 
sequence SNPs in increased ethanol resistance was not progressed. 
Construction of a defined SNP variant of the leader sequence and an allelic 
replacement mutant of NWMN_1774 would be valuable to conduct future 
investigation. The possible divergence of ethanol resistance between the wild-
type and mutant strain will facilitate determining the functions of the SNPs.  The 
DapDA219E variant protein could be studied to examine the effect it has on flux 
through the L-Lysine biosynthesis pathway and whether synthesis of meso-
diaminopimelic acid for cell wall biosynthesis is the critical change that 
improves growth in ethanol by preventing the stress response limitation of this 
catalytic step. 
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7.3 Limitations of the study and relevance to skin 
Over the process of this investigation, one concern that could limit the validity 
and impact of these data is: how do results gained in vitro differ from the in vivo 
scenario. For example, the squalene concentrations used in this study were 0.1 % 
(v/v) and 1 % (v/v), which was lower than that reported in sebum, where 
squalene comprises 12 % of total skin surface lipids. As sebum is unevenly 
distributed all over the body, it would be tempting to suggest that the effects 
observed in this study should be more pronounced in sebum-rich areas but less 
influential in sebum-lacking areas. However, this conclusion may not be always 
true as the ratio of sebaceous lipids to epidermal lipids differs across the body, 
resulting in different extents of dilution of squalene across the skin. 
Furthermore, the water concentration of skin is also extremely reduced 
compared with the assays described here. Given that squalene and some 
antimicrobial lipids are amphipathic molecules these differences could lead to 
considerable divergence for the results presented. Therefore, the use of skin 
models is required to obtain more valid conclusions in future research. 
To overcome the perceived and known divergence between in vitro and in vivo, 
most staphylococcal in vivo experiments rely on a variety of animal models, such 
as inoculation of S. aureus in epidermal rodent skin models (Onunkwo et al., 
2010). However, besides the considerable differences between human skin and 
rodent skin in both histology and immunology such as the amount of squalene, 
the results from studies using rodent skin models have shown a lack of 
consistency over extended periods of time, which complicates interpretation of 
data with respect to bacterial localisation and replication in the skin (Kanzaki et 
al., 1996; Abe et al., 1993; Kugelberg et al., 2005). Moreover, the majority of 
existing S. aureus animal skin models require severe mechanical disruption of 
the skin to compromise the initial barrier function which facilitates bacterial 
growth (Nippe et al., 2010; Cho et al., 2011; Inoshima et al., 2011). Although 
these experiments are useful for studying staphylococcal pathogenesis, they do 
not facilitate our understanding of how S. aureus adapts to an intact tissue or 
how S. aureus transits from asymptomatic colonization state to invasive 
infection (Popov et al., 2014). 
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The use of ex vivo human skin explants provides another method for studying 
the interactions between bacterial colonisers and the human skin components, 
regardless of limitations described in murine model. Ex vivo human skin 
explants are typically acquired from neonatal foreskin, surgical or cadaveric 
tissues, which can be maintained in cell culture media or on supports in an air-
liquid interface and remain viable in culture for up to two weeks (Popov et al., 
2014). The advantage of skin explants is that they contain all components of the 
skin tissue including all resident cell types of the epidermis and dermis as well 
as skin appendages. However, there are also limitations originating from genetic 
variations between each individual, and the relatively restricted availability of 
human skin (Popov et al., 2014). 
At present, there are an increasing number of studies employing a 3-D 
organotropic human skin model as an in vivo like tool to dispel the above 
concern (Ridky et al., 2010; Groeber et al., 2011; Soong et al., 2012; Kretz et al, 
2013; Hogk et al., 2013). The 3-D human skin culture models are a tractable 
experimental system that could contribute to investigations of the determinants 
of S. aureus interaction with the multi-layer skin tissue in future study. 
Organotropic 3-D skin models are developed from immortalised human 
keratinocytes, grown at an air-liquid interface on a supporting matrix which can 
be seeded with fibroblasts (Gangatirkar et al., 2007). In particular, fibroblasts 
are seeded into human dermal tissue to provide the underlying support matrix. 
Subsequently keratinocytes are then seeded on top of the matrix and grown for 
several days until the keratinocytes are fully differentiated thereby establish a 
basement membrane and all of the stratified epidermal layers from stratum 
basale to stratum corneum (Popov et al., 2014). As a result, the entire human 
skin proteins, cells and other components including the skin-derived 
antimicrobials are all involved in the 3-D human organotropic model, displaying 
the very similar thickness and the cellular architecture with the human 
epidermis (Fig 7.1)(Popov et al., 2014).  However, even these models have 
limitations due to the absence of hair follicles and sebaceous glands, which 
means the sebaceous and epidermal lipids including squalene may need to be 
added artificially unlike the human explant skin.  
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The future study of staphylococci, squalene and skin awaits the development 
and publication of new models and on the horizon are models of human skin 
grated onto mice that maintain skin barrier functions for several weeks (Keira 
Mellican, personal communication). 
 
 
 
 
Figure 7.1 Three-dimensional organotropic human epidermal tissues recapitulate the 
stratified structure of the epidermis. (Popov et al., 2014) 
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Appendix 
Appendix Table 1 DE genes of S. aureus in response to 1 % (v/v) squalene challenge. The level of fold change (logFC) is based on log2. All DE genes have 
FDR (false discovery rate)  0.05. DE genes that discussed in this thesis were highlighted. 
Gene Gene description logFC FDR 
NWMN_tRNA17 tRNA-Glu 4.391714365 0.004260181 
NWMN_2304 conserved hypothetical protein 2.618022746 0.000170352 
NWMN_1077 conserved hypothetical protein 2.373553493 2.86E-11 
NWMN_1076 conserved hypothetical protein 2.102404332 9.93E-09 
isdG cytoplasmic heme-iron binding protein 2.037769355 2.92E-05 
NWMN_1075 conserved hypothetical protein 1.946814265 3.99E-07 
NWMN_2081 conserved hypothetical protein 1.939721459 3.28E-06 
fnbB fibronectin binding protein B precursor 1.909883684 0.000803488 
NWMN_1312 conserved hypothetical protein 1.900268288 0.001216333 
NWMN_0118 conserved hypothetical protein 1.860157425 1.46E-05 
sbnD membrane transporter protein 1.845657617 0.003739599 
glpD aerobic glycerol-3-phosphate dehydrogenase 1.833967598 6.51E-06 
lukS leukocidin/hemolysin toxin family S subunit 1.818740226 0.00076537 
hlgB gamma hemolysin, component B 1.81185194 6.23E-06 
isdC iron-regulated cell surface protein 1.799175171 0.002372492 
NWMN_2077 iron compound ABC transporter, permease protein 1.797097422 1.72E-06 
NWMN_2069 conserved hypothetical protein 1.793441637 0.000230585 
sbnI SbnI protein 1.773132477 4.13E-06 
sbnH diaminopimelate decarboxylase 1.757325348 2.13E-06 
hlgC gamma-hemolysin component C 1.739768742 7.00E-06 
NWMN_0429 N-acetylmuramoyl-L-alanine amidase aaa precursor 1.731374712 6.36E-06 
NWMN_0834 conserved hypothetical protein 1.730799388 8.17E-05 
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NWMN_1224 conserved hypothetical protein 1.727076942 0.043338336 
sirA siderophore compound ABC transporter binding protein 1.686526318 0.004260181 
NWMN_0339 conserved hypothetical protein 1.686109726 0.000988679 
NWMN_2215 conserved hypothetical protein 1.653855457 0.001861831 
srtB NPQTN-specific sortase B 1.647542957 0.001618872 
cysM cysteine synthase 1.64122432 1.58E-05 
NWMN_0117 conserved hypothetical protein 1.636898517 0.001169907 
isdF iron/heme permease 1.62096962 0.001676354 
isdA iron-regulated heme-iron binding protein IsdA 1.613074365 0.000373984 
NWMN_2076 FecCD iron compound ABC transporter, permease family protein 1.599974347 6.66E-05 
NWMN_1522 hypothetical protein 1.589735706 0.025741491 
sbnG 2-dehydro-3-deoxyglucarate aldolase 1.575776824 0.000643012 
NWMN_1674 CrcB-like protein 1.572478032 0.021562261 
NWMN_tRNA34 tRNA-Met 1.568784472 0.008740502 
NWMN_0027 conserved hypothetical protein 1.56609009 0.000154633 
NWMN_0116 conserved hypothetical protein 1.542858789 0.001151533 
lukF leukocidin/hemolysin toxin family F subunit 1.537358233 0.01298427 
NWMN_tRNA23 tRNA-Met 1.535625333 0.007633599 
ssl2nm staphylococcal enterotoxin-like toxin 1.520953011 1.22E-05 
sdrD Ser-Asp rich fibrinogen/bone sialoprotein-binding protein sdrD 1.510877499 0.000191935 
lipA lipase/esterase LipA 1.502486288 0.001311868 
NWMN_2185 iron compound ABC transporter, iron compound-binding protein 1.501910669 0.001966684 
NWMN_0703 iron compound ABC transporter, permease protein 1.495454085 0.003213835 
ssp extracellular matrix and plasma binding protein 1.491811753 0.000745931 
sbnE siderophore biosynthesis IucA family protein 1.490842566 0.007181175 
gatC glutamyl-tRNA amidotransferase subunit C 1.481465721 0.049474771 
fhuB ferrichrome transport permease fhuB 1.477806145 0.000275902 
NWMN_0755 conserved hypothetical protein 1.473235181 3.67E-05 
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NWMN_2273 acetyltransferase, GNAT family protein 1.458763544 0.000698424 
NWMN_1503 enterotoxin family protein 1.439145707 0.014526254 
sbnC siderophore biosynthesis IucC family protein 1.433731695 0.022464997 
isdE iron compound ABC transporter 1.418604072 0.003837888 
NWMN_0188 conserved hypothetical protein 1.416044417 0.000335064 
tatA twin-arginine translocation protein TatA 1.41121221 0.021562261 
NWMN_0434 conserved hypothetical protein 1.410512536 0.00019783 
NWMN_0423 sodium-dependent symporter protein 1.410425263 0.002496427 
NWMN_0764 conserved hypothetical protein 1.407957134 0.00063892 
hisC histidinol-phosphate aminotransferase 1.397222632 0.001446274 
NWMN_0907 conserved hypothetical protein 1.378123716 0.001221613 
NWMN_0702 ferrichrome ABC transporter permease 1.376380666 0.003629908 
NWMN_0370 conserved hypothetical protein 1.36933798 0.040337837 
NWMN_2396 C-terminal part of fibronectin binding protein B 1.362213163 0.049914616 
ssl3nm staphylococcal enterotoxin-like toxin 1.35186464 0.000308804 
ssl4nm staphylococcal enterotoxin-like toxin 1.351587362 0.00011058 
rimJ ribosomal-protein-alanine N-acetyltransferase 1.350559232 0.002084534 
NWMN_1999 conserved hypothetical protein 1.338577629 0.003466992 
NWMN_2078 ferrichrome ABC transporter lipoprotein 1.330969337 0.001677384 
NWMN_0231 conserved hypothetical protein 1.32886099 0.000486682 
NWMN_2259 conserved hypothetical protein 1.324491797 0.003429144 
sbnF siderophore biosynthesis IucC family protein 1.323620399 0.01224487 
NWMN_0341 conserved hypothetical protein 1.299596117 0.015677591 
NWMN_2223 conserved hypothetical protein 1.2746435 0.005218439 
ssl5nm staphylococcal enterotoxin-like toxin 1.269335306 0.001390424 
NWMN_0784 conserved hypothetical protein 1.264700366 0.000602344 
NWMN_0115 conserved hypothetical protein 1.260064119 0.002891125 
NWMN_0208 conserved hypothetical protein 1.256511578 0.000689824 
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NWMN_2254 conserved hypothetical protein 1.253603332 0.017315124 
ssl9nm staphylococcal enterotoxin-like toxin 1.245407586 0.001675356 
NWMN_2253 drug resistance transporter EmrB/QacA subfamily protein 1.241263981 0.030982684 
NWMN_0704 ABC transporter ATP-binding protein 1.231132968 0.005117015 
spsA type-I signal peptidase A component 1.225833525 0.008186324 
ssl10 staphylococcal enterotoxin-like toxin 1.225330243 0.001435413 
NWMN_1210 hydrolase 1.213092643 0.001157292 
lytM peptidoglycan hydrolase 1.20831528 0.004177294 
NWMN_0006 conserved hypothetical protein 1.182095903 0.001153031 
NWMN_0028 metallo-beta-lactamase superfamily protein 1.162206966 0.001264841 
NWMN_2467 O-acetyltransferase OatA 1.1589439 0.006615849 
NWMN_0662 conserved hypothetical protein 1.158407355 0.010904473 
NWMN_2316 cation efflux family protein 1.145545991 0.011122739 
nhaC Na?? antiporter NhaC 1.139581368 0.032277029 
NWMN_0378 xanthine phosphoribosyltransferase 1.13481228 0.049983752 
NWMN_0636 AraC family regulatory protein 1.134410771 0.026538061 
NWMN_0997 conserved hypothetical protein 1.126973538 0.039640464 
sirB siderophore compound ABC transporter permease protein SirB 1.125725368 0.041929831 
NWMN_0826 NADH-dependent flavin oxidoreductase 1.121950449 0.003925964 
NWMN_0853 3-oxoacyl-(acyl-carrier-protein) synthase III 1.121152058 0.009144271 
isdB iron-regulated heme-iron binding protein IsdB 1.103608496 0.004666203 
potA spermidine/putrescine ABC transporter, ATP-binding protein 1.088866855 0.011598491 
ssl6nm staphylococcal enterotoxin-like toxin 1.08695326 0.020999208 
NWMN_0026 conserved hypothetical protein 1.083918511 0.006197105 
NWMN_0964 conserved hypothetical protein 1.081836462 0.026889022 
NWMN_2374 conserved hypothetical protein 1.076666957 0.016134957 
NWMN_0230 conserved hypothetical protein 1.075434887 0.048721384 
trmU tRNA (5-methylaminomethyl-2-thiouridylate)-methyltransferase 1.074801549 0.019883136 
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NWMN_2255 transcriptional regulator TetR family protein 1.074408184 0.032365366 
NWMN_2271 acetyltransferase, GNAT family protein 1.068362047 0.049474771 
tagA teichoic acid biosynthesis protein A 1.067987378 0.013923834 
NWMN_0038 conserved hypothetical protein 1.06428277 0.009285357 
pbuX xanthine/uracil permease 1.046172027 0.027082488 
NWMN_0768 conserved hypothetical protein 1.043079883 0.021995218 
NWMN_0356 conserved hypothetical protein 1.040169777 0.0464606 
NWMN_1664 arsenical resistance operon repressor 1.03634975 0.027834257 
NWMN_0849 conserved hypothetical protein 1.03385013 0.048804158 
NWMN_2274 pyridine nucleotide-disulfide oxidoreductase family protein 1.017399281 0.008397784 
NWMN_1667 mannosyl-glycoprotein endo-beta-N-acetylglucosamidase 1.012592943 0.019105916 
NWMN_2341 NAD dependent epimerase/dehydratase family protein 1.011112905 0.009166342 
NWMN_0693 conserved hypothetical protein 1.006752239 0.00674109 
ssl8nm staphylococcal enterotoxin-like toxin 1.000814929 0.012178034 
NWMN_2070 conserved hypothetical protein 0.994037764 0.010047927 
NWMN_0535 conserved hypothetical protein 0.989378763 0.030203328 
NWMN_0119 conserved hypothetical protein 0.984420452 0.033416926 
moaE molybdopterin synthase large subunit 0.969922359 0.032657042 
fhuG ferrichrome transport permease fhuG 0.969351318 0.018740855 
NWMN_1064 conserved hypothetical protein 0.961656036 0.017308553 
pabA para-aminobenzoate synthase component II 0.948707698 0.039640464 
NWMN_0766 conserved hypothetical protein 0.942370621 0.048965994 
NWMN_0189 conserved hypothetical protein 0.935086775 0.013358702 
NWMN_0245 conserved hypothetical protein 0.929775452 0.046219101 
NWMN_1760 A/G-specific adenine glycosylase 0.927418981 0.018213724 
NWMN_0025 conserved hypothetical protein 0.926381005 0.017567592 
NWMN_2159 conserved hypothetical protein 0.921753931 0.024479656 
NWMN_1865 conserved hypothetical protein 0.914643411 0.015677591 
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NWMN_1534 N-acetylmuramoyl-L-alanine amidase, family 3 0.914268756 0.038778203 
NWMN_0374 sodium:dicarboxylate symporter family protein 0.906987071 0.023963343 
porA pyruvate flavodoxin ferredoxin oxidoreductase, alpha subunit 0.906870202 0.039640464 
sdrC Ser-Asp rich fibrinogen/bone sialoprotein-binding protein SdrC 0.904721942 0.042555138 
metB cystathionine gamma-synthase 0.90316923 0.015900184 
NWMN_0150 conserved hypothetical protein 0.896462718 0.029534647 
NWMN_0920 conserved hypothetical protein 0.887581397 0.04455717 
NWMN_1824 conserved hypothetical protein 0.886086239 0.017433034 
NWMN_0954 conserved hypothetical protein 0.870790774 0.034524729 
NWMN_2079 conserved hypothetical protein 0.863468143 0.025469897 
NWMN_1621 conserved hypothetical protein 0.838386113 0.03027165 
NWMN_0320 lipoate-protein ligase A family protein 0.836374471 0.018821644 
NWMN_0582 iron compound ABC transporter, permease protein 0.833668003 0.033416926 
tagG teichoic acid ABC transporter permease protein 0.828950591 0.028045142 
NWMN_0970 conserved hypothetical protein 0.828124023 0.039304655 
NWMN_0978 cell division protein 0.815797794 0.039931332 
NWMN_0691 ABC transporter permease protein 0.814450931 0.04080052 
NWMN_2451 MmpL efflux pump 0.807733405 0.04126105 
NWMN_0143 oligopeptide ABC transporter, ATP-binding protein 0.765887296 0.049474771 
NWMN_2408 conserved hypothetical protein -0.767583415 0.048965994 
NWMN_1471 cytidine deaminase, homotetrameric -0.818324714 0.04455717 
modB molybdenum ABC transporter, permease protein -0.819779415 0.042904756 
NWMN_0140 conserved hypothetical protein -0.819976897 0.046838779 
modC molybdenum ABC transporter, ATP-binding protein ModC -0.82840755 0.048223458 
rbsR ribose transcriptional repressor RbsR -0.877828041 0.029285497 
NWMN_2026 aldehyde dehydrogenase family protein -0.89104504 0.021812136 
rsbV anti-sigma B factor antagonist -0.896540693 0.036574974 
NWMN_2089 osmoprotectant transporter -0.904841818 0.01933896 
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purF amidophosphoribosyltransferase precursor -0.915886383 0.044496604 
atpG ATP synthase, gamma subunit -0.923512623 0.048804158 
deoC deoxyribose-phosphate aldolase -0.930082651 0.015176575 
NWMN_1645 conserved hypothetical protein -0.931146164 0.013362456 
fumC fumarate hydratase, class II -0.944615907 0.047119649 
NWMN_1072 conserved hypothetical protein -0.955345013 0.030903811 
NWMN_2202 conserved hypothetical protein -0.960875918 0.032277029 
NWMN_2212 inositol monophosphatase family protein -0.967152853 0.046641003 
NWMN_0672 aldo/keto reductase family protein -0.968802384 0.025518882 
NWMN_0673 conserved hypothetical protein -0.978104098 0.019424705 
NWMN_0155 conserved hypothetical protein -0.978201068 0.0464606 
NWMN_2479 amidohydrolase family protein -0.982746081 0.007968853 
NWMN_1352 conserved hypothetical protein -0.98839559 0.01322002 
NWMN_2480 hydrolase -0.989761286 0.025671538 
treR trehalose operon repressor -0.991075082 0.01398011 
sarH1 staphylococcal accessory regulator A homolog -0.997863167 0.04126105 
NWMN_0753 conserved hypothetical protein -1.001310114 0.039640464 
NWMN_0083 phosphopentomutase -1.005230335 0.024827903 
NWMN_0321 oxidoreductase family protein -1.007029859 0.01398011 
NWMN_1820 conserved hypothetical protein -1.018554457 0.011168768 
NWMN_1275 4-oxalocrotonate tautomerase -1.033733018 0.019105916 
NWMN_0482 conserved hypothetical protein -1.040971951 0.003813409 
NWMN_0782 ABC transporter, substrate-binding protein -1.041829342 0.006809057 
NWMN_1819 low molecular weight phosphotyrosine protein phosphatase -1.05665713 0.011220097 
NWMN_1767 ThiJ/PfpI family protein -1.059913304 0.007858775 
oppC oligopeptide ABC transporter, permease protein -1.068490901 0.037256536 
katA catalase -1.069271884 0.010242254 
tpi triosephosphate isomerase -1.074946695 0.047694905 
211 
 
NWMN_0973 inositol-1-monophosphatase family protein -1.090966746 0.014325508 
ald1 alanine dehydrogenase 1 -1.091697463 0.006943523 
NWMN_0649 conserved hypothetical protein -1.10589775 0.01293585 
NWMN_1074 conserved hypothetical protein -1.109347115 0.038249752 
rpsU 30S ribosomal protein S21 -1.131760378 0.003546585 
NWMN_0286 conserved hypothetical protein -1.136189433 0.007881096 
clfA clumping factor A -1.168357011 0.00384788 
NWMN_0047 conserved hypothetical protein -1.183808176 0.005729119 
NWMN_1038 phage holin -1.191576812 0.044342298 
NWMN_0289 phage terminase large subunit -1.198356207 0.008100091 
NWMN_1688 conserved hypothetical protein -1.203453656 0.000596259 
NWMN_2417 conserved hypothetical protein -1.210368917 0.042555138 
bsaG lantibiotic ABC transporter protein -1.211687481 0.027795832 
NWMN_0460 conserved hypothetical protein -1.216968484 0.00892544 
NWMN_1689 conserved hypothetical protein -1.217607098 0.000949032 
NWMN_1631 conserved hypothetical protein -1.218147686 0.000920521 
NWMN_2075 conserved hypothetical protein -1.220841125 0.021534821 
NWMN_2594 conserved hypothetical protein -1.231597632 0.008475979 
NWMN_0737 conserved hypothetical protein -1.231628922 0.00125063 
NWMN_2270 conserved hypothetical protein -1.232171882 0.001885155 
NWMN_2217 phosphosugar-binding transcriptional regulator RpiR family protein -1.235868365 0.000785597 
sucB 
dihydrolipoamide succinyltransferase E2 component of 2-oxoglutarate dehydrogenase 
complex 
-1.241262015 0.001342878 
NWMN_0250 ABC transporter, permease protein -1.242121692 0.000596918 
NWMN_0251 ABC transporter ATP-binding protein -1.251793928 0.000578823 
NWMN_1059 hypothetical protein -1.258672252 0.01579016 
NWMN_1821 ribonuclease BN -1.261264898 0.001676354 
srrA DNA-binding response regulator SrrA -1.27091017 0.010803254 
NWMN_0547 conserved hypothetical protein -1.272232738 0.011862374 
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aldA aldehyde dehydrogenase homolog -1.276864757 0.016384269 
NWMN_0601 conserved hypothetical protein -1.28359699 0.039427602 
NWMN_2330 conserved hypothetical protein -1.289935306 0.014072465 
qoxA quinol oxidase polypeptide II QoxA -1.299811326 0.009270761 
NWMN_2353 ABC transporter, ATP-binding protein -1.309722712 0.002918126 
NWMN_0650 conserved hypothetical protein -1.312263499 0.001311868 
NWMN_1632 general stress protein-like protein -1.315279613 0.001047098 
NWMN_1746 conserved hypothetical protein -1.324636718 0.000269303 
malA alpha-D-1,4-glucosidase -1.327595221 0.010568249 
NWMN_0219 conserved hypothetical protein -1.332445675 0.007020509 
NWMN_0603 ABC transporter ATP-binding protein -1.34137692 0.001879748 
NWMN_1831 ferritin -1.343125123 0.000830872 
NWMN_0053 conserved hypothetical protein -1.344645886 0.000164285 
bsaE lantibiotic ABC transporter protein -1.34728546 0.034984162 
NWMN_2465 crtO conserved hypothetical protein -1.353324593 0.013720801 
glcA glucose-specific PTS transporter protein IIABC component -1.353697866 0.002301503 
NWMN_0587 conserved hypothetical protein -1.356405362 0.000345402 
ptsG PTS system, glucose-specific IIABC component -1.369964474 0.000293668 
NWMN_0288 conserved hypothetical protein -1.37459303 0.000477792 
NWMN_0290 phage portal protein -1.378010196 0.001550749 
NWMN_2350 para-nitrobenzyl esterase chain A -1.391709838 0.001096582 
bsaP lantibiotic leader peptide processing serine protease -1.392294145 0.000200322 
NWMN_0856 oligopeptide transport system permease protein -1.394267694 0.012152613 
NWMN_0310 phage tail fiber -1.39730765 0.004185379 
NWMN_0291 conserved hypothetical protein -1.399689293 0.000366213 
treC alpha,alpha-phosphotrehalase -1.403606343 0.00202554 
arcA arginine deiminase -1.410235925 0.045888079 
pckA phosphoenolpyruvate carboxykinase -1.413206543 0.003282012 
213 
 
tnp1 transposase for IS1181 -1.417192718 0.003727185 
cidB holin-like protein CidB -1.419709376 0.000200322 
NWMN_0299 conserved hypothetical protein -1.424594155 0.000789478 
hla alpha-hemolysin precursor -1.426526711 0.041041611 
mtlD mannitol-1-phosphate 5-dehydrogenase -1.426611973 0.000235897 
poxB pyruvate oxidase -1.430850621 0.000117337 
NWMN_2444 conserved hypothetical protein -1.439396126 0.04568425 
NWMN_1861 conserved hypothetical protein -1.440394291 0.019105916 
serS seryl-tRNA synthetase -1.442192501 0.011245842 
NWMN_1601 metallo-beta-lactamase superfamily protein -1.443632497 0.004708024 
qoxB quinol oxidase polypeptide I QoxB -1.460081127 0.003422458 
NWMN_0285 conserved hypothetical protein -1.463969938 0.001120834 
NWMN_0293 conserved hypothetical protein -1.468065948 0.000569633 
NWMN_0050 67 kDa Myosin-crossreactive streptococcal antigen homolog -1.485128575 0.016695602 
ribA riboflavin biosynthesis protein -1.485881222 0.043039003 
NWMN_0173 ABC transporter, substrate-binding protein -1.488557371 0.011771823 
crtN squalene synthase -1.51362285 0.000383827 
NWMN_2229 oxidoreductase, short chain dehydrogenase/reductase family protein -1.51451763 3.36E-05 
NWMN_2356 conserved hypothetical protein -1.515861208 0.000359118 
hutG formiminoglutamase -1.516716748 0.000120711 
ilvD dihydroxy-acid dehydratase -1.525215538 0.018670554 
NWMN_2487 fructosamine kinase family protein -1.52580299 0.010255107 
gntK gluconate kinase -1.526785948 0.002309274 
NWMN_2369 short chain dehydrogenase -1.535682979 8.55E-05 
pyrE orotate phosphoribosyltransferase -1.540463885 7.64E-05 
NWMN_0602 conserved hypothetical protein -1.541760999 0.016559644 
sdhA succinate dehydrogenase flavoprotein subunit -1.551299422 8.20E-05 
mtlA mannitol-specific IIA component -1.562402284 0.000154633 
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sucA 2-oxoglutarate dehydrogenase E1 component -1.568777644 0.001136177 
NWMN_2209 conserved hypothetical protein -1.568980601 3.35E-05 
pryF orotidine 5'-phosphate decarboxylase -1.57492933 0.000335064 
NWMN_1989 conserved hypothetical protein -1.579031698 1.64E-05 
mtlF PTS system, mannitol-specific IIBC component -1.581150174 2.69E-05 
qoxC quinol oxidase polypeptide III -1.588247449 0.000198597 
NWMN_0767 conserved hypothetical protein -1.593792357 0.000120711 
NWMN_0300 conserved hypothetical protein -1.595966377 0.000184327 
NWMN_1730 conserved hypothetical protein -1.619833188 1.46E-05 
NWMN_2419 acetyltransferase, GNAT family protein -1.619928643 0.016559644 
nrdD anaerobic ribonucleoside-triphosphate reductase -1.621304953 0.041237103 
NWMN_1600 universal stress protein family protein -1.643233388 0.006864013 
NWMN_2210 formate dehydrogenase homolog -1.645647927 1.69E-05 
NWMN_0306 conserved hypothetical protein -1.651356271 2.18E-05 
NWMN_2275 conserved hypothetical protein -1.654057221 0.001342878 
NWMN_0303 conserved hypothetical protein -1.6555396 0.000109974 
NWMN_1298 phosphate ABC transporter, permease protein -1.662822391 0.048561295 
NWMN_0137 RpiR family transcriptional regulator -1.663047395 0.003540924 
NWMN_1124 conserved hypothetical protein -1.663917268 0.002515842 
NWMN_0896 conserved hypothetical protein -1.674011077 0.01672517 
NWMN_0302 phage tape measure protein -1.67992967 0.000410558 
NWMN_0297 conserved hypothetical protein -1.680750913 0.00051392 
NWMN_0366 conserved hypothetical protein -1.692731099 0.000999683 
NWMN_0667 fructose operon transcriptional regulator -1.695870549 0.006809057 
NWMN_0695 conserved hypothetical protein -1.706147889 3.30E-06 
spoVG stage V sporulation protein G homolog -1.710639782 3.07E-06 
NWMN_1750 extracellular glutamine-binding protein -1.711584118 0.003546585 
NWMN_0294 phage major head protein -1.712126103 9.13E-05 
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pnp purine nucleoside phosphorylase -1.71302074 0.007386273 
NWMN_0304 phage minor structural protein -1.716879516 0.000109311 
NWMN_2058 transcriptional antiterminator BglG family protein -1.717837161 2.13E-06 
ribH riboflavin synthase, beta subunit -1.718287414 0.015068407 
NWMN_0295 conserved hypothetical protein -1.729203283 1.28E-05 
treP PTS system, trehalose-specific IIBC component -1.730083571 0.002152744 
NWMN_0136 sucrose-specific PTS transporter IIBC component protein -1.745995645 0.005218439 
NWMN_0948 conserved hypothetical protein -1.747510801 0.00892652 
NWMN_0305 conserved hypothetical protein -1.757961623 5.17E-05 
NWMN_0364 conserved hypothetical protein -1.758794739 6.70E-06 
NWMN_2591 conserved hypothetical protein -1.779955967 3.73E-05 
NWMN_0585 conserved hypothetical protein -1.787301175 0.003335764 
NWMN_rRNA12 23S ribosomal RNA -1.796735315 0.014748844 
NWMN_1299 phosphate ABC transporter, permease protein -1.815399927 0.030903811 
crtI phytoene dehydrogenase -1.81784514 3.25E-07 
NWMN_0771 OsmC-like protein -1.823846103 2.44E-06 
NWMN_0377 conserved hypothetical protein -1.829245782 1.28E-06 
gpmA 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase -1.829624939 6.73E-05 
NWMN_2463 crtQ glycosyl transferase, group 2 family protein -1.836278635 1.29E-05 
NWMN_rRNA15 23S ribosomal RNA -1.85179186 0.005052173 
NWMN_0296 conserved hypothetical protein -1.852887404 2.87E-05 
bsaF lantibiotic immunity protein F -1.856893678 1.54E-05 
pyrAB carbamoyl-phosphate synthase, pyrimidine-specific, large chain -1.864114305 2.24E-06 
NWMN_0298 conserved hypothetical protein -1.877776557 1.23E-05 
lacA galactose-6-phosphate isomerase LacA subunit -1.888521425 0.026915502 
NWMN_1749 glutamine transport ATP-binding protein -1.888790695 8.20E-05 
NWMN_0301 conserved hypothetical protein -1.899831791 1.42E-05 
NWMN_0125 conserved hypothetical protein -1.932851738 0.006229133 
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lrgB antiholin-like protein LrgB -1.955615897 0.00843734 
NWMN_2368 conserved hypothetical protein -1.967329979 2.76E-06 
NWMN_1527 conserved hypothetical protein -1.969317656 4.52E-05 
NWMN_1604 universal stress protein family protein -1.987339779 0.000663965 
NWMN_2282 conserved hypothetical protein -1.991792992 8.65E-06 
NWMN_2352 conserved hypothetical protein -1.992833412 2.45E-06 
crtM squalene desaturase -2.014282558 0.000329079 
scdA cell wall metabolism protein -2.020168979 0.001092088 
lacD tagatose 1,6-diphosphate aldolase -2.021269167 0.030982684 
NWMN_2087 conserved hypothetical protein -2.025111086 9.30E-07 
NWMN_2371 alkylhydroperoxidase AhpD family protein -2.025417197 7.31E-06 
NWMN_2502 conserved hypothetical protein -2.029333151 0.001524848 
sdhB succinate dehydrogenase iron-sulfur protein -2.039064459 2.23E-08 
NWMN_2442 conserved hypothetical protein -2.064592907 0.000228957 
NWMN_2557 conserved hypothetical protein -2.066296651 3.14E-06 
thiM hydroxyethylthiazole kinase -2.072183059 0.002742565 
NWMN_2086 alkaline shock protein 23 -2.073915939 3.78E-06 
nrdG anaerobic ribonucleotide reductase, small subunit -2.091118199 0.018737372 
NWMN_0041 conserved hypothetical protein -2.09789887 0.010024104 
NWMN_2088 conserved hypothetical protein -2.099267381 7.21E-07 
cidA holin-like protein CidA -2.105353836 0.004185379 
NWMN_1998 transcriptional regulator TenA family protein -2.105904124 0.012331396 
pstS phosphate ABC transporter, phosphate-binding protein PstS -2.115650483 0.008522657 
qoxD quinol oxidase polypeptide IV -2.122198187 3.30E-06 
alsD alpha-acetolactate decarboxylase -2.133285669 0.000684584 
argH argininosuccinate lyase -2.139712868 0.000449823 
NWMN_0651 conserved hypothetical protein -2.186101106 9.05E-06 
fruB fructose 1-phosphate kinase -2.189272564 0.000341088 
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NWMN_2048 conserved hypothetical protein -2.195718847 4.90E-07 
lip lipase precursor -2.209128171 0.003787795 
NWMN_0247 formate/nitrite transporter family protein -2.210263199 0.031170158 
narI respiratory nitrate reductase, gamma subunit -2.265144815 0.010134274 
NWMN_1526 hypothetical protein -2.304341594 2.23E-08 
NWMN_2507 conserved hypothetical protein -2.306586164 1.84E-10 
NWMN_0135 conserved hypothetical protein -2.313626238 0.012993982 
thiD1 phosphomethylpyrimidine kinase -2.319759035 0.000410259 
NWMN_0944 conserved hypothetical protein -2.376941967 0.000308804 
gntR gluconate operon transcriptional repressor -2.383994781 0.000718315 
thiE thiamine-phosphate pyrophosphorylase -2.385986995 0.001542734 
NWMN_0945 conserved hypothetical protein -2.38610841 0.000260283 
NWMN_rRNA02 23S ribosomal RNA -2.445567144 0.031238834 
pyrAA carbamoyl-phosphate synthase, pyrimidine-specific, small chain -2.465465401 3.68E-06 
NWMN_2597 conserved hypothetical protein -2.472911779 0.000490694 
pyrP uracil permease -2.48357913 8.65E-06 
pyrC dihydroorotase multifunctional complex type -2.487631207 6.13E-07 
argG argininosuccinate synthase -2.516203038 0.00032862 
pyrB aspartate carbamoyltransferase catalytic subunit -2.536274264 7.80E-06 
alsS alpha-acetolactate synthase -2.53830195 0.0004116 
NWMN_0943 conserved hypothetical protein -2.577047175 3.76E-05 
NWMN_0783 CsbD-like superfamily protein -2.598835133 1.33E-07 
NWMN_0078 conserved hypothetical protein -2.6379771 2.63E-09 
fruA fructose specific permease -2.642488034 6.26E-05 
NWMN_2074 conserved hypothetical protein -2.734211938 8.55E-05 
NWMN_0175 flavohemoprotein -2.815939113 0.001157292 
putA proline dehydrogenase -2.818989005 0.000334049 
NWMN_0134 conserved hypothetical protein -2.974493212 0.000373326 
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NWMN_2377 conserved hypothetical protein -3.089043829 0.003230466 
ald alanine dehydrogenase 2 -3.164464926 0.008561475 
NWMN_0721 sigma 54 modulation protein -3.178060333 0.000191978 
agrA staphylococcal accessory gene regulator A -3.17967839 1.35E-05 
NWMN_1346 conserved hypothetical protein -3.191143403 0.000442002 
NWMN_rRNA01 16S ribosomal RNA -3.257403918 0.007881096 
adhE iron-containing alcohol dehydrogenase -3.30235649 0.001311868 
NWMN_2268 L-lactate permease 2 -3.487800488 0.000216958 
agrB staphylococcal accessory gene regulator protein B -3.509905208 8.17E-05 
agrC staphylococcal accessory gene regulator protein C -3.602753557 1.15E-05 
NWMN_1347 amino acid permease -3.666890342 0.000373984 
ilvA threonine dehydratase II -3.99231362 0.000294381 
agrD staphylococcal accessory gene regulator protein D -4.017818192 7.83E-08 
NWMN_2620 phenol-soluble modulin beta 2 -4.133611445 0.000629443 
narJ respiratory nitrate reductase, delta subunit -4.326965147 0.000284867 
ldh1 L-lactate dehydrogenase -4.471711918 0.000452466 
adh1 alcohol dehydrogenase -4.60720312 0.000896027 
cysG uroporphyrin-III C-methyl transferase -4.667737692 4.78E-05 
narH nitrate reductase beta chain -4.675899151 5.34E-05 
nirD assimilatory nitrite reductase [NAD(P)H], small subunit -4.833992474 0.000115345 
nirR nitrite reductase transcriptional regulator NirR -5.308002638 6.26E-05 
narG nitrate reductase, alpha subunit -5.446085452 8.96E-06 
nirB assimilatory nitrite reductase [NAD(P)H], large subunit -5.487423945 1.20E-05 
NWMN_1084 phenol-soluble modulin beta 1 -5.505010759 4.12E-05 
hld delta-hemolysin -5.538554629 1.66E-05 
NWMN_2288 nitrite transport protein -6.279226177 3.50E-05 
NWMN_2616 phenol-soluble modulin alpha 4 -6.29011892 3.67E-06 
NWMN_0163 conserved hypothetical protein -6.568192269 3.67E-06 
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Appendix Table 2 DE genes of S. epidermidis in response to 1 % (v/v) squalene challenge. Only the DE genes with log2 fold change (logFC)  -0.5 or 0.5 
were listed. All DE genes have FDR (false discovery rate)  0.05. DE genes that discussed in this thesis were highlighted. 
Gene Gene_description logFC FDR 
SETU_00201 hypothetical protein 4.040921308 0 
SETU_02044 dihydrolipoamide dehydrogenase 2.721163543 0 
SETU_02043 glutathione peroxidase 2.567467246 7.30E-195 
SETU_01290 heat-shock protein htrA 2.423217529 2.57E-257 
SETU_02045 transcriptional regulator 2.405674936 5.98E-197 
clpC endopeptidase Clp ATP-binding subunit C 2.236031485 8.06E-137 
SETU_00142 ATP:guanido phosphotransferase 2.170979854 1.81E-174 
SETU_01841 NAD(P)H-flavin oxidoreductase 2.080468467 1.97E-291 
SETU_00141 UvrB/UvrC domain-containing protein 2.002942597 6.95E-230 
SETU_01367 protein export protein PrsA 1.972651498 7.39E-198 
SETU_00140 CtsR family transcriptional regulator 1.932741558 3.20E-137 
SETU_02098 general stress protein 170 1.898207562 3.45E-184 
SETU_01218 hypothetical protein 1.838953214 7.29E-29 
SETU_00681 cytochrome d ubiquinol oxidase subunit 1-like protein 1.805068513 1.63E-184 
SETU_00230 hypothetical protein 1.777323412 1.06E-32 
SETU_02169 phosphotransferase mannnose-specific family component IIA 1.742524783 4.95E-173 
SETU_00784 TM2 domain-containing protein 1.728625634 2.76E-67 
SETU_02170 DAK2 domain-containing protein 1.715626669 1.15E-173 
SETU_01442 two-component sensor histidine kinase 1.714237858 2.23E-165 
SETU_00375 ribosomal subunit interface protein 1.682303961 1.33E-55 
SETU_00906 threonine synthase 1.661843548 5.62E-161 
clpP ATP-dependent Clp protease proteolytic subunit 1.658846365 4.16E-119 
SETU_00057 putative transmembrane protein coupled to NADH-ubiquinone 1.633548824 2.39E-159 
SETU_00682 cytochrome d ubiquinol oxidase subunit II-like protein 1.556526974 1.98E-100 
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SETU_00905 homoserine dehydrogenase 1.54127263 3.41E-99 
SETU_02143 hypothetical protein 1.517790053 1.23E-128 
SETU_01654 alanine racemase domain-containing protein 1.509827127 3.00E-124 
SETU_01655 aerobactin biosynthesis protein 1.491591345 8.02E-128 
vraR DNA-binding response regulator VraR 1.474196973 3.63E-129 
SETU_01444 hypothetical protein 1.442875887 8.84E-66 
SETU_01080 alpha-D-1,4-glucosidase 1.434391933 1.40E-138 
SETU_00056 NADH dehydrogenase subunit 5 1.4277874 2.79E-122 
SETU_01443 transporter associated with VraSR 1.417004893 5.56E-83 
SETU_01657 aerobactin biosynthesis protein 1.397732117 1.84E-131 
SETU_00894 aromatic amino acid beta-eliminating lyase 1.352898899 1.22E-113 
SETU_00522 clpB protein 1.322233312 4.91E-54 
SETU_01513 molecular chaperone GroEL 1.300893128 4.35E-68 
cysK cysteine synthase 1.281190216 1.09E-79 
SETU_01656 transporter 1.279534214 1.19E-79 
dapA dihydrodipicolinate synthase 1.268940433 1.58E-80 
SETU_00970 dihydrodipicolinate reductase 1.24698507 1.35E-69 
SETU_01943 aldehyde dehydrogenase 1.235923495 3.13E-118 
SETU_00953 transferrin receptor 1.234674364 4.25E-87 
SETU_02128 triacylglycerol lipase 1.228833569 2.92E-80 
groES co-chaperonin GroES 1.216317159 3.69E-80 
SETU_01840 hypothetical protein 1.214288817 3.19E-38 
SETU_02171 dihydroxyacetone kinase subunit DhaK 1.201430012 8.83E-67 
gldA glycerol dehydrogenase 1.194185225 8.49E-91 
SETU_00903 hypothetical protein 1.187950347 2.40E-26 
SETU_02278 putative membrane protein 1.171470768 4.58E-14 
SETU_01956 D-ribose pyranase 1.15824172 6.89E-18 
tpx thiol peroxidase 1.152045726 1.18E-59 
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SETU_00034 alkyl hydroperoxide reductase 1.132882131 4.22E-47 
SETU_00971 tetrahydrodipicolinate acetyltransferase 1.132166552 3.65E-29 
SETU_02009 L-lactate dehydrogenase 1.131093596 1.07E-63 
SETU_00035 alkyl hydroperoxide reductase 1.1207805 2.40E-67 
sucC succinyl-CoA synthetase subunit beta 1.119982779 2.79E-51 
SETU_00357 ferrichrome ABC transporter permease 1.105569447 1.02E-57 
SETU_00919 hypothetical protein 1.102207259 1.09E-46 
SETU_00989 dihydrolipoamide succinyltransferase 1.09849226 5.82E-75 
SETU_00358 ferrichrome ABC transporter ATP-binding protein 1.097962476 6.31E-54 
SETU_00359 ferrichrome ABC transporter 1.090693493 7.84E-62 
SETU_02042 phosphoadenosine phosphosulfate reductase 1.088473959 3.69E-80 
SETU_01155 heat-inducible transcriptional repressor 1.086743493 5.33E-75 
SETU_01154 heat shock protein GrpE 1.076019674 2.25E-87 
SETU_00250 monovalent cation/H antiporter subunit C 1.064323167 5.78E-17 
SETU_00320 PTS system fructose-specific transporter subunit IIABC 1.054425284 3.29E-52 
SETU_01944 NAD(P)H-flavin oxidoreductase 1.053425765 4.73E-74 
SETU_00981 5-bromo-4-chloroindolyl phosphate hydrolysis protein XpaC 1.052444876 6.22E-75 
SETU_02038 precorrin-2 dehydrogenase 1.045234243 5.43E-38 
hisB imidazoleglycerol-phosphate dehydratase 1.044287588 7.57E-36 
dnaK molecular chaperone DnaK 1.03328307 5.83E-32 
SETU_00536 thimet oligopeptidase-like protein 1.032013674 8.23E-65 
SETU_00221 oxidoreductase ion channel 1.030984189 5.80E-78 
SETU_01653 ferrichrome ABC transporter 1.02591654 1.63E-75 
SETU_02008 acetolactate synthase 1.025456779 1.57E-52 
SETU_00584 lipoate-protein ligase-like protein 1.021998992 4.80E-47 
SETU_01283 glycerophosphoryl diester phosphodiesterase 1.018162096 1.77E-48 
SETU_00516 5-oxo-1,2,5-tricarboxylic-3-penten acid decarboxylase 1.013832867 2.35E-79 
sucD succinyl-CoA synthetase subunit alpha 1.011343537 7.62E-59 
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SETU_01539 ketol-acid reductoisomerase 1.011340142 3.84E-22 
SETU_00356 ferrichrome ABC transporter permease 1.008352901 1.47E-59 
SETU_01538 acetolactate synthase 1 regulatory subunit 1.006974036 0.02902264 
SETU_00798 fatty acid biosynthesis transcriptional regulator 0.997654837 1.69E-59 
SETU_00980 acylphosphatase 0.997492855 3.25E-32 
SETU_00058 hypothetical protein 0.994751891 9.87E-62 
sucA 2-oxoglutarate dehydrogenase E1 0.990918678 5.91E-48 
SETU_00907 homoserine kinase 0.98046572 5.30E-48 
SETU_01986 copper-transporting ATPase copA 0.969115038 2.57E-36 
SETU_00314 putative membrane protein 0.961070895 1.72E-18 
ycnE Putative monooxygenase ycnE 0.946049469 3.33E-48 
SETU_00968 aspartate semialdehyde dehydrogenase 0.942844664 2.22E-54 
SETU_00446 OsmC/Ohr family protein 0.933656827 1.28E-43 
SETU_01959 hypothetical protein 0.93215584 6.46E-05 
SETU_00982 tellurite resistance protein 0.926966474 1.04E-69 
SETU_00538 globin family protein 0.926151725 5.35E-19 
leuD isopropylmalate isomerase small subunit 0.924890728 2.17E-07 
SETU_01874 amino acid ABC transporter-like protein 0.912232238 6.81E-52 
SETU_00302 hypothetical protein 0.909922808 2.09E-62 
SETU_00283 putative integral membrane protein that interacts with FtsH 0.907588572 2.80E-46 
SETU_00537 YjbH-like, GTP pyrophosphokinase domain-containing protein 0.906621869 2.20E-63 
mraZ cell division protein MraZ 0.90625367 6.72E-27 
SETU_00172 branched-chain amino acid aminotransferase 0.905347627 1.45E-49 
SETU_00370 lipophilic protein 0.897761054 2.56E-42 
SETU_00503 NADH-dependent flavin oxidoreductase 0.89107274 2.82E-61 
SETU_00254 monovalent cation/H antiporter subunit G 0.883775374 7.52E-46 
SETU_02039 uroporphyrin-III C-methyltransferase 0.879247542 6.11E-46 
SETU_01061 hypothetical protein 0.875640451 1.90E-29 
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SETU_01191 luciferase 0.875534817 1.02E-47 
trap signal transduction protein 0.871292104 1.62E-29 
hisG ATP phosphoribosyltransferase 0.867197041 2.34E-07 
SETU_01285 aminotransferase class V 0.865164313 4.29E-28 
SETU_00531 peptide binding protein OppA 0.863201412 3.80E-34 
SETU_00449 thioredoxin 0.861580004 6.80E-34 
SETU_01779 hypothetical protein 0.859129752 8.21E-35 
SETU_01259 citrate synthase 0.848388482 1.43E-25 
isaB immunodominant antigen B 0.846529111 2.53E-25 
SETU_01870 hypothetical protein 0.843278051 8.71E-42 
SETU_00458 CsbD family protein 0.841165827 8.23E-40 
SETU_01078 glucose-6-phosphate 1-dehydrogenase 0.832778697 1.03E-23 
SETU_01934 fructose-bisphosphatase 0.826132807 9.54E-49 
SETU_00319 fructose 1-phosphate kinase 0.824234119 4.48E-21 
SETU_01059 elastin binding protein 0.820951899 1.86E-32 
mraW S-adenosyl-methyltransferase MraW 0.820283432 2.48E-41 
SETU_01334 hypothetical protein 0.820032454 7.17E-25 
SETU_01193 Rrf2 family protein 0.81627686 1.05E-42 
pgi glucose-6-phosphate isomerase 0.814435355 3.69E-32 
SETU_01540 2-isopropylmalate synthase 0.809866546 1.15E-25 
SETU_01984 dehydrogenase 0.808824848 3.34E-32 
SETU_01272 alanine dehydrogenase 0.808060864 3.64E-26 
SETU_00252 monovalent cation/H antiporter subunit E 0.806817867 2.19E-15 
SETU_00255 Na?? antiporter 0.802126496 2.76E-52 
SETU_01983 1-pyrroline-5-carboxylate dehydrogenase 0.801409164 3.97E-16 
SETU_01287 HAD superfamily hydrolase 0.799766459 2.20E-33 
gltD glutamate synthase subunit beta 0.798549267 3.24E-24 
sodA2 superoxide dismutase 0.798275727 7.23E-28 
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SETU_01995 regulatory protein 0.797281189 2.72E-33 
SETU_01646 hypothetical protein 0.79581828 5.09E-17 
sarX accessory regulator A-like protein 0.792634637 6.09E-20 
SETU_00871 aerobic glycerol-3-phosphate dehydrogenase 0.792377892 1.98E-40 
SETU_01281 GAF domain-containing protein 0.789743519 4.35E-30 
SETU_00490 Na?? antiporter family protein 0.783296645 1.00E-29 
SETU_01275 Adenine-specific methyltransferase 0.781272021 3.48E-40 
SETU_01613 putative membrane protein 0.779164278 4.46E-12 
SETU_00908 HAD superfamily hydrolase 0.778845049 1.45E-27 
SETU_00318 transcription repressor of fructose operon 0.769429163 1.11E-08 
SETU_00249 monovalent cation/H antiporter subunit B 0.766601872 1.56E-18 
SETU_01333 translaldolase 0.761972507 1.60E-41 
SETU_00448 nitroreductase 0.75782644 6.83E-39 
SETU_00037 nitro/flavin reductase 0.753896623 8.50E-29 
SETU_01900 endo-1,4-beta-glucanase 0.749964968 1.38E-27 
SETU_00751 cell division protein 0.748069702 1.67E-35 
lacG 6-phospho-beta-galactosidase 0.744578134 4.09E-35 
SETU_01868 hypothetical protein 0.744018112 6.02E-22 
SETU_00301 hypothetical protein 0.743462939 7.35E-26 
SETU_01977 3-hydroxy-3-methylglutaryl-CoA synthase 0.740572559 6.83E-39 
SETU_01610 hypothetical protein 0.740493197 1.46E-39 
SETU_01837 general stress protein 26 0.739164104 5.60E-25 
SETU_02007 alpha-acetolactate decarboxylase 0.737199684 7.63E-33 
SETU_02041 sulfite reductase (NADPH) flavoprotein 0.733993583 5.36E-38 
SETU_01041 putative metal-dependent peptidase 0.726492315 9.85E-24 
SETU_00251 monovalent cation/H antiporter subunit D 0.725387735 6.00E-36 
SETU_00212 heme peroxidase 0.720023973 2.11E-37 
SETU_00393 hypothetical protein 0.718700584 4.39E-06 
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SETU_01152 molecular chaperone DnaJ 0.717455787 1.20E-27 
SETU_01658 alkaline shock protein 23 0.715917916 5.52E-23 
SETU_01627 lytic regulatory protein 0.708744447 4.48E-29 
sat sulfate adenylyltransferase 0.708092216 6.15E-34 
SETU_00243 accessory regulator A 0.699393595 4.08E-24 
SETU_00520 PaaD-like protein 0.69618227 2.01E-17 
SETU_00647 acetyltransferase 0.695319554 2.23E-11 
SETU_00875 glutathione peroxidase 0.694108272 4.40E-21 
SETU_01668 tagatose 1,6-diphosphate aldolase 0.688416356 8.52E-19 
SETU_00229 alcohol dehydrogenase 0.686576851 3.72E-30 
hisH imidazole glycerol phosphate synthase subunit HisH 0.682764027 8.33E-06 
SETU_00248 monovalent cation/H antiporter subunit A 0.682146932 7.62E-38 
SETU_01619 hypothetical protein 0.681963558 5.11E-17 
SETU_01940 acetyltransferase 0.680810506 3.01E-20 
SETU_02229 malate:quinone oxidoreductase 0.677241977 2.11E-21 
SETU_02035 adenylylsulfate kinase 0.676454733 1.18E-26 
SETU_01786 dehydrogenase 0.669627768 5.70E-15 
SETU_01760 glycerate dehydrogenase 0.66649 8.99E-34 
SETU_00972 hippurate hydrolase 0.659500524 2.23E-10 
SETU_01941 glyoxalase 0.658294631 2.45E-19 
SETU_00323 plant-metabolite dehydrogenase 0.657466532 5.68E-30 
SETU_02135 histidinol dehydrogenase 0.656248152 3.26E-10 
SETU_02103 hypothetical protein 0.65543462 1.71E-20 
SETU_01015 virulence factor C 0.653699247 1.07E-21 
trxA thioredoxin 0.652036569 5.21E-29 
SETU_00763 cell-divisio initiation protein 0.651840795 1.31E-30 
SETU_01217 hypothetical protein 0.646903298 3.10E-14 
SETU_02150 branched-chain alpha-keto acid dehydrogenase subunit E2 0.639273942 2.09E-15 
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SETU_01102 Xaa-Pro dipeptidase 0.637846656 5.19E-29 
SETU_01271 Xaa-Pro dipeptidase 0.633462924 2.89E-24 
SETU_01955 ribokinase 0.633087254 5.17E-20 
prmA ribosomal protein L11 methyltransferase 0.629085338 6.00E-29 
SETU_01536 dihydroxy-acid dehydratase 0.625772157 2.62E-06 
SETU_00394 cell-division inhibitor 0.623961476 1.47E-26 
pflA pyruvate formate-lyase-activating enzyme 0.623245998 1.40E-19 
SETU_01933 alkaline phosphatase 0.61792155 1.64E-18 
SETU_00519 HAD superfamily hydrolase 0.617907782 1.25E-23 
SETU_02037 putative permease 0.617450092 3.39E-24 
SETU_01216 hypothetical protein 0.615491644 5.99E-11 
SETU_01537 acetolactate synthase large subunit 0.613367948 1.11E-12 
thiE thiamine-phosphate pyrophosphorylase 0.60658784 1.05E-08 
SETU_00701 hypothetical protein 0.606168487 1.17E-27 
SETU_00053 regulatory protein PfoR 0.605572458 2.07E-09 
SETU_01611 amidase 0.605524529 9.64E-25 
SETU_01541 3-isopropylmalate dehydrogenase 0.602158696 2.40E-13 
SETU_01960 poly-gamma-glutamate synthesis protein PgsA 0.60112602 2.15E-12 
SETU_01988 D-lactate dehydrogenase 0.60081181 1.11E-09 
SETU_01337 2,5-didehydrogluconate reductase 0.598545416 7.65E-23 
SETU_01306 D-alanine aminotransferase 0.598233217 1.83E-28 
SETU_01286 D-3-phosphoglycerate dehydrogenase 0.596613134 1.04E-19 
SETU_01667 PTS system lactose-specific transporter subunit IIA 0.59643822 0.000182405 
SETU_01308 hypothetical protein 0.594839672 3.65E-28 
SETU_00102 translation initiation inhibitor-like protein 0.594435778 1.97E-17 
SETU_01064 riboflavin ECF transporter substrate-specific protein RibU 0.592766744 2.65E-18 
SETU_00585 IDEAL domain protein 0.590575715 2.67E-09 
SETU_02151 branched-chain alpha-keto acid dehydrogenase E1 0.590211726 5.40E-05 
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SETU_00345 histidinol-phosphate aminotransferase 0.585594314 4.96E-17 
SETU_00311 anion transporter family protein 0.582892563 1.45E-18 
SETU_02011 amino acid transporter 0.582727165 2.64E-08 
SETU_01432 ThiJ/PfpI family protein 0.581016827 1.76E-16 
fdaB fructose-1,6-bisphosphate aldolase 0.57584036 8.94E-15 
SETU_01307 dipeptidase PepV 0.575112475 6.35E-19 
SETU_01641 SmrB 0.573332571 3.09E-08 
SETU_01614 phosphopentomutase 0.571955174 4.89E-21 
SETU_01602 aldehyde dehydrogenase 0.569858005 4.59E-21 
SETU_01362 ABC transporter ecsB 0.567118504 2.31E-17 
SETU_01709 hypothetical protein 0.565205535 1.66E-13 
SETU_00242 esterase/lipase 0.564462185 4.52E-25 
SETU_01477 6-phosphogluconolactonase 0.563459502 1.82E-23 
SETU_01640 multidrug resistance protein 0.561126338 9.37E-26 
SETU_00315 quinolone resistance protein 0.560810631 4.84E-10 
SETU_00253 monovalent cation/H antiporter subunit F 0.560150799 4.05E-11 
secA preprotein translocase subunit SecA 0.560005953 1.58E-20 
SETU_00071 poly (glycerol-phosphate) alpha-glucosyltransferase 0.556229812 1.01E-22 
SETU_01544 threonine dehydratase 0.552611552 3.49E-08 
SETU_01003 acetyltransferase 0.550891067 2.65E-17 
SETU_00973 alanine racemase 0.549972411 1.60E-13 
SETU_01669 tagatose-6-phosphate kinase 0.549949832 4.88E-12 
SETU_00498 monovalent cation/H antiporter subunit B 0.549739733 2.40E-16 
SETU_01005 hypothetical protein 0.549697886 6.76E-11 
SETU_01007 methionine sulfoxide reductase B 0.548254316 5.12E-12 
SETU_01659 hypothetical protein 0.54783104 0.001896192 
SETU_01901 hypothetical protein 0.546518836 1.42E-09 
SETU_01957 ribose transporter RbsU 0.545952061 3.70E-16 
228 
 
SETU_00525 3-oxoacyl-ACP synthase 0.545831897 1.32E-18 
SETU_00245 Integral membrane protein 0.543303609 5.64E-12 
SETU_00959 oligoendopeptidase 0.542243713 3.35E-23 
SETU_01089 DNA repair protein 0.542165217 1.76E-18 
SETU_00872 lysophospholipase 0.540063139 2.19E-22 
SETU_01966 thioredoxin 0.539858098 1.99E-12 
mnhC putative monovalent cation/H antiporter subunit C 0.538124088 6.12E-16 
SETU_01014 hypothetical protein 0.536688848 2.02E-14 
SETU_02040 sulfite reductase subunit beta 0.53616828 1.27E-23 
SETU_00324 CsbB stress response protein 0.53565646 5.11E-20 
SETU_01615 pyrimidine-nucleoside phosphorylase 0.534380737 9.64E-22 
SETU_01660 hypothetical protein 0.531633883 2.60E-14 
SETU_00539 adenylate cyclase family protein 0.52555577 3.95E-08 
SETU_00033 putative lipoprotein 0.524041487 3.29E-18 
lacE PTS system lactose-specific transporter subunit IIBC 0.523878666 4.36E-14 
SETU_01996 D-serine/D-alanine/glycine transporter 0.522432536 2.73E-17 
SETU_01172 Mn2?? transporter NRAMP family protein 0.521516153 5.55E-15 
SETU_00312 deoxyribodipyrimidine photolyase 0.521350942 3.20E-10 
SETU_01559 membrane-flanked domain-containing protein 0.520522315 5.81E-06 
SETU_00074 YibE/F-like protein 0.520503718 1.34E-16 
SETU_01038 tRNA CCA-pyrophosphorylase 0.520299576 4.28E-19 
SETU_01360 signal transduction protein TRAP 0.517706358 2.13E-16 
SETU_02017 coenzyme A disulfide reductase 0.517579519 7.01E-19 
SETU_01785 putative flavoprotein oxygenase, DIM6/NTAB family protein 0.516817559 9.82E-14 
SETU_00911 catalase 0.514291766 9.59E-18 
SETU_00297 lipoprotein 0.512470159 2.46E-14 
SETU_02096 N-acetylmuramoyl-L-alanine amidase 0.509005538 2.57E-15 
SETU_01424 cysteinyl-tRNA synthetase-like protein -0.514550027 3.80E-16 
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SETU_01105 lipoate-protein ligase A -0.5166228 9.97E-16 
rnpA ribonuclease P -0.517431888 5.08E-13 
SETU_01371 transcriptional regulator -0.518188971 6.53E-08 
SETU_00795 alkaline shock protein -0.518450631 1.74E-13 
SETU_00042 xanthine phosphoribosyltransferase -0.519723937 1.16E-12 
SETU_00709 hypothetical protein -0.520720623 2.02E-14 
SETU_01156 coproporphyrinogen III oxidase -0.521212819 7.45E-14 
hisS histidyl-tRNA synthetase -0.52338417 1.03E-21 
alaS alanyl-tRNA synthetase -0.52717917 3.65E-20 
cbiO_1 cobalt transporter ATP-binding subunit -0.527831237 2.58E-08 
SETU_02030 choline transporter -0.53084102 4.21E-22 
SETU_01759 SMR-type multidrug efflux transporter -0.533065873 0.035219196 
tufA elongation factor Tu -0.533899143 2.80E-09 
SETU_01482 putative membrane protein -0.535677821 3.61E-08 
SETU_01677 cobalt transport family protein -0.535828027 1.32E-14 
truA tRNA pseudouridine synthase A -0.536134677 8.41E-18 
SETU_01490 hypothetical protein -0.536990921 9.37E-11 
SETU_01278 thiamine biosynthesis protein ThiI -0.540690362 1.41E-18 
pheS phenylalanyl-tRNA synthetase subunit alpha -0.547225649 1.03E-20 
SETU_00281 low-affinity inorganic phosphate transporter -0.548086662 3.99E-19 
SETU_01209 ACT domain-containing protein -0.548249644 9.09E-07 
SETU_01806 hypothetical protein -0.548415322 1.99E-12 
SETU_00523 hypothetical protein -0.555930259 8.82E-09 
SETU_00805 signal recognition particle -0.556334267 1.13E-18 
SETU_01672 lactose phosphotransferase system repressor -0.556949991 3.96E-14 
SETU_00664 phosphoribosylformylglycinamidine synthase II -0.561565183 2.41E-24 
SETU_01566 hypothetical protein -0.561800352 0.000496582 
SETU_01715 hypothetical protein -0.56288892 2.81E-05 
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SETU_01381 rRNA methylase -0.566731038 7.04E-13 
SETU_01185 hypothetical protein -0.57065721 6.26E-06 
pheT phenylalanyl-tRNA synthetase subunit beta -0.572335128 1.11E-19 
SETU_01129 ABC transporter ATP-binding protein -0.572648848 2.13E-20 
obgE GTPase ObgE -0.573176135 8.50E-25 
gmk guanylate kinase -0.575483078 2.11E-19 
SETU_01339 S-adenosylmethionine synthetase -0.576431237 2.34E-24 
SETU_01862 ABC transporter ATP binding subunit -0.576539891 4.26E-19 
SETU_01279 iron-sulfur cofactor synthesis protein nifZ -0.583958498 1.68E-17 
pyrH uridylate kinase -0.591081252 6.12E-24 
SETU_00434 CSD family cold shock protein -0.593005127 1.11E-16 
SETU_01474 pyrazinamidase/nicotinamidase-like protein -0.595772709 1.03E-20 
SETU_01974 hypothetical protein -0.599671347 5.30E-09 
SETU_01783 Na?? antiporter -0.603895688 5.68E-25 
rimM 16S rRNA-processing protein RimM -0.613020228 1.84E-11 
ureG urease accessory protein UreG -0.614876321 5.72E-16 
SETU_01277 putative membrane protein YfcA -0.615007532 1.58E-18 
SETU_01456 lipid kinase -0.616091219 1.74E-27 
SETU_02099 hypothetical protein -0.61682017 0.000232286 
SETU_01743 urease subunit gamma -0.619279045 1.12E-07 
SETU_01836 transcription regulatory protein -0.619285525 3.17E-26 
SETU_01596 Sua5/YciO/YrdC/YwlC family protein -0.620678102 2.50E-26 
pyrB aspartate carbamoyltransferase -0.620993502 4.29E-13 
SETU_00931 DNA topoisomerase IV subunit B -0.621565864 8.57E-33 
SETU_00455 ABC transporter permease -0.621648572 2.40E-20 
SETU_01622 mannnose-6 phospate isomelase pmi -0.622299622 4.66E-24 
SETU_00043 xanthine permease -0.628350888 7.43E-28 
SETU_00914 guanosine 5-monophosphate oxidoreductase -0.629075956 1.74E-25 
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SETU_00843 polynucleotide phosphorylase -0.632320782 1.08E-23 
SETU_02363 hypothetical protein -0.634467235 4.81E-06 
SETU_02202 phage protein -0.635565419 8.48E-14 
SETU_01184 Holliday junction resolvase-like protein -0.637796967 2.68E-20 
SETU_02297 hypothetical protein -0.639358074 1.65E-07 
infB translation initiation factor IF-2 -0.639452139 4.17E-26 
aspS aspartyl-tRNA synthetase -0.639884213 1.10E-29 
glyS glycyl-tRNA synthetase -0.640972704 1.15E-19 
SETU_02264 rRNA large subunit methyltransferase -0.646747185 1.53E-26 
SETU_00113 RNA binding protein , contains ribosomal protein S1 domain -0.647586069 1.29E-19 
SETU_00380 hypothetical protein -0.65070153 8.20E-07 
SETU_01528 hypothetical protein -0.655002607 9.98E-06 
SETU_00369 GGDEF domain-containing protein -0.656010389 1.45E-20 
prfA peptide chain release factor 1 -0.65742219 3.23E-31 
SETU_00123 5S ribosomal RNA -0.660938407 0.037666297 
SETU_00932 DNA topoisomerase IV subunit A -0.664285552 3.74E-26 
SETU_01621 hypothetical protein -0.666220076 6.73E-11 
SETU_01757 secretory antigen SsaA -0.666455399 1.17E-27 
SETU_01465 His repressor -0.668229923 5.72E-16 
nusA transcription elongation factor NusA -0.669015151 6.50E-33 
SETU_01597 protoporphyrinogen oxidase -0.669211138 1.86E-27 
frr ribosome recycling factor -0.671247714 8.85E-29 
SETU_00269 membrane protein -0.673414036 6.71E-25 
epiB epidermin biosynthesis protein EpiB -0.674664631 1.15E-20 
SETU_01545 hypothetical protein -0.675450808 1.97E-06 
SETU_00667 phosphoribosylglycinamide formyltransferase -0.67708521 3.38E-23 
SETU_01626 phosphodiesterase -0.677351336 1.93E-22 
guaB inositol-monophosphate dehydrogenase -0.678573591 1.22E-30 
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SETU_00834 clustered with transcriptiontermination protein NusA -0.678822927 1.69E-30 
SETU_00856 phosphodiesterase -0.679046183 1.06E-18 
SETU_01016 preQ0 transporter -0.679676743 2.57E-23 
SETU_02189 branched-chain amino acid transport system carrier protein -0.680346243 3.61E-36 
SETU_01879 integral membrane efflux protein -0.681163688 2.66E-27 
SETU_02282 seryl-tRNA synthetase -0.683349883 4.27E-32 
sdhA succinate dehydrogenase flavoprotein subunit -0.685039685 5.54E-34 
qoxC quinol oxidase subunit III -0.68593681 2.08E-28 
SETU_01790 hypothetical protein -0.688741955 1.24E-05 
SETU_01164 iojap-related protein -0.694892884 1.60E-26 
thrS threonyl-tRNA synthetase -0.699410569 3.04E-30 
SETU_00372 DegV family protein -0.70589375 2.39E-40 
SETU_01789 abortive infection family protein -0.709458389 5.36E-36 
SETU_01555 PemK family protein -0.713293259 3.04E-20 
SETU_01221 folylpolyglutamate synthase -0.714300235 8.29E-29 
SETU_00200 major facilitator family transporter -0.715383148 4.14E-21 
SETU_02358 lantibiotic biosynthesis protein -0.715434201 3.20E-27 
SETU_00836 hypothetical protein -0.718366412 7.98E-14 
sdhB_1 succinate dehydrogenase iron-sulfur subunit -0.7195976 2.09E-31 
SETU_00930 acyl-phosphate:glycerol-3-phosphateO- acyltransferase PlsY -0.71986152 3.75E-24 
SETU_01183 hypothetical protein -0.722014632 1.19E-26 
SETU_01525 probabale ammonium transporter -0.725654403 9.00E-31 
SETU_01433 hypothetical protein -0.734246636 6.54E-25 
qoxA quinol oxidase subunit I -0.736156111 9.08E-25 
purS phosphoribosylformylglycinamidine synthase, PurS protein -0.737061777 1.98E-06 
SETU_00570 permease -0.746397996 1.88E-39 
SETU_00236 iron-binding protein -0.747478648 8.77E-33 
SETU_00484 YuzD-like protein -0.748247621 3.48E-13 
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SETU_01251 Phage-related replication protein -0.754468678 2.36E-36 
SETU_00966 ABC transporter ATP-binding protein -0.755195008 2.22E-40 
SETU_01417 tRNA-Ala -0.762027011 3.17E-08 
SETU_00179 deoxypurine kinase -0.763855806 7.40E-29 
SETU_01556 programmed cell death antitoxin YdcD -0.765042054 2.43E-05 
SETU_00139 pyrimidine nucleoside transport protein -0.771593103 1.49E-37 
ureE urease accessory protein UreE -0.778270159 3.72E-09 
SETU_01606 DNA-directed RNA polymerase subunit delta -0.77836141 6.11E-42 
SETU_01595 phosphatase -0.78084587 3.19E-26 
SETU_00488 NADH dehydrogenase -0.781089506 2.48E-33 
SETU_00837 ribosomal protein L7AE family protein -0.781677493 3.48E-17 
SETU_00656 quinol oxidase polypeptide II QoxA -0.781858439 2.17E-23 
purF amidophosphoribosyltransferase -0.791569113 6.81E-27 
rpsT 30S ribosomal protein S20 -0.792784782 4.94E-30 
SETU_00280 phosphate transport regulator -0.794149597 1.15E-35 
SETU_01633 tRNA-Lys -0.79742966 0.000119561 
SETU_02228 Putative protein-S-isoprenylcysteine methyltransferase -0.805458505 7.60E-33 
SETU_01171 5-methylthioadenosine nucleosidase -0.806612071 1.38E-24 
SETU_00278 ABC transporter ATP-binding protein vraF -0.816247281 3.38E-26 
SETU_00279 ABC transporter permease vraG -0.818748439 2.33E-54 
SETU_00099 Veg protein -0.821970926 7.05E-45 
SETU_02176 hypothetical protein -0.828877258 1.58E-25 
guaA GMP synthase -0.829209175 9.24E-46 
tsf elongation factor Ts -0.83091321 3.31E-31 
SETU_02298 AcrR family transcriptional regulator -0.834260799 6.59E-13 
SETU_01756 hypothetical protein -0.837420573 3.53E-38 
SETU_00736 succinate dehydrogenase cytochrome b-558 -0.838890664 2.52E-28 
SETU_00929 HesB/YadR/YfhF-family protein -0.84177354 5.44E-20 
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SETU_00180 deoxypurine kinase -0.850035111 2.76E-34 
trmD tRNA (guanine-N(1)-)-methyltransferase -0.851946942 3.82E-36 
SETU_02000 hypothetical protein -0.85471345 2.20E-31 
rpsU 30S ribosomal protein S21 -0.856874963 1.15E-12 
rplQ 50S ribosomal protein L17 -0.858653952 3.48E-33 
galU UTP-glucose-1-phosphate uridylyltransferase -0.861463244 6.92E-44 
SETU_00819 DNA topoisomerase I -0.862553837 1.00E-49 
SETU_01182 caffeoyl-CoA O-methyltransferase -0.869499836 7.33E-37 
SETU_01181 protease -0.873719664 2.79E-50 
SETU_00915 SCP family extracellular protein -0.878906178 2.15E-35 
SETU_00137 pyridoxal biosynthesis lyase PdxS -0.883381055 2.80E-42 
ureB urease subunit beta -0.886761301 1.07E-12 
SETU_01106 rhodanese-like domain-containing protein -0.896751003 1.18E-31 
SETU_01601 hypothetical protein -0.897449328 1.24E-59 
purH 
bifunctional phosphoribosylaminoimidazolecarboxamide formyltransferase/IMP 
cyclohydrolase 
-0.904476987 6.00E-56 
SETU_01165 HAD family hydrolase, YqeK -0.914189113 8.33E-34 
SETU_01338 hypothetical protein -0.922299812 6.84E-42 
SETU_01168 shikimate dehydrogenease -0.924387073 3.46E-47 
SETU_01170 HAD superfamily hydrolase -0.92547821 1.75E-40 
SETU_00138 glutamine amidotransferase subunit PdxT -0.927824033 2.03E-57 
SETU_00316 hypothetical protein -0.937066922 1.23E-33 
SETU_00454 ABC transporter ATP-binding protein -0.939129022 3.90E-55 
purD phosphoribosylamine--glycine ligase -0.941505315 5.46E-47 
SETU_00666 phosphoribosylaminoimidazole synthetase -0.944349891 8.62E-42 
SETU_00983 branched-chain amino acid carrier protein -0.947849621 5.00E-66 
SETU_01466 adenylosuccinate lyase -0.948379148 4.50E-62 
SETU_01166 nicotinate-nucleotide adenylyltransferase -0.953387661 8.32E-50 
SETU_01180 protease -0.95715389 2.05E-60 
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SETU_00921 hypothetical protein -0.965846943 6.00E-36 
SETU_00939 4-oxalocrotonate tautomerase -0.967778854 3.01E-37 
SETU_02019 lipoprotein -0.97338347 4.79E-58 
gid tRNA (uracil-5-)-methyltransferase Gid -0.982925844 8.42E-60 
rpmB 50S ribosomal protein L28 -1.009156272 3.48E-65 
SETU_00445 lactococcal prophage ps3 protein 05 -1.013144135 1.28E-29 
rpmF 50S ribosomal protein L32 -1.014087308 4.80E-23 
rpsM 30S ribosomal protein S13 -1.024108891 1.79E-66 
greA transcription elongation factor GreA -1.026302115 1.11E-70 
SETU_01179 uridine kinase -1.028771982 1.66E-57 
SETU_01169 GTP-binding protein YqeH -1.036223367 8.18E-63 
SETU_00770 uracil permease -1.037670701 2.93E-15 
SETU_01167 RNA binding protein -1.04897284 4.61E-24 
rpsK 30S ribosomal protein S11 -1.049739197 2.45E-75 
rpoA DNA-directed RNA polymerase subunit alpha -1.050945161 2.78E-53 
SETU_01372 hypothetical protein -1.056774561 6.51E-48 
typA GTP-binding protein TypA -1.078046208 2.19E-71 
SETU_02085 zinc metalloproteinase aureolysin aur -1.081674979 1.80E-76 
SETU_00106 50S ribosomal protein L25 -1.108007403 1.39E-49 
SETU_00723 protein in cluster with ribosomal protein L32p -1.111548966 5.76E-67 
SETU_00646 N-acetylmuramoyl-L-alanine amidase -1.119232183 1.90E-55 
SETU_00978 CSD family cold shock protein -1.121440263 1.51E-24 
fbaA fructose-bisphosphate aldolase -1.127575751 9.56E-49 
rpsO 30S ribosomal protein S15 -1.132719191 1.75E-71 
SETU_00268 pyrimidine nucleoside transporter -1.135263092 7.26E-78 
SETU_00159 16S rRNA methyltransferase -1.136911455 3.08E-43 
SETU_00936 oxacillin resistance-related FmtC protein -1.13851983 1.36E-102 
rpmA 50S ribosomal protein L27 -1.148391044 1.21E-58 
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SETU_00282 secretory antigen SsaA-like protein -1.150110165 3.29E-87 
rpmJ 50S ribosomal protein L36 -1.152235579 1.53E-97 
secY_1 preprotein translocase subunit SecY -1.171212012 7.58E-77 
rplO 50S ribosomal protein L15 -1.182629757 9.67E-80 
infA translation initiation factor IF-1 -1.185412293 2.79E-95 
rplS 50S ribosomal protein L19 -1.191798868 2.81E-75 
SETU_00165 elongation factor G -1.199376539 2.07E-46 
SETU_01913 poly (glycerol-phosphate) alpha-glucosyltransferase -1.218612547 1.55E-83 
SETU_00925 Large-conductance mechanosensitive channel -1.220080985 2.83E-87 
rpsR 30S ribosomal protein S18 -1.230189513 7.81E-68 
rpsG 30S ribosomal protein S7 -1.230592007 4.64E-66 
SETU_01710 xanthine/uracil permease -1.245378533 3.72E-96 
SETU_00825 30S ribosomal protein S2p (SAe) -1.248416367 4.36E-73 
SETU_00456 ABC transporter substrate-binding protein -1.249640562 5.47E-64 
rpmE2 50S ribosomal protein L31 type B -1.25006402 4.97E-63 
SETU_01839 proton/sodium-glutamate symport protein -1.254363825 2.96E-98 
SETU_00926 glycine betaine transporter -1.272930431 1.57E-90 
rpsP 30S ribosomal protein S16 -1.27401071 6.57E-78 
SETU_01990 ssaA protein -1.2780742 1.92E-79 
sarV accessory regulator V -1.284266738 8.28E-60 
rplW 50S ribosomal protein L23 -1.285448254 3.17E-76 
SETU_01110 shikimate kinase -1.291826327 1.72E-64 
SETU_00769 bifunctional pyrimidine regulatory protein PyrR uracil phosphoribosyltransferase -1.301610095 8.26E-57 
SETU_01823 L-lactate permease lctP-like protein -1.306427861 1.67E-95 
adk adenylate kinase -1.314787809 8.55E-103 
SETU_00272 membrane protein , putative -1.318968897 8.86E-97 
rplB 50S ribosomal protein L2 -1.327105527 3.55E-91 
pyrG CTP synthetase -1.335917099 7.81E-110 
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rplK 50S ribosomal protein L11 -1.336927071 3.26E-76 
SETU_00878 glutamine synthetase repressor -1.339549049 6.04E-95 
rpsF 30S ribosomal protein S6 -1.346515968 2.79E-116 
glnA glutamine synthetase -1.35134612 2.48E-96 
rplR 50S ribosomal protein L18 -1.359034025 4.89E-68 
rpsS 30S ribosomal protein S19 -1.360018668 1.57E-93 
SETU_01373 transcriptional regulator -1.379432916 7.26E-69 
rplX 50S ribosomal protein L24 -1.381652747 7.77E-79 
rplF 50S ribosomal protein L6 -1.381671892 2.50E-73 
rpmD 50S ribosomal protein L30 -1.394733487 3.29E-87 
rplD 50S ribosomal protein L4 -1.400120595 1.89E-116 
rplJ 50S ribosomal protein L10 -1.401783334 3.82E-82 
rplC 50S ribosomal protein L3 -1.403908913 1.67E-100 
rplE 50S ribosomal protein L5 -1.423938929 4.14E-97 
rplP 50S ribosomal protein L16 -1.424834088 3.42E-148 
rpsJ 30S ribosomal protein S10 -1.424869722 1.42E-104 
rpsC 30S ribosomal protein S3 -1.434180747 1.97E-127 
rplM 50S ribosomal protein L13 -1.437060793 1.50E-111 
SETU_01212 ribosomal protein YsxB -1.43812083 3.32E-113 
SETU_00026 ssDNA-binding protein -1.439275766 1.27E-122 
rplN 50S ribosomal protein L14 -1.44118898 7.58E-95 
rplL 50S ribosomal protein L7/L12 -1.444099511 2.52E-61 
rpsL 30S ribosomal protein S12 -1.447102556 4.72E-84 
rpsQ 30S ribosomal protein S17 -1.450602922 3.25E-109 
rplV 50S ribosomal protein L22 -1.455435903 1.23E-140 
rpsN_2 30S ribosomal protein S14 -1.459568288 2.29E-107 
SETU_01891 amino acid transporter -1.459941042 1.45E-129 
rpsI 30S ribosomal protein S9 -1.461785575 1.07E-80 
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SETU_00162 ribosomal protein L7Ae-like protein -1.465839273 1.55E-118 
rpmC 50S ribosomal protein L29 -1.472600002 7.70E-82 
rpsH 30S ribosomal protein S8 -1.478120566 4.09E-108 
rpsE 30S ribosomal protein S5 -1.507386964 4.83E-91 
rplA 50S ribosomal protein L1 -1.508668203 3.39E-82 
isaA immunodominant antigen A -1.516821658 1.92E-107 
rpmH 50S ribosomal protein L34 -1.530874318 3.87E-108 
SETU_01562 ATP-dependent RNA helicase -1.532086472 1.11E-130 
rpsD 30S ribosomal protein S4 -1.580314316 1.70E-101 
SETU_01842 transcriptional regulator -1.619006092 1.06E-160 
rplU 50S ribosomal protein L21 -1.653364113 6.12E-102 
rpmI 50S ribosomal protein L35 -1.702738163 3.19E-139 
rplT 50S ribosomal protein L20 -1.717312369 1.12E-93 
SETU_01975 secretory antigen SsaA -1.730221491 1.25E-113 
infC translation initiation factor IF-3 -1.784440433 1.84E-174 
SETU_00466 hypothetical protein -1.834984719 1.89E-154 
SETU_00070 autolysin (N-acetylmuramoyl-L-alanine amidase -2.027264232 9.36E-208 
SETU_00325 histidine protein kinase saeS -2.094124501 6.70E-152 
SETU_00326 response regulator saeR -2.099735516 1.86E-185 
SETU_00327 DoxX family protein -2.15956713 1.25E-203 
SETU_00328 lipoprotein -2.23398693 1.34E-235 
SETU_00482 poly(glycerophosphate chain) D-alanine transfer protein -2.394369248 2.12E-254 
SETU_00480 DltB membrane protein -2.43795197 0 
dltC D-alanine--poly(phosphoribitol) ligase subunit 2 -2.717241101 1.35E-151 
SETU_00479 D-alanine--poly(phosphoribitol) ligase subunit 1 -2.751652683 0 
dltX D-Ala-teichoic acid biosynthesis protein -2.7954962 3.97E-253 
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Appendix Table 3 DE genes of S. aureus in response to 1 % (v/v) ethanol challenge. The level of fold change (logFC) is based on log2. All DE genes have 
FDR (false discovery rate)  0.05. DE genes that discussed in this thesis were highlighted. 
Gene Gene_description logFC FDR 
NWMN_2304 conserved hypothetical protein 3.102706418 6.28E-08 
NWMN_1224 conserved hypothetical protein 2.72192875 1.49E-05 
NWMN_1077 conserved hypothetical protein 2.397187795 4.14E-15 
NWMN_0265 conserved hypothetical protein 2.11429059 8.03E-06 
ssl3nm staphylococcal enterotoxin-like toxin 2.113070988 1.13E-11 
ssl2nm staphylococcal enterotoxin-like toxin 2.08567587 9.72E-13 
NWMN_1075 conserved hypothetical protein 2.068180248 9.15E-11 
NWMN_1076 conserved hypothetical protein 2.018335972 4.41E-11 
lytR autolysin two-component response regulator 2.003392836 1.44E-07 
ssl4nm staphylococcal enterotoxin-like toxin 1.878247595 9.18E-11 
gatC glutamyl-tRNA amidotransferase subunit C 1.868116982 0.000586103 
NWMN_0116 conserved hypothetical protein 1.866612313 1.13E-06 
NWMN_0356 conserved hypothetical protein 1.838976847 1.34E-06 
NWMN_1083 DNA-binding protein 1.838384405 0.004204336 
NWMN_2000 hypothetical protein 1.825173505 0.00442656 
ssl10 staphylococcal enterotoxin-like toxin 1.787660796 9.68E-09 
ssp extracellular matrix and plasma binding protein 1.778664304 7.62E-07 
NWMN_2396 C-terminal part of fibronectin binding protein B 1.742822997 0.000484395 
NWMN_2160 conserved hypothetical protein 1.714378261 0.00327232 
NWMN_1312 conserved hypothetical protein 1.692622602 0.000298143 
NWMN_2215 conserved hypothetical protein 1.609619668 0.000135876 
ssl5nm staphylococcal enterotoxin-like toxin 1.597223738 5.86E-07 
NWMN_1225 conserved hypothetical protein 1.564449484 8.52E-06 
NWMN_2259 conserved hypothetical protein 1.56313504 1.17E-05 
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NWMN_0907 conserved hypothetical protein 1.561996406 5.15E-06 
NWMN_1811 phage anti-repressor 1.535402157 6.24E-05 
NWMN_1828 conserved hypothetical protein 1.534412103 0.000365805 
NWMN_2203 secretory antigen precursor SsaA 1.5318344 0.000307249 
NWMN_0115 conserved hypothetical protein 1.524989066 5.28E-06 
NWMN_2316 cation efflux family protein 1.492572421 1.52E-05 
NWMN_1012 conserved hypothetical protein 1.479444094 0.000177515 
nupC pyrimidine nucleoside transport protein 1.47833266 6.61E-06 
ssl11nm staphylococcal enterotoxin-like toxin 1.466827226 0.001433362 
NWMN_2260 truncated transposase for IS1272 1.457704875 0.004375022 
NWMN_0118 conserved hypothetical protein 1.455084948 3.48E-05 
NWMN_0374 sodium:dicarboxylate symporter family protein 1.451430983 1.30E-06 
NWMN_0834 conserved hypothetical protein 1.439721481 5.45E-05 
NWMN_tRNA23 tRNA-Met 1.434063591 0.001155099 
fnbB fibronectin binding protein B precursor 1.419969753 0.001693579 
NWMN_0401 conserved hypothetical protein 1.407089774 0.004109273 
NWMN_0429 N-acetylmuramoyl-L-alanine amidase aaa precursor 1.407001024 7.57E-06 
pryR pyrimidine operon regulatory protein 1.388373415 2.59E-06 
NWMN_1276 ImpB/MucB/SamB family DNA-damage repair protein 1.387940284 0.001758848 
NWMN_0766 conserved hypothetical protein 1.373271561 6.52E-05 
NWMN_1673 conserved hypothetical protein 1.368009423 0.002109237 
NWMN_0964 conserved hypothetical protein 1.367439413 0.000151945 
NWMN_2467 O-acetyltransferase OatA 1.365337409 3.63E-05 
NWMN_0022 conserved hypothetical protein 1.36424801 2.82E-05 
isdG cytoplasmic heme-iron binding protein 1.362954079 0.000582833 
NWMN_1860 conserved hypothetical protein 1.360473226 0.000628632 
tcaA teicoplanin resistance associated protein A 1.354751897 0.004585478 
NWMN_2469 immunodominant antigen A 1.340665366 0.000395471 
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NWMN_0117 conserved hypothetical protein 1.338499752 0.000852524 
NWMN_0995 phage anti-repressor protein 1.335421637 0.000411344 
ssl6nm staphylococcal enterotoxin-like toxin 1.329708966 0.000155455 
NWMN_0157 conserved hypothetical protein 1.324644414 0.000345662 
NWMN_0266 conserved hypothetical protein 1.322521692 4.18E-06 
pabA para-aminobenzoate synthase component II 1.314217304 8.42E-05 
ssl9nm staphylococcal enterotoxin-like toxin 1.310127102 3.42E-05 
ssl8nm staphylococcal enterotoxin-like toxin 1.299124086 1.88E-05 
NWMN_0416 conserved hypothetical protein 1.297430405 0.000929049 
NWMN_0006 conserved hypothetical protein 1.287630095 1.03E-05 
NWMN_1921 phage cI-like repressor 1.282134748 0.000280098 
NWMN_1343 conserved hypothetical protein 1.273239086 0.005795289 
spsA type-I signal peptidase A component 1.267138777 0.000362864 
NWMN_1739 conserved hypothetical protein 1.263576562 0.001101372 
NWMN_0997 conserved hypothetical protein 1.254707613 0.001500101 
cysM cysteine synthase 1.232199417 7.77E-05 
NWMN_0165 conserved hypothetical protein 1.22548222 0.001597512 
sbi immunoglobulin G-binding protein Sbi 1.19333474 0.004308893 
NWMN_0725 conserved hypothetical protein 1.190183736 2.10E-05 
NWMN_2246 sodium/glutamate symporter 1.083278296 0.004184942 
NWMN_0849 conserved hypothetical protein 1.079620391 0.00393837 
potA spermidine/putrescine ABC transporter, ATP-binding protein 1.074653717 0.001001675 
oatA secretory antigen precursor SsaA homolog 1.072450253 0.00464117 
lukS leukocidin/hemolysin toxin family S subunit 1.070578307 0.012185339 
NWMN_1636 conserved hypothetical protein 1.044190404 0.003694685 
NWMN_0249 5'-nucleotidase, lipoprotein e(P4) family protein 1.033365308 0.003066422 
NWMN_0714 conserved hypothetical protein 1.03325113 0.003891235 
NWMN_1865 conserved hypothetical protein 1.026372137 0.00031247 
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hlgB gamma hemolysin, component B 1.02242267 0.001648931 
NWMN_1674 CrcB-like protein 1.013997822 0.04457468 
NWMN_2273 acetyltransferase, GNAT family protein 1.010213753 0.003451285 
NWMN_1342 conserved hypothetical protein 1.009893304 0.003108872 
hlgC gamma-hemolysin component C 1.001448617 0.001452626 
rimJ ribosomal-protein-alanine N-acetyltransferase 0.992959102 0.004149538 
arsC arsenate reductase 0.980464334 0.004891006 
NWMN_2587 conserved hypothetical protein 0.973126021 0.00536495 
NWMN_1812 phage repressor 0.961478682 0.002230475 
lytS autolysin sensor histidine kinase protein 0.944435185 0.000914738 
hsdS type I restriction modification system, site specificity determination subunit 0.942518043 0.002970029 
NWMN_1623 glycosyl transferase, family 51 0.931621407 0.003347848 
NWMN_0622 conserved hypothetical protein 0.909737422 0.002363459 
NWMN_2236 abortive infection protein family protein 0.86088258 0.005537797 
NWMN_0143 oligopeptide ABC transporter, ATP-binding protein 0.848250028 0.002286138 
NWMN_0434 conserved hypothetical protein 0.608112411 0.045856979 
tagG teichoic acid ABC transporter permease protein 0.601208325 0.029164456 
NWMN_1689 conserved hypothetical protein -0.57745596 0.048268046 
NWMN_0635 conserved hypothetical protein -0.592618958 0.037297398 
NWMN_0587 conserved hypothetical protein -0.617819476 0.041847509 
sdhB succinate dehydrogenase iron-sulfur protein -0.64720583 0.028337905 
katA catalase -0.65420436 0.037565297 
NWMN_2545 conserved hypothetical protein -0.655471877 0.046588838 
atpG ATP synthase, gamma subunit -0.670675857 0.043840467 
NWMN_0467 conserved hypothetical protein -0.675625023 0.011776538 
NWMN_1471 cytidine deaminase, homotetrameric -0.690307966 0.017757981 
NWMN_0296 conserved hypothetical protein -0.701259166 0.047891918 
msrB methionine sulfoxide reductase B -0.719918253 0.035690871 
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glcA glucose-specific PTS transporter protein IIABC component -0.72470482 0.036742215 
NWMN_0251 ABC transporter ATP-binding protein -0.7364494 0.011319894 
NWMN_0295 conserved hypothetical protein -0.74726141 0.019566202 
spoVG stage V sporulation protein G homolog -0.751325061 0.011394321 
fumC fumarate hydratase, class II -0.752621331 0.02626678 
NWMN_1767 ThiJ/PfpI family protein -0.760251484 0.01241162 
NWMN_2253 drug resistance transporter EmrB/QacA subfamily protein -0.818734402 0.049010633 
NWMN_2548 conserved hypothetical protein -0.824482574 0.004025891 
atpB ATP synthase subunit a -0.837716945 0.004961709 
NWMN_1477 conserved hypothetical protein -0.838927434 0.005166506 
NWMN_2480 hydrolase -0.84063864 0.009813954 
tpi triosephosphate isomerase -0.845680465 0.028324519 
NWMN_1038 phage holin -0.860172168 0.041163732 
NWMN_0250 ABC transporter, permease protein -0.869523911 0.002716795 
NWMN_2417 conserved hypothetical protein -0.871633722 0.040182749 
mnhC1 Na?? antiporter subunit -0.872137334 0.003710961 
NWMN_0029 conserved hypothetical protein -0.875910669 0.001104369 
srrA DNA-binding response regulator SrrA -0.878310954 0.019324862 
NWMN_0285 conserved hypothetical protein -0.898226994 0.011401438 
NWMN_2202 conserved hypothetical protein -0.902796079 0.005652482 
NWMN_2314 drug resistance transporter EmrB/QacA subfamily protein -0.903411394 0.002806745 
hutG formiminoglutamase -0.921748775 0.003753688 
qoxC quinol oxidase polypeptide III -0.924600728 0.006924014 
NWMN_1688 conserved hypothetical protein -0.929659924 0.000955664 
treR trehalose operon repressor -0.93427235 0.002109621 
NWMN_2460 aminotransferase, class I -0.93564036 0.005154791 
NWMN_2026 aldehyde dehydrogenase family protein -0.936571171 0.00115695 
NWMN_1730 conserved hypothetical protein -0.937602855 0.002048212 
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serS seryl-tRNA synthetase -0.959803877 0.024457678 
NWMN_1472 diacylglycerol kinase -0.959947833 0.002974531 
gltB glutamate synthase, large subunit -0.979423904 0.005165572 
ilvA1 threonine dehydratase -0.979993692 0.020593868 
NWMN_0705 ferrichrome ABC transporter lipoprotein -0.980831919 0.004134269 
modB molybdenum ABC transporter, permease protein -0.985214531 0.000730577 
rplP 50S ribosomal protein L16 -0.98572401 0.001764223 
hslU ATP-dependent protease ATP-binding subunit -0.987356118 0.00167422 
NWMN_2459 D-isomer specific 2-hydroxyacid dehydrogenase family protein -0.99182 0.001805982 
ipdC indole-3-pyruvate decarboxylase -0.992912713 0.000514872 
NWMN_2275 conserved hypothetical protein -1.01461124 0.012374602 
qoxB quinol oxidase polypeptide I QoxB -1.019872126 0.008357485 
NWMN_0737 conserved hypothetical protein -1.025165696 0.000743823 
NWMN_1124 conserved hypothetical protein -1.025664055 0.016474718 
NWMN_2557 conserved hypothetical protein -1.032367809 0.003665352 
entB isochorismatase -1.035069188 0.000974365 
NWMN_0673 conserved hypothetical protein -1.035375558 0.000922122 
NWMN_1989 conserved hypothetical protein -1.03810591 0.000518303 
mnaA UDP-GlcNAc 2-epimerase -1.0456847 0.001047525 
NWMN_2018 conserved hypothetical protein -1.052747471 0.003116038 
NWMN_1746 conserved hypothetical protein -1.06113212 0.000307703 
NWMN_1631 conserved hypothetical protein -1.061265209 0.00031225 
sucB 
dihydrolipoamide succinyltransferase E2 component of 2-oxoglutarate dehydrogenase 
complex 
-1.068025172 0.000531332 
NWMN_0973 inositol-1-monophosphatase family protein -1.070368793 0.001428956 
NWMN_2254 conserved hypothetical protein -1.072324339 0.006406326 
NWMN_2444 conserved hypothetical protein -1.075253838 0.035154096 
thrC threonine synthase -1.08005808 0.00100889 
NWMN_0779 conserved hypothetical protein -1.082104718 0.003554141 
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NWMN_1645 conserved hypothetical protein -1.082275751 0.00014753 
atpE ATP synthase subunit c -1.087383969 0.001890503 
NWMN_0083 phosphopentomutase -1.08801947 0.001000076 
NWMN_0482 conserved hypothetical protein -1.094986252 0.000101295 
hisD histidinol dehydrogenase HisD -1.102620822 0.001778838 
pckA phosphoenolpyruvate carboxykinase -1.107701136 0.003067709 
leuC 3-isopropylmalate dehydratase, large subunit -1.11674044 0.006590703 
NWMN_1819 low molecular weight phosphotyrosine protein phosphatase -1.117213085 0.000412484 
NWMN_0650 conserved hypothetical protein -1.118994698 0.000576157 
NWMN_1230 phospholipase -1.128006525 0.002369866 
sdhA succinate dehydrogenase flavoprotein subunit -1.137450824 0.000366372 
NWMN_0048 conserved hypothetical protein -1.140349572 0.00035003 
NWMN_2350 para-nitrobenzyl esterase chain A -1.140644156 0.000780289 
clfA clumping factor A -1.141023788 0.000303571 
NWMN_2353 ABC transporter, ATP-binding protein -1.141925515 0.00092749 
NWMN_0321 oxidoreductase family protein -1.154014987 0.000196959 
malA alpha-D-1,4-glucosidase -1.156373076 0.0032609 
ald1 alanine dehydrogenase 1 -1.164439652 0.000190445 
hisIE histidine biosynthesis bifunctional protein HisIE -1.164581208 0.002062534 
NWMN_2205 D-isomer specific 2-hydroxyacid dehydrogenase family protein -1.182765093 0.003858385 
NWMN_0621 conserved hypothetical protein -1.183974756 0.004668218 
bsaP lantibiotic leader peptide processing serine protease -1.18811376 9.17E-05 
NWMN_2465 crtO conserved hypothetical protein -1.189217454 0.003992611 
NWMN_1820 conserved hypothetical protein -1.19368005 9.36E-05 
NWMN_2210 formate dehydrogenase homolog -1.195796764 0.000132344 
NWMN_1505 conserved hypothetical protein -1.198232846 0.001037402 
NWMN_2330 conserved hypothetical protein -1.207805793 0.002269296 
gapA glyceraldehyde 3-phosphate dehydrogenase 1 -1.209669534 0.003738249 
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cidB holin-like protein CidB -1.212821277 8.94E-05 
gntK gluconate kinase -1.212909656 0.002037738 
NWMN_0377 conserved hypothetical protein -1.233785918 5.97E-05 
mnhB1 Na?? antiporter subunit -1.240201861 0.000427257 
NWMN_1601 metallo-beta-lactamase superfamily protein -1.245273976 0.001619485 
NWMN_2369 short chain dehydrogenase -1.2557302 7.75E-05 
crtN squalene synthase -1.257872443 0.000255219 
NWMN_1259 conserved hypothetical protein -1.261278999 0.030177572 
NWMN_2456 conserved hypothetical protein -1.270347624 6.65E-05 
NWMN_1298 phosphate ABC transporter, permease protein -1.27228017 0.032234776 
NWMN_1527 conserved hypothetical protein -1.277419148 0.0010079 
NWMN_1749 glutamine transport ATP-binding protein -1.278024362 0.000913657 
NWMN_1821 ribonuclease BN -1.283567944 6.05E-05 
nrdD anaerobic ribonucleoside-triphosphate reductase -1.283991983 0.023202247 
NWMN_0771 OsmC-like protein -1.286430611 4.45E-05 
NWMN_2212 inositol monophosphatase family protein -1.295997042 0.000214195 
NWMN_0136 sucrose-specific PTS transporter IIBC component protein -1.304918224 0.00638549 
NWMN_1059 hypothetical protein -1.305761555 0.00087228 
NWMN_2039 conserved hypothetical protein -1.318856876 0.000756058 
NWMN_0780 ABC transporter ATP-binding protein -1.322806852 6.25E-05 
NWMN_0695 conserved hypothetical protein -1.323900495 1.08E-05 
lacA galactose-6-phosphate isomerase LacA subunit -1.328836905 0.030267144 
NWMN_0053 conserved hypothetical protein -1.331279159 4.72E-06 
NWMN_2591 conserved hypothetical protein -1.331787407 0.000142746 
leuD 3-isopropylmalate dehydratase, small subunit -1.335660064 0.008522584 
NWMN_0173 ABC transporter, substrate-binding protein -1.340926046 0.002621312 
treP PTS system, trehalose-specific IIBC component -1.34368647 0.002372615 
hisB imidazole glycerol phosphate dehydratase HisB -1.345719029 0.004992592 
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bsaG lantibiotic ABC transporter protein -1.347080567 0.000884716 
leuB 3-isopropylmalate dehydrogenase -1.347403201 0.00164158 
NWMN_2487 fructosamine kinase family protein -1.349279692 0.002719852 
metL homoserine dehydrogenase -1.355495573 0.000161797 
NWMN_2454 delta-1-pyrroline-5-carboxylate dehydrogenase -1.35601388 0.002850203 
pgm 2,3-bisphosphoglycerate-independent phosphoglycerate mutase -1.357800016 0.00060372 
NWMN_0137 RpiR family transcriptional regulator -1.358107329 0.002146592 
hisC1 histidinol-phosphate aminotransferase -1.358949999 0.000272713 
scdA cell wall metabolism protein -1.362866778 0.005014654 
treC alpha,alpha-phosphotrehalase -1.364375754 0.000154062 
NWMN_0860 conserved hypothetical protein -1.370215153 3.20E-06 
purH bifunctional purine biosynthesis protein -1.376584649 4.03E-05 
mtlF PTS system, mannitol-specific IIBC component -1.383084281 7.31E-06 
purD phosphoribosylamine-glycine ligase -1.385076686 3.70E-06 
thrB homoserine kinase -1.391985703 2.61E-05 
NWMN_2229 oxidoreductase, short chain dehydrogenase/reductase family protein -1.412587892 2.46E-06 
NWMN_2463 crtQ glycosyl transferase, group 2 family protein -1.415975286 3.79E-05 
NWMN_1750 extracellular glutamine-binding protein -1.418390791 0.00185543 
NWMN_2422 D-isomer specific 2-hydroxyacid dehydrogenase family protein -1.423130619 0.003760843 
NWMN_2270 conserved hypothetical protein -1.432197257 6.15E-06 
accC1 acetyl-CoA biotin carboxylase -1.439034457 0.000617644 
mtlD mannitol-1-phosphate 5-dehydrogenase -1.453235571 4.34E-06 
purQ phosphoribosylformylglycinamidine synthase I -1.45378777 2.45E-05 
NWMN_1632 general stress protein-like protein -1.457220268 6.37E-06 
NWMN_1509 urea amidolyase-related protein -1.462439191 0.001149505 
trpD anthranilate phosphoribosyltransferase -1.482148431 0.000842975 
NWMN_2089 osmoprotectant transporter -1.503868473 2.73E-07 
purN phosphoribosylglycinamide formyltransferase -1.507840627 1.03E-05 
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NWMN_2479 amidohydrolase family protein -1.51631052 1.41E-07 
aldA aldehyde dehydrogenase homolog -1.517124896 0.00015831 
gpmA 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase -1.518788379 4.57E-05 
NWMN_0078 conserved hypothetical protein -1.545932647 1.70E-05 
pgk phosphoglycerate kinase -1.548511472 0.000168984 
leuA 2-isopropylmalate synthase -1.549427815 5.84E-05 
hisH imidazole glycerol phosphate synthase, subunit H -1.573793282 0.000947982 
ldh L-lactate dehydrogenase 2 -1.585869463 0.004231775 
sucA 2-oxoglutarate dehydrogenase E1 component -1.587979277 3.92E-05 
NWMN_0364 conserved hypothetical protein -1.588920647 7.74E-07 
ilvC ketol-acid reductoisomerase -1.592944513 0.000758414 
NWMN_2086 alkaline shock protein 23 -1.608807862 1.19E-05 
NWMN_2368 conserved hypothetical protein -1.623128063 2.32E-06 
poxB pyruvate oxidase -1.628207649 9.75E-08 
crtI phytoene dehydrogenase -1.63436426 2.40E-08 
NWMN_0125 conserved hypothetical protein -1.635125372 0.00245518 
NWMN_1600 universal stress protein family protein -1.64120673 0.000454448 
NWMN_2500 amino acid permease family protein -1.651161002 0.000411866 
NWMN_0247 formate/nitrite transporter family protein -1.653687014 0.024135727 
NWMN_0667 fructose operon transcriptional regulator -1.654543514 0.000599733 
pryF orotidine 5'-phosphate decarboxylase -1.657265138 3.61E-06 
oppD oligopeptide transport ATP-binding protein -1.663075187 1.05E-05 
pyrE orotate phosphoribosyltransferase -1.676402185 1.66E-07 
NWMN_2442 conserved hypothetical protein -1.69293587 0.000173163 
NWMN_1604 universal stress protein family protein -1.707377783 0.000255921 
ilvB acetolactate synthase, large subunit, biosynthetic type -1.712881806 9.66E-05 
NWMN_2371 alkylhydroperoxidase AhpD family protein -1.73838802 2.74E-06 
thrA aspartate kinase -1.751819663 0.001180336 
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pyrAB carbamoyl-phosphate synthase, pyrimidine-specific, large chain -1.757400218 6.19E-08 
accB1 acetyl-CoA carboxylase, biotin carboxyl carrier protein -1.759943423 0.000330955 
NWMN_0651 conserved hypothetical protein -1.782531726 9.41E-06 
purM phosphoribosylformylglycinamidine cyclo-ligase -1.783231368 4.67E-09 
agrA staphylococcal accessory gene regulator A -1.785173008 0.001815813 
crtM squalene desaturase -1.791258451 7.44E-05 
NWMN_2074 conserved hypothetical protein -1.799324658 0.001071496 
NWMN_2419 acetyltransferase, GNAT family protein -1.806449776 0.000408182 
bsaF lantibiotic immunity protein F -1.809207258 3.56E-07 
NWMN_0041 conserved hypothetical protein -1.816609177 0.003102767 
dapD tetrahydrodipicolinate acetyltransferase -1.82076467 0.000341357 
purL phosphoribosylformylglycinamidine synthase II -1.841888681 3.70E-07 
NWMN_2087 conserved hypothetical protein -1.846756053 5.03E-08 
NWMN_0782 ABC transporter, substrate-binding protein -1.874909469 6.99E-10 
NWMN_0366 conserved hypothetical protein -1.893651874 5.17E-06 
mtlA mannitol-specific IIA component -1.897421781 2.56E-08 
oppC oligopeptide ABC transporter, permease protein -1.905169318 6.05E-07 
pyrP uracil permease -1.915224093 2.32E-05 
NWMN_0542 conserved hypothetical protein -1.918092232 2.19E-05 
trpB tryptophan synthase, beta subunit -1.931193955 2.60E-05 
ilvD dihydroxy-acid dehydratase -1.94553129 7.42E-05 
pyrC dihydroorotase multifunctional complex type -1.97385491 1.04E-06 
nrdG anaerobic ribonucleotide reductase, small subunit -1.978253283 0.002765895 
NWMN_1531 conserved hypothetical protein -1.980681121 0.000240284 
bsaE lantibiotic ABC transporter protein -1.981559033 2.80E-05 
dapB dihydrodipicolinate reductase -1.984949316 3.96E-06 
gntR gluconate operon transcriptional repressor -1.990002715 0.000382079 
NWMN_0781 ABC transporter permease protein -2.022973716 1.47E-06 
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NWMN_1526 hypothetical protein -2.023651568 3.07E-09 
NWMN_0856 oligopeptide transport system permease protein -2.033456005 2.34E-06 
NWMN_2088 conserved hypothetical protein -2.039438011 5.05E-09 
fruA fructose specific permease -2.051474127 0.0001044 
lip lipase precursor -2.069585594 0.000489429 
fruB fructose 1-phosphate kinase -2.070218725 2.84E-05 
NWMN_0603 ABC transporter ATP-binding protein -2.076279049 3.67E-09 
thiM hydroxyethylthiazole kinase -2.109538007 0.000112812 
trpF N-(5'phosphoribosyl)anthranilate isomerase -2.121818982 2.33E-06 
NWMN_1346 conserved hypothetical protein -2.149536789 0.002310932 
NWMN_2048 conserved hypothetical protein -2.154564836 2.29E-09 
NWMN_0134 conserved hypothetical protein -2.180411145 0.0008999 
argH argininosuccinate lyase -2.18849859 9.85E-06 
alsD alpha-acetolactate decarboxylase -2.188704192 1.64E-05 
ribD riboflavin biosynthesis protein RibD -2.195737152 4.33E-06 
purF amidophosphoribosyltransferase precursor -2.197870507 8.98E-11 
pyrB aspartate carbamoyltransferase catalytic subunit -2.21297817 1.87E-06 
pyrAA carbamoyl-phosphate synthase, pyrimidine-specific, small chain -2.214599589 4.34E-07 
NWMN_2502 conserved hypothetical protein -2.215517197 1.70E-05 
NWMN_0175 flavohemoprotein -2.221583234 0.001049404 
oppF oligopeptide ABC transporter, ATP-binding protein -2.223006211 4.40E-09 
NWMN_1998 transcriptional regulator TenA family protein -2.248094501 0.000453209 
argG argininosuccinate synthase -2.2828285 5.12E-05 
NWMN_2377 conserved hypothetical protein -2.285549159 0.00409883 
NWMN_1347 amino acid permease -2.297103014 0.003633173 
NWMN_0896 conserved hypothetical protein -2.334072317 1.37E-05 
NWMN_2597 conserved hypothetical protein -2.363224893 3.62E-05 
agrC staphylococcal accessory gene regulator protein C -2.416666813 0.000178072 
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asd aspartate-semialdehyde dehydrogenase -2.416914824 4.17E-06 
ald alanine dehydrogenase 2 -2.418933942 0.006765065 
NWMN_2268 L-lactate permease 2 -2.435281338 0.000919785 
ribA riboflavin biosynthesis protein -2.437071897 7.41E-06 
dapA dihydrodipicolinate synthase -2.447829364 1.76E-06 
trpC indole-3-glycerol phosphate synthase -2.458007547 2.26E-06 
narI respiratory nitrate reductase, gamma subunit -2.469668759 0.000258796 
thiD1 phosphomethylpyrimidine kinase -2.496432407 3.35E-06 
NWMN_0163 conserved hypothetical protein -2.506268785 0.010189532 
thiE thiamine-phosphate pyrophosphorylase -2.561010324 2.39E-05 
putA proline dehydrogenase -2.583472572 4.36E-05 
NWMN_0602 conserved hypothetical protein -2.596651393 2.35E-07 
ribH riboflavin synthase, beta subunit -2.60219292 2.19E-06 
ribB riboflavin synthase, alpha subunit -2.603676542 3.11E-06 
NWMN_0943 conserved hypothetical protein -2.636779722 3.16E-07 
agrD staphylococcal accessory gene regulator protein D -2.69651701 4.73E-06 
alsS alpha-acetolactate synthase -2.732019261 3.34E-06 
ldh1 L-lactate dehydrogenase -2.74287702 0.004075409 
ilvA threonine dehydratase II -2.75058395 0.001177457 
agrB staphylococcal accessory gene regulator protein B -2.824509884 6.55E-05 
adhE iron-containing alcohol dehydrogenase -2.840542572 0.000419628 
NWMN_0944 conserved hypothetical protein -2.864396841 1.55E-07 
lysC aspartokinase II -2.865536217 2.20E-06 
NWMN_0945 conserved hypothetical protein -2.870176536 1.19E-07 
NWMN_0721 sigma 54 modulation protein -3.023380113 1.17E-05 
adh1 alcohol dehydrogenase -3.203644942 0.002151334 
NWMN_2620 phenol-soluble modulin beta 2 -3.38727687 0.000324066 
cidA holin-like protein CidA -3.399602135 2.55E-08 
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hld delta-hemolysin -3.607432124 0.0002027 
pflB formate acetyltransferase -3.687382755 0.000554865 
narJ respiratory nitrate reductase, delta subunit -4.104988919 1.89E-05 
NWMN_1084 phenol-soluble modulin beta 1 -4.20471231 4.98E-05 
narH nitrate reductase beta chain -4.227760678 5.45E-06 
cysG uroporphyrin-III C-methyl transferase -4.228474397 4.54E-06 
NWMN_2616 phenol-soluble modulin alpha 4 -4.573754093 9.02E-06 
NWMN_2102 conserved hypothetical protein -4.904640643 0.001514021 
 
 
 
 
 
